EP2011864B1 - Polypeptide mit Alkalin-Alpha-Amylase-Aktivität und Nukleinsäuren, die diese codieren - Google Patents

Polypeptide mit Alkalin-Alpha-Amylase-Aktivität und Nukleinsäuren, die diese codieren Download PDF

Info

Publication number
EP2011864B1
EP2011864B1 EP08075617.4A EP08075617A EP2011864B1 EP 2011864 B1 EP2011864 B1 EP 2011864B1 EP 08075617 A EP08075617 A EP 08075617A EP 2011864 B1 EP2011864 B1 EP 2011864B1
Authority
EP
European Patent Office
Prior art keywords
polypeptide
alpha
seq
nucleic acid
amylase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP08075617.4A
Other languages
English (en)
French (fr)
Other versions
EP2011864A1 (de
Inventor
Helle Outtrup
Lisbeth Hedegaard Hoeck
Bjarne Ronfeldt Nielsen
Torben Vedel Borchert
Vibeke Skovgaard Nielsen
Henrik Bisgard-Frantzen
Allan Svendsen
Carsten Andersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/290,734 external-priority patent/US6361989B1/en
Application filed by Novozymes AS filed Critical Novozymes AS
Priority to EP14199566.2A priority Critical patent/EP2889375B1/de
Publication of EP2011864A1 publication Critical patent/EP2011864A1/de
Application granted granted Critical
Publication of EP2011864B1 publication Critical patent/EP2011864B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38609—Protease or amylase in solid compositions only

Definitions

  • the present invention relates to isolated polypeptides having alpha-amylase activity and isolated nucleic acid sequences encoding the polypeptides. Further, the invention relates to variants of the alpha-amylase of the invention. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides. Further, the invention also relates to compositions for laundry, dish wash and/or hard surface cleaning.
  • alpha-amylase enzymes have been used for a variety of different purposes, the most important of which are starch liquefaction, textile desizing, starch modification in the paper and pulp industry, and for brewing and baking.
  • a further use of alpha-amylases, which is becoming increasingly important, is the removal of starchy stains during washing with a detergent at alkaline pH.
  • alpha-amylase products examples include Termamyl TM , Duramyl TM , Natalase TM , BAN TM and Fungamyl TM , all available from Novo Nordisk A/S, Denmark. These and similar products from other commercial sources have an acidic to a neutral pH optimum, typically in the range of from pH 5 to pH 7.5, and they do not display optimal activity in detergent solutions at alkaline pH.
  • WO 95/26397 discloses an alpha-amylase from a Bacillus strain.
  • WO 96/23873 describes variants of Bacillus amylases with improved performance under washing conditions.
  • WO 97/00324 discloses a gene encoding an alkaline liquefying alpha-amylase derived from Bacillus sp. strain KSM-AP1378 with the deposited no. FERM BP-3048 suitable for detergents.
  • the present invention relates to an isolated polypeptide having alpha-amylase activity comprising the amino acid sequence of SEQ ID NO:2 and variants thereof having an amino acid sequence which has at least 96% identity with amino acids 1 to 485 of SEQ ID NO: 2, wherein the variant has an improved wash performance in comparison to the parent alpha-amylase, where the wash performance is determined under the following wash conditions: test swatches soiled with orange rice starch are washed for 15 minutes at 25°C at a pH of 10.5, a water hardness of 6 °dH and a Ca:Mg ratio of 2:1 in a solution of 3g/l A/P Model detergent consisting of: 20% sodium tripolyphosphate, 25% Na2SO4, 15% Na2CO3, 20% linear alkyl benzene sulfonate, 5% C12-C15 alcohol ethoxylate, 5% Na2Si2O5 and 0.3% NaCI, containing 1 mg/l of the polypeptide having alpha-amylase activity; after washing the s
  • the present invention also relates to isolated nucleic acid sequences encoding the polypeptides and to nucleic acid constructs, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides.
  • the alkaline alpha-amylase of the invention may be derived from a strain of Bacillus.
  • Preferred strains are of Bacillus sp. DSM 12649 (the AA560 alpha-amylase) or Bacillus sp. DSM 12648 (the AA349 alpha-amylase). These strains were deposited on 25 th January 1999 by the inventors under the terms of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure at Deutshe Sammmlung von Microorganismen und Zellkulturen GmbH (DSMZ), Mascheroder Weg 1b, D-38124 Braunschweig DE.
  • DSMZ Sammmlung von Microorganismen und Zellkulturen GmbH
  • Alpha-amylases (alpha-1,4-glucan-4-glucanohydrolases, EC 3.2.1.1) constitute a group of enzymes, which catalyze hydrolysis of starch and other linear and branched 1,4-glucosidic oligo- and polysaccharides.
  • alpha-amylase activity is determined using the Phadebas assay or the pNPG7 assay described below in the "Materials and Methods" section.
  • the present invention relates to isolated polypeptides comprising the amino acid sequence of SEQ ID NO:2 (i.e., the mature polypeptide) and variants thereof having at least about 96%, preferably at least about 97%, more preferably at least about 98%, even more preferably at least about 99% identity with amino acids 1 to 485 of SEQ ID NO:2, which have alpha-amylase activity (hereinafter "homologous polypeptides"), and which have an improved wash performance in comparision to the parent alpha-amylase as defined above.
  • homologous polypeptides which have alpha-amylase activity
  • the variants have an amino acid sequence which differs by five amino acids, preferably by four amino acids, more preferably by three amino acids, even more preferably by two amino acids, and most preferably by one amino acid from amino acids 1 to 485 of SEQ ID NO:2 or SEQ ID NO: 4.
  • SEQ ID NO: 2 and SEQ ID NO: 4 are identical.
  • the DNA sequences, i.e. , SEQ ID NO: 1 and SEQ ID NO: 3, respectively, encoding the alpha-amylase of the invention shown in SEQ ID NO: 2 and SEQ ID NO: 4 are not identical.
  • the amino acid sequence homology may be determined as the degree of homology between the two sequences indicating a derivation of the first sequence from the second.
  • the homology may suitably be determined by means of computer programs known in the art.
  • GAP provided in GCG version 8 ( Needleman, S.B. and Wunsch, C.D., (1970), Journal of Molecular Biology, 48, 443-453 ) may be used for a pairwise alignment of the sequences and calculation of the degree of identity or degree of homology using the default settings.
  • the gap settings may be the following parameters: gap creation penalty of 5.0 and gap extension penalty of 0.3.
  • a homology search of known sequences showed homologies for the sequences of the invention with a number of Bacillus amylases in the range 65-95 % on amino acid basis determined as described above.
  • the most homologous alpha-amylases found are SP690 (SEQ ID NO: 1 of US patent no. 5,856,164 which is about 87% homologous), SP722 (SEQ ID NO: 2 of US patent no. 5,856,164 which is about 87% homologous), the mature part (i.e., amino acids no. 31-516) of the alpha-amylase obtained from Bacillus sp. KSM-AP1378 disclosed as SEQ ID NO: 2 of WO 97/00324 which is about 86% homologous, and the alpha-amylase disclosed in Tsukamoto et. al., (1988), Biochem. Biophys. Res Commun. 151, p. 25-33 ) (shown as sequence "707 amy" in the alignment in fig. 1 ) which is about 95% homologous to SEQ ID NO: 2 and SEQ ID NO: 4 determined as describe above.
  • polypeptides which comprise the amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 4 or allelic variants thereof; or fragments thereof that has alpha-amylase activity.
  • SEQ ID NO: 2 and SEQ ID NO: 4 show the mature part of the alkaline alpha-amylases of the invention.
  • a fragment of SEQ ID NO:2 or SEQ ID NO: 4 are polypeptides having one or more amino acids deleted from the amino and/or carboxyl terminus of this amino acid sequence.
  • allelic variant denotes any of two or more alternative forms of a gene occupying the same chromosomal locus. Allelic variation arises naturally through mutation, and may result in polymorphism within populations. Gene mutations can be silent (no change in the encoded polypeptide) or may encode polypeptides having altered amino acid sequences.
  • An allelic variant of a polypeptide is a polypeptide encoded by an allelic variant of a gene.
  • amino acid sequences of the homologous polypeptides may differ from the amino acid sequence of SEQ ID NO:2 or SEQ ID NO: 4 by an insertion or deletion of one or more amino acid residues and/or the substitution of one or more amino acid residues by different amino acid residues.
  • amino acid changes are of a minor nature, that is conservative amino acid substitutions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of one to about 30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino-terminal methionine residue; a small linker peptide of up to about 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding domain.
  • conservative substitutions are within the group of basic amino acids (arginine, lysine and histidine), acidic amino acids (glutamic acid and aspartic acid), polar amino acids (glutamine and asparagine), hydrophobic amino acids (leucine, isoleucine and valine), aromatic amino acids (phenylalanine, tryptophan and tyrosine), and small amino acids (glycine, alanine, serine, threonine and methionine).
  • Amino acid substitutions which do not generally alter the specific activity are known in the art and are described, for example, by H. Neurath and R.L. Hill, 1979, In, The Proteins, Academic Press, New York .
  • the most commonly occurring exchanges are Ala/Ser, Val/Ile, Asp/Glu, Thr/Ser, Ala/Gly, Ala/Thr, Ser/Asn, Ala/Val, Ser/Gly, Tyr/Phe, Ala/Pro, Lys/Arg, Asp/Asn, Leu/Ile, Leu/Val, Ala/Glu, and Asp/Gly as well as these in reverse.
  • isolated polypeptides having alpha-amylase activity which are encoded by nucleic acid sequences which hybridize under medium stringency conditions, preferably medium-high stringency conditions, more preferably high stringency conditions, and most preferably very high stringency conditions with a nucleic acid probe which hybridizes under the same conditions with (i) the nucleic acid sequence of SEQ ID NO: 1 or SEQ ID NO: 3, (ii) the cDNA sequence of SEQ ID NO:1 or SEQ ID NO: 3, (iii) a subsequence of (i) or (ii), or (iv) a complementary strand of (i), (ii), or (iii) ( J. Sambrook, E.F. Fritsch, and T.
  • the subsequence of SEQ ID NO:1 may be at least 100 nucleotides or preferably at least 200 nucleotides. Moreover, the subsequence may encode a polypeptide fragment, which has alpha-amylase activity. The polypeptides may also be allelic variants or fragments of the polypeptides that have alpha-amylase activity.
  • nucleic acid sequence of SEQ ID NO:1 or SEQ ID NO: 3 or a subsequence thereof, as well as the amino acid sequence of SEQ ID NO:2 or SEQ ID NO: 4 or a fragment thereof, may be used to design a nucleic acid probe to identify and clone DNA encoding polypeptides having alpha-amylase activity from strains of different genera or species according to methods well known in the art.
  • probes can be used for hybridization with the genomic or cDNA of the genus or species of interest, following standard Southern blotting procedures, in order to identify and isolate the corresponding gene therein.
  • probes can be considerably shorter than the entire sequence, but should be at least 15, preferably at least 25, and more preferably at least 35 nucleotides in length. Longer probes can also be used. Both DNA and RNA probes can be used.
  • the probes are typically labeled for detecting the corresponding gene (for example, with 32 P, 3 H, 35 S, biotin, or avidin). Such probes are encompassed by the present invention.
  • genomic DNA or cDNA library prepared from such other organisms may be screened for DNA, which hybridizes with the probes described above and which encodes a polypeptide having alpha-amylase activity.
  • Genomic or other DNA from such other organisms may be separated by agarose or polyacrylamide gel electrophoresis, or other separation techniques.
  • DNA from the libraries or the separated DNA may be transferred to and immobilized on nitrocellulose or other suitable carrier material.
  • the carrier material is used in a Southern blot.
  • hybridization indicates that the nucleic acid sequence hybridizes to a nucleic acid probe corresponding to the nucleic acid sequence shown in SEQ ID NO:1 or SEQ ID NO: 3, its complementary strand, or subsequences thereof, under medium to very high stringency conditions. Molecules to which the nucleic acid probe hybridizes under these conditions are detected using X-ray film.
  • the nucleic acid probe is the nucleic acid sequence contained in plasmids pLiH1274 (AA349) or pTVB299 (AA560) which are contained in Escherichia coli DSM12761 or Escherichia coli DSM12764, respectively, or, wherein the nucleic acid sequence encodes a polypeptide having acid alpha-amylase activity of the invention and shown in SEQ ID NO: 2 and SEQ ID NO: 4, respectively.
  • medium to very high stringency conditions are defined as prehybridization and hybridization at 42°C in 5X SSPE, 0.3% SDS, 200 micro g/ml sheared and denatured salmon sperm DNA, 35% formamide for medium and medium-high stringencies, or 50% formamide for high and very high stringencies, following standard Southern blotting procedures.
  • the carrier material is finally washed three times each for 15 minutes using 2 x SSC, 0.2% SDS preferably at least at 55°C (medium stringency), preferably at least at 60°C (medium-high stringency), more preferably at least at 65°C (high stringency), and most preferably at least at 70°C (very high stringency).
  • stringency conditions are defined as prehybridization, hybridization, and washing post-hybridization at 5°C to 10°C below the calculated T m using the calculation according to Bolton and McCarthy (1962, Proceedings of the National Academy of Sciences USA 48:1390 ) in 0.9 M NaCl, 0.09 M Tris-HCl pH 7.6, 6 mM EDTA, 0.5% NP-40, 1X Denhardt's solution, 1 mM sodium pyrophosphate, 1 mM sodium monobasic phosphate, 0.1 mM ATP, and 0.2 mg of yeast RNA per ml following standard Southern blotting procedures.
  • the carrier material is washed once in 6X SCC plus 0.1% SDS for 15 minutes and twice each for 15 minutes using 6X SSC at 5°C to 10°C below the calculated T m .
  • the present invention relates to isolated polypeptides, i.e., the polypeptides shown in SEQ ID NO: 2 or SEQ ID NO: 4, having the following physicochemical properties:
  • a pH optimum (see Fig. 2 ) determined using the Phadebas method (37°C) was found to be in the range between pH 8 and 9, more precisely at about 8.5.
  • a temperature optimum (See Fig. 3 ) determined using the Phasebas method (pH 9.0) was found to be in the range between 55 and 65°C, more precisely about 60°C.
  • a pI between 7-8 was determined by isoelectric focusing (Pharmacia, Ampholine, pH 3.5-9.3).
  • a specific activity (see Table 1 of Example 6) of 35,000 NU/mg was determined using the Phadebas method and 6,000 NU/mg using the pNPG7 method.
  • polypeptides disclosed herein have at least 20%, preferably at least 40%, more preferably at least 60%, even more preferably at least 80%, even more preferably at least 90%, and most preferably at least 100% of the alpha-amylase activity of the mature polypeptide shown in SEQ ID NO: 2 and SEQ ID NO: 4.
  • a polypeptide of the present invention may be obtained from microorganisms of any genus.
  • the term "obtained from” as used herein in connection with a given source shall mean that the polypeptide encoded by the nucleic acid sequence is produced by the source or by a cell in which the nucleic acid sequence from the source has been inserted.
  • a polypeptide of the present invention is a bacterial polypeptide.
  • the polypeptide may be a gram positive bacterial polypeptide such as a Bacillus polypeptide, e.g. , a Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus coagulans, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus stearothermophilus, Bacillus subtilis, or Bacillus thuringiensis polypeptide; or a Streptomyces polypeptide, e.g.
  • a Streptomyces lividans or Streptomyces murinus polypeptide or a gram negative bacterial polypeptide, e.g. , an E. coli or a Pseudomonas sp. polypeptide.
  • polypeptide is a Bacillus sp. polypeptide
  • polypeptide is a Bacillus sp. DSM 12648 or Bacillus sp. DSM 12649 polypeptide, e.g. , the polypeptides with the amino acid sequence of SEQ ID NO: 2 and SEQ ID NO: 4, respectively.
  • the invention encompasses both the perfect and imperfect states, and other taxonomic equivalents, e.g. , anamorphs, regardless of the species name by which they are known. Those skilled in the art will readily recognize the identity of appropriate equivalents.
  • ATCC American Type Culture Collection
  • DSM Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH
  • CBS Centraalbureau Voor Schimmelcultures
  • NRRL Northern Regional Research Center
  • polypeptides may be identified and obtained from other sources including microorganisms isolated from nature (e.g. , soil, composts, water, etc.) using the above-mentioned probes. Techniques for isolating microorganisms from natural habitats are well known in the art.
  • the nucleic acid sequence may then be derived by in a similar manner screening a genomic or cDNA library of another microorganism. Once a nucleic acid sequence encoding a polypeptide has been detected with the probe(s), the sequence may be isolated or cloned by utilizing techniques which are known to those of ordinary skill in the art (see, e.g. , Sambrook et al. , 1989, supra ).
  • an "isolated" polypeptide is a polypeptide which is essentially free of other non-alpha-amylase polypeptides, e.g. , at least about 20% pure, preferably at least about 40% pure, more preferably about 60% pure, even more preferably about 80% pure, most preferably about 90% pure, and even most preferably about 95% pure, as determined by SDS-PAGE.
  • Polypeptides encoded by nucleic acid sequences of the present invention also include fused polypeptides or cleavable fusion polypeptides in which another polypeptide is fused at the N-terminus or the C-terminus of the polypeptide or fragment thereof.
  • a fused polypeptide is produced by fusing a nucleic acid sequence (or a portion thereof) encoding another polypeptide to a nucleic acid sequence (or a portion thereof) of the present invention.
  • Techniques for producing fusion polypeptides are known in the art, and include ligating the coding sequences encoding the polypeptides so that they are in frame and that expression of the fused polypeptide is under control of the same promoter(s) and terminator.
  • improved wash performance means in the context of the polypeptide with the amino acid of SEQ ID NO.2 a performance determined under the washing conditions described in Example 8, which is higher than other alpha-amylase used for washing, e.g., SP690, SP722 and Termamyl ® , or in the case of a mutant/variant of the invention in comparison to the parent alpha-amylase, i.e., the un-mutated, such as un-substituted alpha-amylase backbone.
  • Invention also relates to a mutant of the alpha-amylases (i.e., alpha-amylase variants) shown in SEQ ID NO: 2.
  • the mutant alpha-amylase of to the invention is characterized by the fact that one or more of the Methionine amino acid residues is exchanged with any amino acid residue except for Cys and Met.
  • the amino acid residues to replace the methionine amino acid residue are the following: Ala, Arg, Asn, Asp, Gln, Glu, Gly, His, Ile, Leu, Lys, Phe, Pro, Ser, Thr, Trp, Tyr, and Val.
  • a preferred embodiment of the mutant alpha-amylase of the invention is characterized by the fact that one or more of the Methionine amino acid residues is (are) exchanged with a Leu, Thr, Ala, Gly, Ser, Ile, or Val amino acid residue, preferably a Leu, Thr, Ala, or Gly amino acid residue.
  • a very satisfactory activity level and stability in the presence of oxidizing agents is obtained.
  • one or more of the Methionines in the following position may be replaced or deleted using any suitable technique known in the art, including especially site directed mutagenesis and gene shuffling. Contemplated position, using the SEQ ID NO: 2 numbering, are: 9, 10, 105, 116, 202, 208, 261, 309, 323, 382, 430, 440.
  • the mutant alpha-amylase of the invention is characterized by the fact that the Methionine amino acid residue at position 202 is exchanged with any of amino acid residue expect for Cys and Met, preferably with a Leu, Thr, Ala, Gly, Ser, Ile, or Asp.
  • Other contemplated preferred mutations include deletion of one, two or more residues of amino acids R181, G182, D183 or G184, K185, G186 or substitution of one or more of these residues.
  • a preferred mutation is the deletion of D183-G184.
  • Particularly relevant mutations are substitutions of G186 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, and Val.
  • a particularly preferred substitution is G186R.
  • N195F substitution of N195 with Ala, Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr, and Val.
  • a particularly interesting substitution is N195F.
  • deletion of (D183-G184)+N195F deletion of (D183-G184)+G186R ; deletion of (D183-G184)+G186R+N195F, and G186R+N195F.
  • Mutations resulting in variants of the invention, e.g., having increased thermostability, in particular at acidic pH and/or at low Ca 2+ concentration include mutations at the following positions (using the AA560 alpha-amylase numbering, i.e., SEQ ID NO: 2): R158, N174, G186, N195, N197, H210, E212, V214, V215, E216, K269, N270.
  • acidic pH means a pH below 7.0, especially below the pH range, in which industrial starch liquefaction processes are normally performed, which is between pH 5.5 and 6.2.
  • low Calcium concentration means concentrations below the normal level used in industrial starch liquefaction. Normal concentrations vary depending of the concentration of free Ca 2+ in the corn. Normally a dosage corresponding to 1 mM (40ppm) is added which together with the level in corn gives between 40 and 60ppm free Ca 2+ .
  • high temperatures means temperatures between 95°C and 160°C, especially the temperature range in which industrial starch liquefaction processes are normally performed, which is between 95°C and 105°C.
  • thermostability in particular at acidic pH and/or at low Ca 2+ concentration can be increased even more by combining other mutations including the above-mentioned mutations and/or I206 with each other.
  • Said "other" mutations are the following (relative to the AA560 alpha-amylase, SEQ ID NO: 2): N195, E212, E216, K269 and I206.
  • Said mutation may further be combined with deletions in one, preferably two or even three positions as described in WO 96/23873 ( i.e. , in positions R181, G182, D183, G184 in SEQ ID NO: 2 herein).
  • variants of a parent AA560 alpha-amylase with alpha-amylase activity comprise mutations in two, three, four, five, six or seven of the above positions are contemplated.
  • alpha-amylases having a degree of homologous (identical) as defined below are contemplated to be within the scope of the present invention.
  • amino acid residues, respectively, at positions corresponding to N195, I206, E212 and E216, respectively, in SEQ ID NO: 2 constitute amino acid residues, which are conserved in numerous Termamyl-like alpha-amylases, i.e., Termamyl ® ( B. licheniformis alpha-amylase).
  • Termamyl ® B. licheniformis alpha-amylase
  • the corresponding positions of residues in AA560 and Termamyl can be see in the alignment in Fig. 1 and in Table 1 and Table 2, below. Table 1.
  • licheniformis (Termamyl) N190 I201 H205 E211 N265 AA560 (SEQ ID NO: 5) N195 I206 H210 E211 N270 Table 2.
  • Termamyl-like alpha-amylase SP690 R181, G182, T183, G184, K185, A186 SP722 R181, G182, D183, G184, K185, A186 AA560 (SEQ ID NO: 2) R181, G182, D183, G184, K185, G186
  • SEQ ID NO: 2 When using SEQ ID NO: 2 for numbering two, three, four, five, six or seven mutations may according to the invention be made in the following positions to alter the properties, in particular to increase the thermostability at acidic pH and/or at low Ca 2+ concentrations (relative to SEQ ID NO: 2 herein):
  • Contemplated according to the present invention is combining three, four, five, six or seven mutations.
  • the variant comprises the following mutations: N195F/K264S in SEQ ID NO: 2 or in corresponding positions in 96% homologous alpha-amylases as defined herein.
  • the variant of the invention comprises the following mutations: R181*/G182*/N195F in SEQ ID NO: 2 or in corresponding positions in another homologous alpha-amylases. Said variant may further comprise a substitution in position E216Q.
  • Improved Ca 2+ stability means the stability of the enzyme under Ca 2+ depletion has been improved.
  • mutations including amino acid substitutions and deletions
  • mutations and/or deletions disclosed above in the section "increased thermostability" .
  • a variant of the invention comprises one or more modifications in addition to those outlined above.
  • one or more proline residues present in the part of the alpha-amylase variant which is modified is/are replaced with a non-proline residue which may be any of the possible, naturally occurring non-proline residues, and which preferably is an alanine, glycine, serine, threonine, valine or leucine.
  • cysteine residues present among the amino acid residues with which the parent alpha-amylase is modified is/are replaced with a non-cysteine residue such as serine, alanine, threonine, glycine, valine or leucine.
  • a variant of the invention may - either as the only modification or in combination with any of the above outlined modifications - be modified so that one or more Asp and/or Glu present in an amino acid fragment corresponding to the amino acid fragment 190-214 of SEQ ID NO: 2 is replaced by an Asn and/or Gln, respectively. Also of interest is the replacement, in the alpha-amylase, of one or more of the Lys residues present in an amino acid fragment corresponding to the amino acid fragment 190-214 of SEQ ID NO: 2 by an Arg.
  • Mutations may suitably include mutations in the following positions: Y133, L17, M202, V214.
  • the DNA sequence encoding a parent alpha-amylase as defined above may be isolated from any cell or microorganism producing the alpha-amylase in question, using various methods well known in the art.
  • a genomic DNA and/or cDNA library should be constructed using chromosomal DNA or messenger RNA from the organism that produces the alpha-amylase to be studied.
  • homologous, labelled oligonucleotide probes may be synthesized and used to identify alpha-amylase-encoding clones from a genomic library prepared from the organism in question.
  • a labelled oligonucleotide probe containing sequences homologous to a known alpha-amylase gene could be used as a probe to identify alpha-amylase-encoding clones, using hybridization and washing conditions of lower stringency.
  • Yet another method for identifying alpha-amylase-encoding clones would involve inserting fragments of genomic DNA into an expression vector, such as a plasmid, transforming alpha-amylase-negative bacteria with the resulting genomic DNA library, and then plating the transformed bacteria onto agar containing a substrate for alpha-amylase, thereby allowing clones expressing the alpha-amylase to be identified.
  • an expression vector such as a plasmid
  • transforming alpha-amylase-negative bacteria with the resulting genomic DNA library
  • the DNA sequence encoding the enzyme may be prepared synthetically by established standard methods, e.g. the phosphoroamidite method described by S.L. Beaucage and M.H. Caruthers (1981) or the method described by Matthes et al. (1984).
  • phosphoroamidite method oligonucleotides are synthesized, e.g., in an automatic DNA synthesizer, purified, annealed, ligated and cloned in appropriate vectors.
  • the DNA sequence may be of mixed genomic and synthetic origin, mixed synthetic and cDNA origin or mixed genomic and cDNA origin, prepared by ligating fragments of synthetic, genomic or cDNA origin (as appropriate, the fragments corresponding to various parts of the entire DNA sequence), in accordance with standard techniques.
  • the DNA sequence may also be prepared by polymerase chain reaction (PCR) using specific primers, for instance as described in US 4,683,202 or R.K. Saiki et al. (1988 ).
  • mutations may be introduced using synthetic oligonucleotides. These oligonucleotides contain nucleotide sequences flanking the desired mutation sites; mutant nucleotides are inserted during oligonucleotide synthesis.
  • a single-stranded gap of DNA, bridging the alpha-amylase-encoding sequence is created in a vector carrying the alpha-amylase gene.
  • the synthetic nucleotide, bearing the desired mutation is annealed to a homologous portion of the single-stranded DNA.
  • Random mutagenesis is suitably performed either as localised or region-specific random mutagenesis in at least three parts of the gene translating to the amino acid sequence shown in question, or within the whole gene.
  • the random mutagenesis of a DNA sequence encoding a parent alpha-amylase may be conveniently performed by use of any method known in the art.
  • a further aspect of the present invention relates to a method for generating a variant of a parent alpha-amylase, e.g. wherein the variant exhibits altered or increased thermal stability relative to the parent, the method comprising:
  • Step (a) of the above method of the invention is preferably performed using doped primers.
  • the random mutagenesis may be performed by use of a suitable physical or chemical mutagenizing agent, by use of a suitable oligonucleotide, or by subjecting the DNA sequence to PCR generated mutagenesis.
  • the random mutagenesis may be performed by use of any combination of these mutagenizing agents.
  • the mutagenizing agent may, e.g ., be one that induces transitions, transversions, inversions, scrambling, deletions, and/or insertions.
  • Examples of a physical or chemical mutagenizing agent suitable for the present purpose include ultraviolet (UV) irradiation, hydroxylamine, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), O-methyl hydroxylamine, nitrous acid, ethyl methane sulphonate (EMS), sodium bisulphite, formic acid, and nucleotide analogues.
  • UV ultraviolet
  • MNNG N-methyl-N'-nitro-N-nitrosoguanidine
  • EMS ethyl methane sulphonate
  • sodium bisulphite formic acid
  • nucleotide analogues examples include ultraviolet (UV) irradiation, hydroxylamine, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), O-methyl hydroxylamine, nitrous acid, ethyl methane sulphonate (EMS), sodium bisulphite, formic acid, and nucleotide ana
  • the oligonucleotide may be doped or spiked with the three non-parent nucleotides during the synthesis of the oligonucleotide at the positions which are to be changed.
  • the doping or spiking may be done so that codons for unwanted amino acids are avoided.
  • the doped or spiked oligonucleotide can be incorporated into the DNA encoding the alpha-amylase enzyme by any published technique, using e.g. PCR, LCR or any DNA polymerase and ligase as deemed appropriate.
  • the doping is carried out using "constant random doping", in which the percentage of wild-type and mutation in each position is predefined.
  • the doping may be directed toward a preference for the introduction of certain nucleotides, and thereby a preference for the introduction of one or more specific amino acid residues.
  • the doping may be made, e.g. , so as to allow for the introduction of 90% wild type and 10% mutations in each position.
  • An additional consideration in the choice of a doping scheme is based on genetic as well as protein-structural constraints.
  • the doping scheme may be made using the DOPE program (see “Material and Methods" section), which, inter alia , ensures that introduction of stop codons is avoided.
  • PCR-generated mutagenesis When PCR-generated mutagenesis is used, either a chemically treated or non-treated gene encoding a parent alpha-amylase is subjected to PCR under conditions that increase the misincorporation of nucleotides (Deshler 1992; Leung et al., Technique, Vol.1, 1989, pp. 11-15 ).
  • a mutator strain of E. coli Fowler et al., Molec. Gen. Genet., 133, 1974, pp. 179-191
  • S. cereviseae or any other microbial organism may be used for the random mutagenesis of the DNA encoding the alpha-amylase by, e.g. , transforming a plasmid containing the parent glycosylase into the mutator strain, growing the mutator strain with the plasmid and isolating the mutated plasmid from the mutator strain. The mutated plasmid may be subsequently transformed into the expression organism.
  • the DNA sequence to be mutagenized may be conveniently present in a genomic or cDNA library prepared from an organism expressing the parent alpha-amylase.
  • the DNA sequence may be present on a suitable vector such as a plasmid or a bacteriophage, which as such may be incubated with or otherwise exposed to the mutagenising agent.
  • the DNA to be mutagenized may also be present in a host cell either by being integrated in the genome of said cell or by being present on a vector harboured in the cell.
  • the DNA to be mutagenized may be in isolated form. It will be understood that the DNA sequence to be subjected to random mutagenesis is preferably a cDNA or a genomic DNA sequence.
  • telomere amplification may be performed in accordance with methods known in the art, the presently preferred method being PCR-generated amplification using oligonucleotide primers prepared on the basis of the DNA or amino acid sequence of the parent enzyme.
  • the mutated DNA is expressed by culturing a suitable host cell carrying the DNA sequence under conditions allowing expression to take place.
  • the host cell used for this purpose may be one which has been transformed with the mutated DNA sequence, optionally present on a vector, or one which was carried the DNA sequence encoding the parent enzyme during the mutagenesis treatment.
  • suitable host cells are the following: gram positive bacteria such as Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Bacillus stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus circulans, Bacillus lautus, Bacillus megaterium, Bacillus thuringiensis, Streptomyces lividans or Streptomyces murinus; and gram-negative bacteria such as E. coli.
  • gram positive bacteria such as Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Bacillus stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus circulans, Bacillus lautus, Bacillus megaterium, Bacillus thuringiensis, Streptomyces livi
  • the mutated DNA sequence may further comprise a DNA sequence encoding functions permitting expression of the mutated DNA sequence.
  • the random mutagenesis may be advantageously localized to a part of the parent alpha-amylase in question. This may, e.g. , be advantageous when certain regions of the enzyme have been identified to be of particular importance for a given property of the enzyme, and when modified are expected to result in a variant having improved properties. Such regions may normally be identified when the tertiary structure of the parent enzyme has been elucidated and related to the function of the enzyme.
  • the localized, or region-specific, random mutagenesis is conveniently performed by use of PCR generated mutagenesis techniques as described above or any other suitable technique known in the art.
  • the DNA sequence encoding the part of the DNA sequence to be modified may be isolated, e.g. , by insertion into a suitable vector, and said part may be subsequently subjected to mutagenesis by use of any of the mutagenesis methods discussed above.
  • a DNA sequence encoding the variant produced by methods described above, or by any alternative methods known in the art can be expressed, in enzyme form, using an expression vector which typically includes control sequences encoding a promoter, operator, ribosome binding site, translation initiation signal, and, optionally, a repressor gene or various activator genes.
  • the recombinant expression vector carrying the DNA sequence encoding an alpha-amylase variant of the invention may be any vector which may conveniently be subjected to recombinant DNA procedures, and the choice of vector will often depend on the host cell into which it is to be introduced.
  • the vector may be an autonomously replicating vector, i.e. a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid, a bacteriophage or an extrachromosomal element, minichromosome or an artificial chromosome.
  • the vector may be one which, when introduced into a host cell, is integrated into the host cell genome and replicated together with the chromosome(s) into which it has been integrated.
  • the DNA sequence should be operably connected to a suitable promoter sequence.
  • the promoter may be any DNA sequence, which shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
  • Suitable promoters for directing the transcription of the DNA sequence encoding an alpha-amylase variant of the invention, especially in a bacterial host are the promoter of the lac operon of E.coli, the Streptomyces coelicolor agarase gene dagA promoters, the promoters of the Bacillus licheniformis alpha-amylase gene ( amyL ), the promoters of the Bacillus stearothermophilus maltogenic amylase gene ( amyM ), the promoters of the Bacillus amyloliquefaciens alpha-amylase ( amyQ ), the promoters of the Bacillus subtilis xylA and xylB genes etc.
  • useful promoters are those derived from the gene encoding A. oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, A. niger neutral alpha-amylase, A. niger acid stable alpha-amylase, A. niger glucoamylase, Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose phosphate isomerase or A. nidulans acetamidase.
  • the expression vector of the invention may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably connected to the DNA sequence encoding the alpha-amylase variant of the invention. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter.
  • the vector may further comprise a DNA sequence enabling the vector to replicate in the host cell in question.
  • a DNA sequence enabling the vector to replicate in the host cell in question. Examples of such sequences are the origins of replication of plasmids pUC19, pACYC177, pUB110, pE194, pAMB1 and pIJ702.
  • the vector may also comprise a selectable marker, e.g. a gene the product of which complements a defect in the host cell, such as the dal genes from B. subtilis or B. licheniformis, or one which confers antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracyclin resistance.
  • a selectable marker e.g. a gene the product of which complements a defect in the host cell, such as the dal genes from B. subtilis or B. licheniformis, or one which confers antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracyclin resistance.
  • the vector may comprise Aspergillus selection markers such as amdS, argB, niaD and sC, a marker giving rise to hygromycin resistance, or the selection may be accomplished by co-transformation, e.g., as described in WO 91/17243 .
  • Bacillus alpha-amylases mentioned herein comprise a preregion permitting secretion of the expressed protease into the culture medium. If desirable, this preregion may be replaced by a different preregion or signal sequence, conveniently accomplished by substitution of the DNA sequences encoding the respective preregions.
  • the cell of the invention is advantageously used as a host cell in the recombinant production of an alpha-amylase variant of the invention.
  • the cell may be transformed with the DNA construct of the invention encoding the variant, conveniently by integrating the DNA construct (in one or more copies) in the host chromosome. This integration is generally considered to be an advantage as the DNA sequence is more likely to be stably maintained in the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g., by homologous or heterologous recombination. Alternatively, the cell may be transformed with an expression vector as described above in connection with the different types of host cells.
  • the cell of the invention may be a cell of a higher organism such as a mammal or an insect, but is preferably a microbial cell, e.g. , a bacterial or a fungal (including yeast) cell.
  • a microbial cell e.g. , a bacterial or a fungal (including yeast) cell.
  • suitable bacteria are grampositive bacteria such as Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Bacillus stearothermophilus,Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus circulans, Bacillus lautus, Bacillus megaterium, Bacillus thuringiensis, or Streptomyces lividans or Streptomyces murinus, or gramnegative bacteria such as E.coli .
  • the transformation of the bacteria may, for instance, be effected by protoplast transformation or by using competent cells in a manner known per se.
  • the yeast organism may favourably be selected from a species of Saccharomyces or Schizosaccharomyces, e.g., Saccharomyces cerevisiae.
  • the filamentous fungus may advantageously belong to a species of Aspergillus, e.g., Aspergillus oryzae or Aspergillus niger.
  • Fungal cells may be transformed by a process involving protoplast formation and transformation of the protoplasts followed by regeneration of the cell wall in a manner known per se. A suitable procedure for transformation of Aspergillus host cells is described in EP 238 023 .
  • the present invention relates to a method of producing an alpha-amylase variant of the invention, which method comprises cultivating a host cell as described above under conditions conducive to the production of the variant and recovering the variant from the cells and/or culture medium.
  • the medium used to cultivate the cells may be any conventional medium suitable for growing the host cell in question and obtaining expression of the alpha-amylase variant of the invention. Suitable media are available from commercial suppliers or may be prepared according to published recipes ( e.g. as described in catalogues of the American Type Culture Collection).
  • the alpha-amylase variant secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating proteinaceous components of the medium by means of a salt such as ammonium sulphate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
  • the present invention also relates to isolated nucleic acid sequences, which encode a polypeptide of the present invention.
  • the nucleic acid sequence is set forth in SEQ ID NO: 1.
  • the nucleic acid sequence is the sequence contained in plasmid pLiH1274 or plasmid pTVB299 that is contained in Escherichia coli DSM12761 and Escherichia coli DSM12764, respectively.
  • the nucleic acid sequence is the mature polypeptide coding region of SEQ ID NO:1.
  • the present invention also encompasses nucleic acid sequences which encode a polypeptide having the amino acid sequence of SEQ ID NO:2 which differ from SEQ ID NO:1 or SEQ ID NO: 3 by virtue of the degeneracy of the genetic code. Also disclosed are subsequences of SEQ ID NO:1 or SEQ ID NO: 3 which encode fragments of SEQ ID NO:2 or SEQ ID NO: 4, respectively, that have alpha-amylase activity.
  • Subsequences of SEQ ID NO:1 or SEQ ID NO: 3 are nucleic acid sequences encompassed by SEQ ID NO: 1 or SEQ ID NO: 3 except that one or more nucleotides from the 5' and/or 3' end have been deleted.
  • the present invention also relates to mutant nucleic acid sequences comprising at least one mutation in the mature polypeptide coding sequence of SEQ ID NO:1, in which the mutant nucleic acid sequence encodes a polypeptide which consists of amino acids 1 to 485 of SEQ ID NO: 2.
  • the techniques used to isolate or clone a nucleic acid sequence encoding a polypeptide include isolation from genomic DNA, preparation from cDNA, or a combination thereof.
  • the cloning of the nucleic acid sequences of the present invention from such genomic DNA can be effected, e.g. , by using the well-known polymerase chain reaction (PCR) or antibody screening of expression libraries to detect cloned DNA fragments with shared structural features. See, e.g. , Innis et al., 1990, PCR: A Guide to Methods and Application, Academic Press, New York .
  • nucleic acid amplification procedures such as ligase chain reaction (LCR), ligated activated transcription (LAT) and nucleic acid sequence-based amplification (NASBA) may be used.
  • LCR ligase chain reaction
  • LAT ligated activated transcription
  • NASBA nucleic acid sequence-based amplification
  • the nucleic acid sequence may be cloned from a strain of Bacillus, or another or related organism and thus, for example, may be an allelic or species variant of the polypeptide encoding region of the nucleic acid sequence.
  • isolated nucleic acid sequence refers to a nucleic acid sequence which is essentially free of other nucleic acid sequences, e.g. , at least about 20% pure, preferably at least about 40% pure, more preferably at least about 60% pure, even more preferably at least about 80% pure, and most preferably at least about 90% pure as determined by agarose electrophoresis.
  • an isolated nucleic acid sequence can be obtained by standard cloning procedures used in genetic engineering to relocate the nucleic acid sequence from its natural location to a different site where it will be reproduced.
  • the cloning procedures may involve excision and isolation of a desired nucleic acid fragment comprising the nucleic acid sequence encoding the polypeptide, insertion of the fragment into a vector molecule, and incorporation of the recombinant vector into a host cell where multiple copies or clones of the nucleic acid sequence will be replicated.
  • the nucleic acid sequence may be of genomic, cDNA, RNA, semisynthetic, synthetic origin, or any combinations thereof.
  • nucleic acid sequences which have a degree of homology to the mature polypeptide coding sequence of SEQ ID NO: 1 (i.e. , nucleotides 1 to 1458) or SEQ ID NO: 3 (i.e. , nucleotide 1 to 1458) of at least about 96% homology on DNA level, preferably aat least about 97%, preferably at least about 98%, more preferably at least about 99% homology, which encode an active polypeptide.
  • the DNA sequence homology may be determined as the degree of identity between the two sequences indicating a derivation of the first sequence from the second.
  • the homology may suitably be determined by means of computer programs known in the art such as GAP provided in the GCG program package (described above).
  • GAP provided in the GCG program package (described above).
  • GAP creation penalty of 5.0
  • GAP extension penalty of 0.3
  • default scoring matrix default scoring matrix.
  • GAP uses the method of Needleman/Wunsch/Sellers to make alignments.
  • Modification of a nucleic acid sequence encoding a polypeptide of the present invention may be necessary for the synthesis of polypeptides substantially similar to the polypeptide.
  • the term "substantially similar" to the polypeptide refers to non-naturally occurring forms of the polypeptide.
  • These polypeptides may differ in some engineered way from the polypeptide isolated from its native source, e.g. , variants that differ in specific activity, thermostability, pH optimum, or the like.
  • the variant sequence may be constructed on the basis of the nucleic acid sequence presented as the polypeptide encoding part of SEQ ID NO:1 or SEQ ID NO: 3, e.g.
  • nucleotide substitutions which do not give rise to another amino acid sequence of the polypeptide encoded by the nucleic acid sequence, but which correspond to the codon usage of the host organism intended for production of the enzyme, or by introduction of nucleotide substitutions which may give rise to a different amino acid sequence.
  • nucleotide substitution see, e.g. , Ford et al., 1991, Protein Expression and Purification 2: 95-107 .
  • amino acid residues essential to the activity of the polypeptide encoded by the isolated nucleic acid sequence of the invention may be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (see, e.g. , Cunningham and Wells, 1989, Science 244: 1081-1085 ). In the latter technique, mutations are introduced at every positively charged residue in the molecule, and the resultant mutant molecules are tested for [enzyme] activity to identify amino acid residues that are critical to the activity of the molecule.
  • Sites of substrate-enzyme interaction can also be determined by analysis of the three-dimensional structure as determined by such techniques as nuclear magnetic resonance analysis, crystallography or photoaffinity labelling (see, e.g. , de Vos et al., 1992, Science 255: 306-312 ; Smith et al., 1992, Journal of Molecular Biology 224: 899-904 ; Wlodaver et al., 1992, FEBS Letters 309: 59-64 ).
  • isolated nucleic acid sequences encoding a polypeptide of the present invention, which hybridize under medium stringency conditions, preferably medium-high stringency conditions, more preferably high stringency conditions, and most preferably very high stringency conditions with a nucleic acid probe which hybridizes under the same conditions with the nucleic acid sequence of SEQ ID NO:1 or SEQ ID NO: 3 or its complementary strand; or allelic variants and subsequences thereof (Sambrook et al., 1989, supra ), as defined herein.
  • isolated nucleic acid sequences identified by (a) hybridizing a DNA under medium, medium-high, high, or very high stringency conditions with the sequence of SEQ ID NO:1 or SEQ ID NO: 3, or their complementary strands, or a subsequence thereof; and (b) isolating the nucleic acid sequence.
  • the subsequence is preferably a sequence of at least 100 nucleotides such as a sequence, which encodes a polypeptide fragment, which has alpha-amylase activity.
  • the present invention further relates to methods for producing a mutant nucleic acid sequence, comprising introducing at least one mutation into the mature polypeptide coding sequence of SEQ ID NO: 1 or a subsequence thereof, wherein the mutant nucleic acid sequence encodes a polypeptide which consists of 1 to 485 of SEQ ID NO: 2.
  • the introduction of a mutation into the nucleic acid sequence to exchange one nucleotide for another nucleotide may be accomplished by site-directed mutagenesis using any of the methods known in the art. Particularly useful is the procedure, which utilizes a supercoiled, double stranded DNA vector with an insert of interest and two synthetic primers containing the desired mutation.
  • the oligonucleotide primers, each complementary to opposite strands of the vector extend during temperature cycling by means of Pfu DNA polymerase. On incorporation of the primers, a mutated plasmid containing staggered nicks is generated. Following temperature cycling, the product is treated with Dpn I, which is specific for methylated and hemimethylated DNA to digest the parental DNA template and to select for mutation-containing synthesized DNA.
  • the present invention also relates to nucleic acid constructs comprising a nucleic acid sequence of the present invention operably linked to one or more control sequences, which direct the expression of the coding sequence in a suitable host cell under conditions compatible with the control sequences.
  • Expression will be understood to include any step involved in the production of the polypeptide including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion.
  • Nucleic acid construct is defined herein as a nucleic acid molecule, either single- or double-stranded, which is isolated from a naturally occurring gene or which has been modified to contain segments of nucleic acid which are combined and juxtaposed in a manner which would not otherwise exist in nature.
  • nucleic acid construct is synonymous with the term expression cassette when the nucleic acid construct contains all the control sequences required for expression of a coding sequence of the present invention.
  • coding sequence is defined herein as a portion of a nucleic acid sequence, which directly specifies the amino acid sequence of its protein product.
  • the boundaries of the coding sequence are generally determined by a ribosome binding site (prokaryotes) or by the ATG start codon (eukaryotes) located just upstream of the open reading frame at the 5' end of the mRNA and a transcription terminator sequence located just downstream of the open reading frame at the 3' end of the mRNA.
  • a coding sequence can include, but is not limited to, DNA, cDNA, and recombinant nucleic acid sequences.
  • An isolated nucleic acid sequence encoding a polypeptide of the present invention may be manipulated in a variety of ways to provide for expression of the polypeptide. Manipulation of the nucleic acid sequence prior to its insertion into a vector may be desirable or necessary depending on the expression vector. The techniques for modifying nucleic acid sequences utilizing recombinant DNA methods are well known in the art.
  • control sequences is defined herein to include all components, which are necessary or advantageous for the expression of a polypeptide of the present invention.
  • Each control sequence may be native or foreign to the nucleic acid sequence encoding the polypeptide.
  • control sequences include, but are not limited to, a leader, polyadenylation sequence, propeptide sequence, promoter, signal peptide sequence, and transcription terminator.
  • the control sequences include a promoter, and transcriptional and translational stop signals.
  • the control sequences may be provided with linkers for the purpose of introducing specific restriction sites facilitating ligation of the control sequences with the coding region of the nucleic acid sequence encoding a polypeptide.
  • operably linked is defined herein as a configuration in which a control sequence is appropriately placed at a position relative to the coding sequence of the DNA sequence such that the control sequence directs the expression of a polypeptide.
  • the control sequence may be an appropriate promoter sequence, a nucleic acid sequence, which is recognized by a host cell for expression of the nucleic acid sequence.
  • the promoter sequence contains transcriptional control sequences, which mediate the expression of the polypeptide.
  • the promoter may be any nucleic acid sequence which shows transcriptional activity in the host cell of choice including mutant, truncated, and hybrid promoters, and may be obtained from genes encoding extracellular or intracellular polypeptides either homologous or heterologous to the host cell.
  • Suitable promoters for directing the transcription of the nucleic acid constructs of the present invention are the promoters obtained from the E. coli lac operon, Streptomyces coelicolor agarase gene ( dagA ), Bacillus subtilis levansucrase gene ( sacB ), Bacillus licheniformis alpha-amylase gene ( amyL ), Bacillus stearothermophilus maltogenic amylase gene ( amyM ), Bacillus amyloliquefaciens alpha-amylase gene ( amyQ ), Bacillus licheniformis penicillinase gene ( penP ), Bacillus subtilis xylA and xylB genes, and prokaryotic beta-lactamase gene ( Villa-Kamaroff et al., 1978, Proceedings of the National Academy of Sciences USA 75: 3727-3731 ), as well as the tac promoter ( DeBoer et al.,
  • the control sequence may also be a suitable transcription terminator sequence, a sequence recognized by a host cell to terminate transcription.
  • the terminator sequence is operably linked to the 3' terminus of the nucleic acid sequence encoding the polypeptide. Any terminator, which is functional in the host cell of choice may be used in the present invention.
  • the control sequence may also be a signal peptide-coding region that codes for an amino acid sequence linked to the amino terminus of a polypeptide and directs the encoded polypeptide into the cell's secretory pathway.
  • the 5' end of the coding sequence of the nucleic acid sequence may inherently contain a signal peptide-coding region naturally linked in translation reading frame with the segment of the coding region, which encodes the secreted polypeptide.
  • the 5' end of the coding sequence may contain a signal peptide-coding region, which is foreign to the coding sequence.
  • the foreign signal peptide-coding region may be required where the coding sequence does not naturally contain a signal peptide-coding region.
  • the foreign signal peptide-coding region may simply replace the natural signal peptide-coding region in order to enhance secretion of the polypeptide.
  • any signal peptide-coding region which directs the expressed polypeptide into the secretory pathway of a host cell of choice, may be used in the present invention.
  • Effective signal peptide coding regions for bacterial host cells are the signal peptide coding regions obtained from the genes for Bacillus NCIB 11837 maltogenic amylase, Bacillus stearothermophilus alpha-amylase, Bacillus licheniformis subtilisin, Bacillus licheniformis beta-lactamase, Bacillus stearothermophilus neutral proteases ( nprT, nprS, nprM ), and Bacillus subtilis prsA. Further signal peptides are described by Simonen and Palva, 1993, Microbiological Reviews 57: 109-137 .
  • regulatory sequences which allow the regulation of the expression of the polypeptide relative to the growth of the host cell.
  • regulatory systems are those which cause the expression of the gene to be turned on or off in response to a chemical or physical stimulus, including the presence of a regulatory compound.
  • Regulatory systems in prokaryotic systems include the lac, tac , and trp operator systems.
  • yeast the ADH2 system or GAL1 system may be used.
  • filamentous fungi the TAKA alpha-amylase promoter, Aspergillus niger glucoamylase promoter, and Aspergillus oryzae glucoamylase promoter may be used as regulatory sequences.
  • Other examples of regulatory sequences are those, which allow for gene amplification.
  • these include the dihydrofolate reductase gene, which is amplified in the presence of methotrexate, and the metallothionein genes which are amplified with heavy metals.
  • the nucleic acid sequence encoding the polypeptide would be operably linked with the regulatory sequence.
  • the present invention also relates to recombinant expression vectors comprising a nucleic acid sequence of the present invention, a promoter, and transcriptional and translational stop signals.
  • the various nucleic acid and control sequences described above may be joined together to produce a recombinant expression vector which may include one or more convenient restriction sites to allow for insertion or substitution of the nucleic acid sequence encoding the polypeptide at such sites.
  • the nucleic acid sequence of the present invention may be expressed by inserting the nucleic acid sequence or a nucleic acid construct comprising the sequence into an appropriate vector for expression.
  • the coding sequence is located in the vector so that the coding sequence is operably linked with the appropriate control sequences for expression.
  • the recombinant expression vector may be any vector (e.g. , a plasmid or virus), which can be conveniently subjected to recombinant DNA procedures and can bring about the expression of the nucleic acid sequence.
  • the choice of the vector will typically depend on the compatibility of the vector with the host cell into which the vector is to be introduced.
  • the vectors may be linear or closed circular plasmids.
  • the vector may be an autonomously replicating vector, i.e. , a vector, which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. , a plasmid, an extrachromosomal element, a minichromosome, or an artificial chromosome.
  • the vector may contain any means for assuring self-replication.
  • the vector may be one which, when introduced into the host cell, is integrated into the genome and replicated together with the chromosome(s) into which it has been integrated.
  • a single vector or plasmid or two or more vectors or plasmids which together contain the total DNA to be introduced into the genome of the host cell, or a transposon may be used.
  • the vectors of the present invention preferably contain one or more selectable markers, which permit easy selection of transformed cells.
  • a selectable marker is a gene the product of which provides for biocide or viral resistance, resistance to heavy metals, prototrophy to auxotrophs, and the like.
  • Examples of bacterial selectable markers are the dal genes from Bacillus subtilis or Bacillus licheniformis, or markers, which confer antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracycline resistance.
  • Suitable markers for yeast host cells are ADE2, HIS3, LEU2, LYS2, MET3, TRP1, and URA3.
  • a selectable marker for use in a filamentous fungal host cell may be selected from the group including, but not limited to, amdS (acetamidase), argB (ornithine carbamoyltransferase), bar (phosphinothricin acetyltransferase), hygB (hygromycin phosphotransferase), niaD (nitrate reductase), pyrG (orotidine-5'-phosphate decarboxylase), sC (sulfate adenyltransferase), trpC (anthranilate synthase), as well as equivalents thereof.
  • Preferred for use in an Aspergillus cell are the amdS and pyrG genes of Aspergillus nidulans or Aspergillus oryzae and the bar gene of Streptomyces hygroscopicus.
  • the vectors of the present invention preferably contain an element(s) that permits stable integration of the vector into the host cell genome or autonomous replication of the vector in the cell independent of the genome of the cell.
  • the vector may rely on the nucleic acid sequence encoding the polypeptide or any other element of the vector for stable integration of the vector into the genome by homologous or nonhomologous recombination.
  • the vector may contain additional nucleic acid sequences for directing integration by homologous recombination into the genome of the host cell.
  • the additional nucleic acid sequences enable the vector to be integrated into the host cell genome at a precise location(s) in the chromosome(s).
  • the integrational elements should preferably contain a sufficient number of nucleic acids, such as 100 to 1,500 base pairs, preferably 400 to 1,500 base pairs, and most preferably 800 to 1,500 base pairs, which are highly homologous with the corresponding target sequence to enhance the probability of homologous recombination.
  • the integrational elements may be any sequence that is homologous with the target sequence in the genome of the host cell.
  • the integrational elements may be non-encoding or encoding nucleic acid sequences.
  • the vector may be integrated into the genome of the host cell by nonhomologous recombination.
  • the vector may further comprise an origin of replication enabling the vector to replicate autonomously in the host cell in question.
  • origins of replication are the origins of replication of plasmids pBR322, pUC19, pACYC177, and pACYC184 permitting replication in E. coli, and pUB110, pE194, pTA1060, and pAMß1 permitting replication in Bacillus.
  • origins of replication for use in a yeast host cell are the 2 micron origin of replication, ARS1, ARS4, the combination of ARS1 and CEN3, and the combination of ARS4 and CEN6.
  • the origin of replication may be one having a mutation which makes its functioning temperature-sensitive in the host cell (see, e.g., Ehrlich, 1978, Proceedings of the National Academy of Sciences USA 75: 1433 ).
  • More than one copy of a nucleic acid sequence of the present invention may be inserted into the host cell to increase production of the gene product.
  • An increase in the copy number of the nucleic acid sequence can be obtained by integrating at least one additional copy of the sequence into the host cell genome or by including an amplifiable selectable marker gene with the nucleic acid sequence where cells containing amplified copies of the selectable marker gene, and thereby additional copies of the nucleic acid sequence, can be selected for by cultivating the cells in the presence of the appropriate selectable agent.
  • the present invention also relates to recombinant host cells, comprising a nucleic acid sequence of the invention, which are advantageously used in the recombinant production of the polypeptides.
  • a vector comprising a nucleic acid sequence of the present invention is introduced into a host cell so that the vector is maintained as a chromosomal integrant or as a self-replicating extra-chromosomal vector as described earlier.
  • host cell encompasses any progeny of a parent cell that is not identical to the parent cell due to mutations that occur during replication. The choice of a host cell will to a large extent depend upon the gene encoding the polypeptide and its source.
  • the host cell may be a unicellular microorganism, e.g. , a prokaryote, or a non-unicellular microorganism, e.g. , a eukaryote.
  • Useful unicellular cells are bacterial cells such as gram positive bacteria including, but not limited to, a Bacillus cell, e.g., Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus stearothermophilus, Bacillus subtilis, and Bacillus thuringiensis; or a Streptomyces cell, e.g., Streptomyces lividans or Streptomyces murinus, or gram negative bacteria such as E.
  • a Bacillus cell e.g., Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus
  • the bacterial host cell is a Bacillus lentus, Bacillus licheniformis, Bacillus stearothermophilus or Bacillus subtilis cell.
  • the Bacillus cell is an alkalophilic Bacillus .
  • the introduction of a vector into a bacterial host cell may, for instance, be effected by protoplast transformation (see, e.g. , Chang and Cohen, 1979, Molecular General Genetics 168: 111-115 ), using competent cells (see, e.g. , Young and Spizizin, 1961, Journal of Bacteriology 81: 823-829 , or Dubnau and Davidoff-Abelson, 1971, Journal of Molecular Biology 56: 209-221 ), electroporation (see, e.g. , Shigekawa and Dower, 1988, Biotechniques 6: 742-751 ), or conjugation (see, e.g. , Koehler and Thorne, 1987, Journal of Bacteriology 169: 5771-5278 ).
  • Also disclosed herein are methods for producing a polypeptide of the present invention comprising (a) cultivating a strain, which in its wild-type form is capable of producing the polypeptide, to produce a supernatant comprising the polypeptide; and (b) recovering the polypeptide.
  • the strain is of the genus Bacillus sp
  • the present invention also relates to methods for producing a polypeptide of the present invention comprising (a) cultivating a host cell under conditions conducive for production of the polypeptide; and (b) recovering the polypeptide.
  • Also disclosed herein are methods for producing a polypeptide of the present invention comprising (a) cultivating a host cell under conditions conducive for production of the polypeptide, wherein the host cell comprises a mutant nucleic acid sequence having at least one mutation in the mature polypeptide coding region of SEQ ID NO:1 or SEQ ID NO: 3, wherein the mutant nucleic acid sequence encodes a polypeptide which consists of amino acids 1 to 485 of SEQ ID NO:2 or SEQ ID NO: 4, and (b) recovering the polypeptide.
  • the present invention relates to compositions comprising an alpha-amylase or a variant thereof of the present invention.
  • the compositions are enriched in an alpha-amylase or variant thereof of the present invention.
  • the term "enriched" indicates that the alpha-amylase activity of the composition has been increased, e.g. , with an enrichment factor of 1.1.
  • the composition may comprise a polypeptide of the invention as the major enzymatic component, e.g. , a mono-component composition.
  • the composition may comprise multiple enzymatic activities, such as an aminopeptidase, amylase, carbohydrase, carboxypeptidase, catalase, cellulase, chitinase, cutinase, cyclodextrin glycosyltransferase, deoxyribonuclease, esterase, alpha-galactosidase, beta-galactosidase, glucoamylase, alpha-glucosidase, beta-glucosidase, haloperoxidase, invertase, laccase, lipase, mannosidase, oxidase, pectinolytic enzyme, peptidoglutaminase, peroxidase, phytase, polyphenoloxidase, proteolytic enzyme
  • the additional enzyme (s) may be producible by means of a microorganism belonging to the genus Aspergillus, preferably Aspergillus aculeatus, Aspergillus awamori, Aspergillus niger, or Aspergillus oryzae, or Trichoderma, Humicola, preferably Humicola insolens, or Fusarium, preferably Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum , Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi , Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum , Fusarium sarcochroum, Fusarium sulphureum, Fusarium toruloseum, Fusarium trichothecioides
  • polypeptide compositions may be prepared in accordance with methods known in the art and may be in the form of a liquid or a dry composition.
  • the polypeptide composition may be in the form of granulate or a microgranulate.
  • the polypeptide to be included in the composition may be stabilized in accordance with methods known in the art.
  • polypeptide compositions of the invention examples are given below of preferred uses of the polypeptide compositions of the invention.
  • the dosage of the polypeptide composition of the invention and other conditions under which the composition is used may be determined on the basis of methods known in the art.
  • the alpha-amylases of the invention are well suited for use in a variety of industrial processes, in particular the enzyme finds potential applications as a component in detergents, e.g., laundry, dishwashing and hard surface cleaning detergent compositions, but it may also be useful for desizing of textiles, fabrics and garments, beer making or brewing, in pulp and paper production, and further in the production of sweeteners and ethanol, such as fuel, drinking and industrial ethanol, from starch or whole grains.
  • detergents e.g., laundry, dishwashing and hard surface cleaning detergent compositions
  • sweeteners and ethanol such as fuel, drinking and industrial ethanol, from starch or whole grains.
  • the alkaline alpha-amylase of the invention may also be used in the production of lignocellulosic materials, such as pulp, paper and cardboard, from starch reinforced waste paper and cardboard, especially where re-pulping occurs at pH above 7 and where amylases facilitate the disintegration of the waste material through degradation of the reinforcing starch.
  • the alpha-amylase of the invention is especially useful in a process for producing a papermaking pulp from starch-coated printed-paper. The process may be performed as described in WO 95/14807 , comprising the following steps:
  • the alpha-amylases of the invention may also be very useful in modifying starch where enzymatically modified starch is used in papermaking together with alkaline fillers such as calcium carbonate, kaolin and clays. With the alkaline alpha-amylases of the invention it becomes possible to modify the starch in the presence of the filler thus allowing for a simpler integrated process.
  • alpha-amylase of the invention may also be very useful in textile, fabric or garment desizing.
  • alpha-amylases are traditionally used as auxiliaries in the desizing process to facilitate the removal of starch-containing size, which has served as a protective coating on weft yarns during weaving. Complete removal of the size coating after weaving is important to ensure optimum results in the subsequent processes, in which the fabric is scoured, bleached and dyed. Enzymatic starch breakdown is preferred because it does not involve any harmful effect on the fiber material.
  • the desizing processing is sometimes combined with the scouring and bleaching steps.
  • non-enzymatic auxiliaries such as alkali or oxidation agents are typically used to break down the starch, because traditional alpha-amylases are not very compatible with high pH levels and bleaching agents.
  • the non-enzymatic breakdown of the starch size does lead to some fiber damage because of the rather aggressive chemicals used. Accordingly, it would be desirable to use the alpha-amylases of the invention as they have an improved performance in alkaline solutions.
  • the alpha-amylases may be used alone or in combination with a cellulase when desizing cellulose-containing fabric or textile.
  • Desizing and bleaching processes are well known in the art. For instance, such processes are described in WO 95/21247 , US patent 4,643,736 , EP 119,920 hereby in corporate by reference.
  • the alpha-amylases of the invention may also be very useful in a beer-making process; the alpha-amylases will typically be added during the mashing process.
  • the enzyme of the invention may be added to and thus become a component of a detergent composition.
  • the detergent composition of the invention may for example be formulated as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre-treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
  • the invention provides a detergent additive comprising the enzyme of the invention.
  • the detergent additive as well as the detergent composition may comprise one or more other enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidase, e.g., a laccase, and/or a peroxidase.
  • enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidas
  • the properties of the chosen enzyme(s) should be compatible with the selected detergent, (i.e., pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
  • proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included.
  • the protease may be a serine protease or a metallo protease, preferably an alkaline microbial protease or a trypsin-like protease.
  • alkaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279 ).
  • trypsin-like pro-teases are trypsin (e.g., of porcine or bovine origin) and the Fusarium protease described in WO 89/06270 and WO 94/25583 .
  • Examples of useful proteases are the variants described in WO 92/19729 , WO 98/20115 , WO 98/20116 , and WO 98/34946 , especially the variants with substitutions in one or more of the following positions: 27, 36, 57, 76, 87, 97, 101, 104, 120, 123, 167, 170, 194, 206, 218, 222, 224, 235 and 274.
  • Preferred commercially available protease enzymes include Alcalase ® , Savinase ® , Primase ® , Duralase ® , Esperase ® , and Kannase ® (Novo Nordisk A/S), Maxatase ® , Maxacal, Maxapem ® , Properase ® , Purafect ® , Purafect OxP ® , FN2 ® , and FN3 ® (Genencor International Inc.).
  • Lipases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful lipases include lipases from Humicola (synonym Thermomyces ), e.g., from H. lanuginosa ( T. lanuginosus ) as described in EP 258 068 and EP 305 216 or from H. insolens as described in WO 96/13580 , a Pseudomonas lipase, e.g., from P. alcaligenes or P. pseudoalcaligenes ( EP 218 272 ), P. cepacia ( EP 331 376 ), P.
  • lipase variants such as those described in WO 92/05249 , WO 94/01541 , EP 407 225 , EP 260 105 , WO 95/35381 , WO 96/00292 , WO 95/30744 , WO 94/25578 , WO 95/14783 , WO 95/22615 , WO 97/04079 and WO 97/07202 .
  • Preferred commercially available lipase enzymes include Lipolase TM and Lipolase Ultra TM (Novo Nordisk A/S).
  • Amylases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, alpha-amylases obtained from Bacillus , e.g., a special strain of B. licheniformis, described in more detail in GB 1,296,839 .
  • alpha-amylases examples are the variants described in WO 94/02597 , WO 94/18314 , WO 96/23873 , and WO 97/43424 , especially the variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 181, 188, 190, 197, 202, 208, 209, 243, 264, 304, 305, 391, 408, and 444.
  • amylases are Duramyl TM , Termamyl TM , Fungamyl TM and BAN TM (Novo Nordisk A/S), Rapidase TM and Purastar TM (from Genencor International Inc.).
  • Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g., the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307 , US 5,648,263 , US 5,691,178 , US 5,776,757 and WO 89/09259 .
  • cellulases are the alkaline or neutral cellulases having colour care benefits.
  • Examples of such cellulases are cellulases described in EP 0 495 257 , EP 0 531 372 , WO 96/11262 , WO 96/29397 , WO 98/08940 .
  • Other examples are cellulase variants such as those described in WO 94/07998 , EP 0 531 315 , US 5,457,046 , US 5,686,593 , US 5,763,254 , WO 95/24471 , WO 98/12307 and PCT/DK98/00299 .
  • cellulases include Celluzyme ® , and Carezyme ® (Novo Nordisk A/S), Clazinase ® , and Puradax HA ® (Genencor International Inc.), and KAC-500(B) ® (Kao Corporation).
  • Peroxidases/Oxidases include those of plant, bac-terial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g., from C. cinereus, and variants thereof as those described in WO 93/24618 , WO 95/10602 , and WO 98/15257 .
  • peroxidases include Guardzyme ® (Novo Nordisk A/S).
  • the detergent enzyme(s) may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes.
  • a detergent additive of the invention i.e., a separate additive or a combined additive, can be formulated, e.g., granulate, a liquid, a slurry, etc.
  • Preferred detergent additive formulations are granulates, in particular non-dusting granulates, liquids, in particular stabilized liquids, or slurries.
  • Non-dusting granulates may be produced, e.g., as disclosed in US 4,106,991 and 4,661,452 and may optionally be coated by methods known in the art.
  • waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids.
  • film-forming coating materials suitable for application by fluid bed techniques are given in GB 1483591 .
  • Liquid enzyme pre-parations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods.
  • a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods.
  • Protected enzymes may be prepared according to the method disclosed in EP 238,216 .
  • the detergent composition of the invention may be in any convenient form, e.g., a bar, a tablet, a powder, a granule, a paste or a liquid.
  • a liquid detergent may be aqueous, typically containing up to 70 % water and 0-30 % organic solvent, or non-aqueous.
  • the detergent composition comprises one or more surfactants, which may be non-ionic including semi-polar and/or anionic and/or cationic and/or zwitterionic.
  • the surfactants are typically present at a level of from 0.1% to 60% by weight.
  • the detergent When included therein the detergent will usually contain from about 1% to about 40% of an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
  • an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
  • the detergent When included therein the detergent will usually contain from about 0.2% to about 40% of a non-ionic surfactant such as alcohol ethoxylate, nonyl-phenol ethoxylate, alkylpolyglycoside, alkyldimethylamine-oxide, ethoxylated fatty acid monoethanol-amide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides").
  • a non-ionic surfactant such as alcohol ethoxylate, nonyl-phenol ethoxylate, alkylpolyglycoside, alkyldimethylamine-oxide, ethoxylated fatty acid monoethanol-amide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides”).
  • a non-ionic surfactant such as alcohol ethoxylate, non
  • the detergent may contain 0-65 % of a detergent builder or complexing agent such as zeolite, diphosphate, tripho-sphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediaminetetraacetic acid, diethylenetri-aminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
  • a detergent builder or complexing agent such as zeolite, diphosphate, tripho-sphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediaminetetraacetic acid, diethylenetri-aminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
  • the detergent may comprise one or more polymers.
  • examples are carboxymethylcellulose, poly(vinyl-pyrrolidone), poly (ethylene glycol), poly(vinyl alcohol), poly(vinylpyridine-N-oxide), poly(vinylimidazole), polycarboxylates such as polyacrylates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid co-polymers.
  • the detergent may contain a bleaching system, which may comprise a H 2 O 2 source such as perborate or percarbonate which may be combined with a peracid-forming bleach activator such as tetraacetylethylenediamine or nonanoyloxyben-zenesul-fonate.
  • a bleaching system may comprise peroxyacids of, e.g., the amide, imide, or sulfone type.
  • the enzyme(s) of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid, and the com-position may be formulated as described in, e.g., WO 92/19709 and WO 92/19708 .
  • stabilizing agents e.g., a polyol such as propylene glycol or glycerol
  • a sugar or sugar alcohol lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid
  • the com-position may be formulated as described in, e
  • the detergent may also contain other conventional detergent ingredients such as e.g. fabric conditioners including clays, foam boosters, suds suppressors, anticorrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • fabric conditioners including clays, foam boosters, suds suppressors, anticorrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • any enzyme in particular the enzyme of the invention, may be added in an amount corresponding to 0.01-100 mg of enzyme protein per liter of wash liquor, preferably 0.05-5 mg of enzyme protein per liter of wash liquor, in particular 0.1-1 mg of enzyme protein per liter of wash liquor.
  • the enzyme of the invention may additionally be incorporated in the detergent formulations disclosed in WO 97/07202 , which is hereby incorporated as reference.
  • the enzyme of the invention mat also be used in dish wash detergent compositions, including the following:
  • Nonionic surfactant 0.4 - 2.5% Sodium metasilicate 0 - 20% Sodium disilicate 3 - 20% Sodium triphosphate 20 - 40% Sodium carbonate 0 - 20% Sodium perborate 2 - 9% Tetraacetyl ethylene diamine (TAED) 1 - 4% Sodium sulphate 5 - 33% Enzymes 0.0001 - 0.1%
  • Nonionic surfactant e.g. alcohol ethoxylate 1 - 2% Sodium disilicate 2 - 30% Sodium carbonate 10 - 50% Sodium phosphonate 0 - 5% Trisodium citrate dihydrate 9 - 30% Nitrilotrisodium acetate (NTA) 0 - 20% Sodium perborate monohydrate 5 - 10% Tetraacetyl ethylene diamine (TAED) 1 - 2% Polyacrylate polymer (e.g. maleic acid/acrylic acid co-polymer) 6 - 25% Enzymes 0.0001 - 0.1% Perfume 0.1 - 0.5% Water 5 - 10
  • NTAED Nitrilotrisodium acetate
  • Polyacrylate polymer e.g. maleic acid/acrylic acid co-polymer 6 - 25% Enzymes 0.0001 - 0.1% Perfume 0.1 - 0.5% Water 5 - 10
  • Nonionic surfactant 0.5 - 2.0% Sodium disilicate 25 - 40% Sodium citrate 30 - 55% Sodium carbonate 0 - 29% Sodium bicarbonate 0 - 20% Sodium perborate monohydrate 0 - 15% Tetraacetyl ethylene diamine (TAED) 0 - 6% Maleic acid/acrylic acid copolymer 0 - 5% Clay 1 - 3% Polyamino acids 0 - 20% Sodium polyacrylate 0 - 8% Enzymes 0.0001 - 0.1%
  • Nonionic surfactant 1 - 7% Sodium disilicate 18 - 30% Trisodium citrate 10 - 24% Sodium carbonate 12 - 20% Monopersulphate (2 KHSO 5 .KHSO 4 .K 2 SO 4 ) 15 - 21% Bleach stabilizer 0.1 - 2% Maleic acid/acrylic acid copolymer 0 - 6% Diethylene triamine pentaacetate, pentasodium salt 0 - 2.5% Enzymes 0.0001 - 0.1% Sodium sulphate, water Balance
  • Nonionic surfactant 0 - 1.5% Octadecyl dimethylamine N-oxide dihydrate 0 - 5% 80:20 wt.C18/C16 blend of octadecyl dimethylamine N-oxide dihydrate and hexadecyldimethyl amine N-oxide dihydrate 0 - 4% 70:30 wt.C18/C16 blend of octadecyl bis (hydroxyethyl)amine N-oxide anhydrous and hexadecyl bis (hydroxyethyl)amine N-oxide anhydrous 0 - 5% C 13 -C 15 alkyl ethoxysulfate with an average degree of ethoxylation of 3 0 - 10% C 12 -C 15 alkyl ethoxysulfate with an average degree of ethoxylation of 3 0 - 5% C 13 -C 15 ethoxylated alcohol with an average degree of ethoxylation of
  • Liquid nonionic surfactant e.g. alcohol ethoxylates
  • Alkali metal silicate 3.0 - 15.0%
  • Stabilizer e.g. a partial ester of phosphoric acid and a C 16 -C 18 alkanol
  • Foam suppressor e.g. silicone
  • Liquid nonionic surfactant e.g. alcohol ethoxylates 2.0 - 10.0% Sodium silicate 3.0 - 15.0% Alkali metal carbonate 7.0 - 20.0% Sodium citrate 0.0 - 1.5%
  • Stabilizing system e.g. mixtures of finely divided silicone and low molecular weight dialkyl polyglycol ethers
  • Low molecule weight polyacrylate polymer 5.0 - 15.0%
  • Clay gel thickener e.g. bentonite
  • the present invention is also directed to methods for using the polypeptides having alpha-amylase activity of the invention in detergents, in particular laundry detergent compositions and dishwashing detergent compositions, hard surface cleaning compositions, and in composition for desizing of textiles, fabrics or garments, for production of pulp and paper, beer making, and starch conversion processes as described above.
  • Chemicals used as buffers and substrates were commercial products of at least reagent grade.
  • SP690 alpha-amylase disclosed in SEQ ID NO: 1 of US patent no. 5,856,164 .
  • SP722 alpha-amylase disclosed in SEQ ID NO: 2 of US patent no. US patent no. 5,856,164 .
  • Termamyl ® alpha-amylase from Bacillus licheniformis disclosed in SEQ ID NO: 1 of US patent no. 5,830,837 .
  • AA560 alpha-amylase of the invention shown in SEQ ID NO: 2.
  • BAN alpha-amylase derived from Bacillus amyloliquefaciens and available from Novo Nordisk A/S
  • BSG alpha-amylase derived from Bacillus stearothermophilus and available from Novo Noridsk A/S
  • A/P (Asia/Pacific) Model Detergent has the following composition: 20% STPP (sodium tripolyphosphate), 25% Na 2 SO 4 , 15% Na 2 CO 3 , 20% LAS (linear alkylbenzene sulfonate, Nansa 80S), 5% C 12 -C 15 alcohol ethoxylate (Dobanol 25-7), 5% Na 2 Si 2 O 5 , 0.3% NaCl.
  • Omo Multi Acao Brazil
  • Omo concentrated powder (EU) Unilever
  • Ariel Futur liquid (EU) Procter and Gamble
  • the strains have been deposited under conditions that assure that access to the culture will be available during the pendency of this patent application to one determined by the Commissioner of Patents and Trademarks to be entitled thereto under 37 C.F.R. ⁇ 1.14 and 35 U.S.C. ⁇ 122.
  • the deposit represents a substantially pure culture of the deposited strain.
  • the deposit is available as required by foreign patent laws in countries wherein counterparts of the subject application, or its progeny are filed. However, it should be understood that the availability of a deposit does not constitute a license to practice the subject invention in derogation of patent rights granted by governmental action.
  • Bacillus subtilis strain SHa273 is disclosed in WO 95/10603 E. coli strain SJ2 ( Diderichsen et al. (1990)), J. Bacteriol., vol. 172, pp. 4315-4321 .
  • the gene bank vector pSJ1678 is further disclosed in WO 94/19454 , which is hereby incorporated by reference.
  • pTVB110 is a plasmid replicating in Bacillus subtilis by the use of origin of replication from pUB110 ( Gryczan, T.J. (1978) J. Bact. 134:318-329 ).
  • the plasmid further encodes the cat gene, conferring resistance towards chlorampenicol, obtained from plasmid pC194 ( Horinouchi, S. and Weisblum, B. (1982), J. Bact. 150: 815-825 ).
  • the plasmid harbors a truncated version of the Bacillus licheniformis alpha-amylase gene, amyL, such that the amyL promoter, signal sequence and transcription terminator are present, but the plasmid does not provide an amy-plus phenotype (halo formation on starch containing agar).
  • pTVB299 see the construction in Example 10.
  • Fermentation may be performed by methods well known in the art or as follows.
  • a B. subtilis strain harboring the relevant expression plasmid is streaked on a LB-agar plate with 10 micro g/ml Kanamycin from -80°C stock, and grown overnight at 37°C.
  • BPX media The colonies are transferred to 100 ml BPX media supplemented with 10 micro g/ml kanamycin in a 500 ml shaking flask.
  • Composition of BPX medium Potato starch 100 g/l Barley flour 50 g/l BAN 5000 SKB 0.1 g/l Sodium caseinate 10 g/l Soy Bean Meal 20 g/l Na 2 HPO 4 , 12 H 2 O 9 g/l Pluronic TM 0.1 g/l
  • the culture is shaken at 37°C at 270 rpm for 5 days.
  • Phadebas ® tablets contain a crosslinked insoluble blue-colored starch polymer, which has been mixed with bovine serum albumin and a buffer substance and tabletted.
  • the measured 620 nm absorbance after 10 or 15 minutes of incubation is in the range of 0.2 to 2.0 absorbance units at 620 nm. In this absorbance range there is linearity between activity and absorbance (Lambert-Beer law). The dilution of the enzyme must therefore be adjusted to fit this criterion. Under a specified set of conditions (temp., pH, reaction time, buffer conditions) 1 mg of a given alpha-amylase will hydrolyze a certain amount of substrate and a blue colour will be produced. The colour intensity is measured at 620 nm. The measured absorbance is directly proportional to the specific activity (activity/mg of pure alpha-amylase protein) of the alpha-amylase in question under the given set of conditions.
  • Alpha-amylase activity is determined by a method employing the PNP-G7 substrate.
  • PNP-G7 which is a abbreviation for p-nitrophenyl-alpha,D-maltoheptaoside is a blocked oligosaccharide which can be cleaved by an endo-amylase.
  • Kits containing PNP-G7 substrate and alpha-Glucosidase is manufactured by Boehringer-Mannheim (cat.No. 1054635).
  • BM 1442309 To prepare the substrate one bottle of substrate (BM 1442309) is added to 5 ml buffer (BM1442309). To prepare the ⁇ -Glucosidase one bottle of alpha-Glucosidase (BM 1462309) is added to 45 ml buffer (BM1442309). The working solution is made by mixing 5 ml alpha-Glucosidase solution with 0.5 ml substrate.
  • the assay is performed by transforming 20 micro 1 enzyme solution to a 96 well microtitre plate and incubating at 25°C. 200 micro 1 working solution, 25°C is added. The solution is mixed and pre-incubated 1 minute and absorption is measured every 15 sec. over 3 minutes at OD 405 nm.
  • the slope of the time dependent absorption-curve is directly proportional to the specific activity (activity per mg enzyme) of the alpha-amylase in question under the given set of conditions.
  • Method 1 One assay which measures the stability at reduced pH, pH 5.0, in the presence of 5 ppm free calcium. 10 micro g of the variant are incubated under the following conditions: A 0.1 M acetate solution, pH adjusted to pH 5.0, containing 5ppm calcium and 5% w/w common corn starch (free of calcium). Incubation is made in a water bath at 95°C for 30 minutes.
  • Method 2 One assay, which measure the stability in the absence of free calcium and where the pH is maintained at pH 6.0. This assay measures the decrease in calcium sensitivity: 10 micro g of the variant were incubated under the following conditions: A 0.1 M acetate solution, pH adjusted to pH 6.0, containing 5% w/w common corn starch (free of calcium). Incubation was made in a water bath at 95°C for 30 minutes.
  • the enzyme is incubated under the relevant conditions (1-4). Samples are taken at 0, 5, 10, 15 and 30 minutes and diluted 25 times (same dilution for all taken samples) in assay buffer (0.1M 50mM Britton buffer pH 7.3) and the activity is measured using the Phadebas assay (Pharmacia) under standard conditions pH 7.3, 37°C.
  • the activity measured before incubation (0 minutes) is used as reference (100%).
  • the decline in percent is calculated as a function of the incubation time.
  • the specific activity is determined using the Phadebas assay (Pharmacia) as activity/mg enzyme.
  • Cornstarch slurries are prepared by suspending about 11.8 kg Cerestar C*Pharm GL 03406 (89 % starch) in deionized water and making up to 30 kg. The pH is adjusted to 5.5 at ambient temperature, after the addition of 0.55 g CaCl 2 . 2H 2 O.
  • the liquefied starch is collected and transported in sealed thermos-flasks from the pilot plant to the laboratory, where secondary liquefaction is continued at 95°C.
  • Standard fabrics TS526, twill weave, 100% cotton.
  • Impregnation 55°C, 60 ppm CaCl 2 , pH 6.5
  • Enzyme solutions parent AA560 (1 g/l)
  • the random mutagenesis may be carried out by the following steps:
  • Suitable dope algorithms for use in step 6 are well known in the art.
  • One such algorithm is described by Tomandl, D. et al., 1997, Journal of Computer-Aided Molecular Design 11:29-38 .
  • Another algorithm is DOPE ( Jensen, LJ, Andersen, KV, Svendsen, A, and Kretzschmar, T (1998) Nucleic Acids Research 26:697-702 ).
  • the assay can be used to screening of AA560 variants having an improved stability at high pH compared to the parent enzyme and AA560 alpha-amylase variants having an improved stability at high pH and medium temperatures compared to the parent enzyme depending of the screening temperature setting
  • Bacillus libraries are plated on a sandwich of cellulose acetate (OE 67, Schleicher & Schuell, Dassel, Germany) - and nitrocellulose filters (Protran-Ba 85, Schleicher & Schuell, Dassel, Germany) on TY agar plates with 10 micro g/ml kanamycin at 37°C for at least 21 hours.
  • the cellulose acetate layer is located on the TY agar plate.
  • Each filter sandwich is specifically marked with a needle after plating, but before incubation, in order to be able to localize positive variants on the filter and the nitrocellulose filter with bound variants is transferred to a container with glycin-NaOH buffer, pH 8.6-10.6 and incubated at room temperature (can be altered from 10°-60°C) for 15 min.
  • the cellulose acetate filters with colonies are stored on the TY-plates at room temperature until use. After incubation, residual activity is detected on plates containing 1% agarose, 0.2% starch in glycin-NaOH buffer, pH 8.6-10.6.
  • the assay plates with nitrocellulose filters are marked the same way as the filter sandwich and incubated for 2 hours. at room temperature. After removal of the filters the assay plates are stained with 10% Lugol solution. Starch degrading variants are detected as white spots on dark blue background and then identified on the storage plates. Positive variants are rescreened twice under the same conditions as the first screen.
  • the Bacillus library are plated on a sandwich of cellulose acetate (OE 67, Schleicher & Schuell, Dassel, Germany) - and nitrocellulose filters (Protran-Ba 85, Schleicher & Schuell, Dassel, Germany) on TY agar plates with a relevant antibiotic, e.g. , kanamycin or chloramphenicol, at 37°C for at least 21 hours.
  • a relevant antibiotic e.g. , kanamycin or chloramphenicol
  • Each filter sandwich is specifically marked with a needle after plating, but before incubation in order to be able to localize positive variants on the filter and the nitrocellulose filter with bound variants is transferred to a container with carbonate/bicarbonate buffer pH 8.5-10 and with different EDTA concentrations (0.001 mM - 100 mM).
  • the filters are incubated at room temperature for 1 hour.
  • the cellulose acetate filters with colonies are stored on the TY-plates at room temperature until use. After incubation, residual activity is detected on plates containing 1% agarose, 0.2% starch in carbonate/bicarbonate buffer pH 8.5-10.
  • the assay plates with nitrocellulose filters are marked the same way as the filter sandwich and incubated for 2 hours. at room temperature. After removal of the filters the assay plates are stained with 10% Lugol solution. Starch degrading variants are detected as white spots on dark blue background and then identified on the storage plates. Positive variants are rescreened twice under the same conditions as the first screen.
  • the strains Bacillus sp. DSM 12649 (the AA560 alpha-amylase) and Bacillus sp. DSM 12648 (the AA349 alpha-amylase) were propagated in liquid TY medium (as described in Ausubel et al.(1995)). After 16 hours incubation at 37°C and 300 rpm, the cells were harvested, and genomic DNA isolated by the method described by Pitcher et al. (1989).
  • Genomic DNA of strain DSM 12649 was partially digested with restriction enzyme Sau3A, and size-fractionated by electrophoresis on a 0.7 % agarose gel. Fragments between 2 and 10 kb in size was isolated by electrophoresis onto DEAE-cellulose paper (Dretzen et al. (1981).
  • Isolated DNA fragments were ligated to BamHI digested pSJ1678 plasmid DNA, and the ligation mixture was used to transform E. coli SJ2.
  • E. coli SJ2 host cells were prepared for and transformed by electroporation using a gene PULSER TM electroporator from BIO-RAD as described by the supplier.
  • the degenerate primers were directed towards the following regions/amino acid sequences:
  • the DNA fragments were purified by QIAquick spin colums (QUIGEN) and sequenced utilizing the same degenerate primers.
  • QUIGEN QIAquick spin colums
  • Example 1 A preparation of chromosomal DNA from strain DSM 12649 (Example 1) was utilized as template in a similar experiment to the one described above in Example 2 in order to determine the DNA sequence of the AA560 alpha-amylase (SEQ ID NO: 4).
  • pTVB110 is a plasmid replicating in Bacillus subtilis by the use of origin of replication from pU3l10 ( Gryczan, T.J. (1978) J. Bact. 134:318-329 ).
  • the plasmid further encodes the cat gene, conferring resistance towards chlorampenicol, obtained from plasmid pC194 ( Horinouchi, S. and Weisblum, B. (1982), J. Bact. 150: 815-825 ).
  • the plasmid harbors a truncated version of the Bacillus licheniformis alpha-amylase gene, amyL , such that the amyL promoter, signal sequence and transcription terminator are present, but the plasmid does not provide an amy-plus phenotype (halo formation on starch containing agar).
  • the mature gene was fused precisely to the amyL signal sequence so that transcription is initiated by the amyL promoter and translocation is directed by the amyL signal sequence.
  • a PstI site is found within the mature AA349 alpha-amylase. Since the cloning of the gene into pTVB110 would utilize the PstI site in pTVB110, the PstI site located within the AA349 alpha-amylase gene was destroyed during the cloning (by introduction of a silent mutation for amino acid Alanine 88 (GCA to GCG).
  • Primers 188cloningN and 188(Pst-) were used to amplify an approximately 280 bp fragment by PCR on plasmid pLiH1274 using the Pwo polymerase under conditions recommended by the manufacturer (Boehringer Mannheim). This fragment was purified from agarose gel and used as a megaprimer ( G. Sarkar and S.S. Sommer (1990) Biotechniques 8: 404-407 ) together with primer 188cloningC to amplify the full length gene encoding the mature amylase in a second PCR.
  • the resulting approximately 1480 bp fragment was digested with restriction endonucleases PstI and SfiI and ligated with plasmid pTVB110 digested with the same enzymes.
  • Bacillus subtilis strain SHa273 (mentioned in WO 95/10603 ) was transformed with the ligation mixture and the DNA sequence of an amy-plus transformant was verified. This plasmid is denoted pTVB231.
  • DNA sequencing revealed a high DNA identity between alpha-amylases from stains DSM12648 (AA349) and DSM 12649 (AA560). Consequently the same oligonucleotides and strategy was utilized for the cloning of AA560 alpha-amylase into expression vector pTVB110 resulting in plasmid pTVB232, which was then fermented using standard techniques.
  • the culture broth was flocculated by adding 0.01 ml 50%(w/w) CaCl 2 , 2H 2 0, 0.0125 ml 12% (w/w) Sodium aluminate, 0.025 ml 10% C521 and 0.075 ml 0.1% A130 pr. ml culture broth. A clear solution was obtained after centrifugation.
  • the enzyme solution was added ammonium sulphate to a final concentration of 1.2 M and applied on a Butyl Toyo Pearl column (100 ml) previously equilibrated in 1.2 M ammonium sulphate, 10 mM Tris-HCl, pH 7.0.
  • the amylase was eluted using 5 mM Tris-HCl, pH 7.0 and the eluted pool was dialysed against 5 mM Tris-HCl over night. The fraction was then subjected to ion exchange chromatography using a Q-Sepharose column (200 ml) previously equilibrated in 20 mM Tris-HCl, pH 9.0. Unbound material was washed out with the equilibration buffer, and the amylase was eluted using a linear gradient 0 - 1 M NaCl, 20 mM Tris-HCl, pH 9.0. Purity of the amylase preparation was above 95% judged by SDS-PAGE.
  • the alpha-amylase activity was measured using both the Phadebas assay (37°C, pH 7.3) and the Alternative pNPG7 Assay (25°C, pH 7.1) described above. pH- and temperature profiles were made at selected pH- and temperature values. The pH-profile was measured at 37°C and the temperature profile was measured at pH 9.0
  • Washing performance was evaluated by washing soiled test swatches for 15 and 30 minutes at 25°C and 40°C, respectively, in detergent solutions with the AA560 alpha-amylase of the invention.
  • the detergents used are disclosed in Table 2 below.
  • the A/P Model Detergent is described in the Materials section above.
  • the other detergents are commercially available detergents.
  • Commercial detergents containing alpha-amylase was inactivated by microwaves before wash.
  • the purified recombinant AA560 alpha-amylase of Example 6 was added to the detergent solutions at the concentration indicated below.
  • the test swatches were soiled with orange rice starch (CS-28 swatches available from CFT, Center for Test Material, Holland).
  • the parent AA560 alpha-amylase was used for desizing of fabrics using the TEGEWA method (Method and standard scales obtainable from Verband TEGEWA, Karlstrasse 21, Frankfurt a.M., Germany). The conditions are described in the "Materials & Methods" section.
  • the AA560 alpha-amylase was used in desizing tests carried out at 30 and 55°C.
  • the enzyme was dosed from 0.05 to 2 g/l in the impregnation solution.
  • the after-washing procedure was carried out by washing the fabrics in water - instead of the usually hot soda wash.
  • the mature gene has been subcloned into plasmid pzero-2 (Invitrogen, Groningen, The Nederlands).
  • An approximately 1.5 kb PstI-SacI fragment containing the complete mature region of AA560 (obtained from pTVB232) was ligated with vector pZero-2, digested with the same restriction endonucleases.
  • the ligatation mixture was transformed into competent E. coli cells. Transformants were analyzed by PCR to verify the presence of the inserted fragment and the part of this fragment encoding the mature alpha-amylase was sequenced.
  • the resulting plasmid, denoted pTVB299 is deposited at DSMZ as DSM12764.
  • the gene encoding the AA560 alpha-amylase shown in SEQ ID NO: 2 is located in a plasmid pTVB223.
  • the amylase is expressed from the amyL promoter in this construct in Bacillus subtilis.
  • a variant of the invention with delta(D183-G184) mutations was constructed by the mega-primer method as described by Sarkar and Sommer, (1990), BioTechniques 8: 404-407 .
  • Gene specific primer B1 and mutagenic primer 101458 were used to amplify by PCR an approximately 645 bp DNA fragment from a pTVB223 plasmid encoding AA560 shown in SEQ ID NO: 12).
  • the 645 bp fragment was purified from an agarose gel and used as a mega-primer together with primer Y2 in a second PCR carried out on the same template.
  • the resulting approximately 1080 bp fragment was digested with restriction enzymes BstEII and AflIII and the resulting approximately 510 bp DNA fragment was purified and ligated with the pTVB223 plasmid digested with the same enzymes.
  • Competent Bacillus subtilis SHA273 (amylase and protease low) cells were transformed with the ligation and Chlorampenicol resistant transformants and was checked by DNA sequencing to verify the presence of the correct mutations on the plasmid.
  • the resulting plasmid encoding the AA560 alpha-amylase with delta(D183-G184)+N195F was named pTVB232.
  • the polypeptide may comprise the amino acid sequence of SEQ ID NO: 2 or 4.
  • the polypeptide may consist of the amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 4 or a fragment thereof.
  • the polypeptide may consist of amino acids 1 to 485 of SEQ ID NO: 2 or SEQ ID NO: 4.
  • the polypeptide may be encoded by a nucleic acid sequence which hybridizes under medium stringency conditions with (i) the nucleic acid sequence of SEQ ID NO: 1 or SEQ ID NO: 3, (ii) the CDNA sequence of SEQ ID NO: 1 or SEQ ID NO: 3, (iii) a subsequence of (i) or (ii) of at least 100 nucleotides, or (iv) a complementary strand of (i), (ii), or (iii).
  • the polypeptide may be encoded by the nucleic acid sequence contained in plasmid pLiH1274 or pTRBb299 contained in E. coli DSM12761 or E. coli DSM12764, respectively. Also disclosed is a polypeptide having the same alpha-amylase activity as the polypeptide as disclosed above.
  • Also disclosed is a method for producing the above polypeptide comprising (a) cultivating a strain to produce a supernatant comprising the polypeptide; and (b) recovering the polypeptide.
  • a further method for producing the above polypeptide comprises (a) cultivating a host cell comprising a nucleic acid construct comprising a nucleic acid sequence encoding the polypeptide under conditions suitable for production of the polypeptide; and (b) recovering the polypeptide.
  • nucleic acid sequence comprising a nucleic acid sequence which encodes the polypeptide as described above.
  • nucleic acid sequence comprising a nucleic acid sequence having at least one mutation in the mature polypeptide coding sequence of SEQ ID NO:1 or SEQ ID NO:3, in which the mutant nucleic acid sequence encodes a polypeptide consisting of amino acids 1 to 485 of SEQ ID NO: 2 or SEQ ID NO:4.
  • Either of the above isolated nucleic acid sequence may be identified by (a) hybridizing a DNA under medium stringency conditions with (i) the nucleic acid sequence of SEQ ID NO:1, (ii) the cDNA sequence of SEQ ID NO:1, or (iii) a subsequence of (i) or (ii) above of at least 100 nucleotides, or (iv) a complementary strand of (i), (ii) or (iii); and (b) isolating the nucleic acid sequence.
  • Also disclosed is a recombinant expression vector comprising the above nucleic acid construct and a recombinant host cell comprising the above nucleic acid construct.
  • the application further discloses a method for producing a mutant nucleic acid sequence, comprising (a) introducing at least one mutation into the mature polypeptide coding sequence of SEQ ID NO: 1 or SEQ ID NO:3, wherein the mutant nucleic acid sequence encodes a polypeptide consisting of amino acids 1 to 485 of SEQ ID NO: 2 or SEQ ID NO:4; and (b) recovering the mutant nucleic acid sequence; and a mutant nucleic acid sequence produced by the above method.
  • the application discloses a mutant of the above polypeptide with alpha-amylase activity, wherein said alpha-amylase has one or more mutations, in particular substitution or deletions, in the following positions (relative to SEQ ID NO: 2):
  • the application also discloses a use of the above polypeptide or variant (mutant) in a detergent composition, in particular a laundry detergent composition and a dishwash detergent composition; the use of the above polypeptide or variant (mutant) in a desizing composition; the use of the above polypeptide or variant (mutant) for liquefaction of starch; use of the above polypeptide or variant (mutant) for ethanol production.
  • Also disclosed is a method for producing a polypeptide comprising (a) cultivating a strain comprising the above mutant nucleic acid sequence encoding the polypeptide to produce a supernatant comprising the polypeptide; and (b) recovering the polypeptide.
  • a further method for producing a polypeptide comprising (a) cultivating a host cell under conditions conducive for production of the polypeptide, wherein the host cell comprises a mutant nucleic acid sequence having at least one mutation in the mature polypeptide coding sequence of SEQ ID NO: 1 or SEQ ID NO:3, wherein the mutant nucleic acid sequence encodes a polypeptide consisting of amino acids 1 to 485 of SEQ ID NO: 2 or SEQ ID NO:4, and (b) recovering the polypeptide.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Claims (11)

  1. Isoliertes Polypeptid mit alpha-Amylaseaktivität, umfassend die Aminosäuresequenz von SEQ ID NO: 2 und Varianten davon mit einer Aminosäuresequenz, die mindestens 96% Identität mit Aminosäuren 1 bis 485 von SEQ ID NO: 2 aufweist, wobei die Variante eine verbesserte Waschleistung im Vergleich zu der parentalen alpha-Amylase aufweist, wo die Waschleistung bestimmt wird unter den folgenden Waschbedingungen: Teststoffproben, verschmutzt mit orangener Reisstärke, werden für 15 Minuten bei 25 °C bei einem pH von 10,5, einer Wasserhärte von 6 °dH und einem Ca:Mg-Verhältnis von 2:1 in einer Lösung von 3 g/l A/P Modelldetergens, bestehend aus: 20% Natriumtripolyphosphat, 25% Na2SO4, 15% Na2CO3, 20% linearem Alkylbenzolsulfonat, 5% C12-C15-Alkoholethoxylat, 5% Na2Si2O5 und 0,3% NaCl, enthaltend 1 mg/l des Polypeptids mit alpha-Amylaseaktivität, gewaschen; nach dem Waschen werden die Stoffproben evaluiert durch Messen der Remission bei 460 nm und die Waschleistung wird bestimmt als die Remission der gewaschenen Stoffproben minus die Remission einer unter den gleichen Bedingungen aber ohne ein Polypeptid mit alpha-Amylaseaktivität gewaschenen Stoffprobe.
  2. Polypeptid nach Anspruch 1, welches aus Aminosäuren 1 bis 485 von SEQ ID NO: 2 besteht.
  3. Isolierte Nukleinsäuresequenz, umfassend eine Nukleinsäuresequenz, die das Polypeptid nach einem beliebigen der Ansprüche 1-2 kodiert.
  4. Isolierte Nukleinsäuresequenz nach Anspruch 3, umfassend eine Nukleinsäuresequenz mit mindestens einer Mutation in der das maturierte Polypeptid kodierenden Sequenz von SEQ ID NO: 1, in der die mutierte Nukleinsäuresequenz ein Polypeptid kodiert, bestehend aus Aminosäuren 1 bis 485 von SEQ ID NO: 2.
  5. Rekombinanter Expressionsvektor, umfassend das Nukleinsäurekonstrukt gemäß Ansprüchen 3-4.
  6. Rekombinante Wirtszelle, umfassend das Nukleinsäurekonstrukt gemäß Anspruch 5.
  7. Verfahren zum Herstellen einer mutierten Nukleinsäuresequenz gemäß Ansprüchen 3 oder 4, umfassend (a) das Einführen mindestens einer Mutation in die das maturierte Polypeptid kodierenden Sequenz von SEQ ID NO: 1, wobei die mutierte Nukleinsäuresequenz ein Polypeptid kodiert, bestehend aus Aminosäuren 1 bis 485 von SEQ ID NO: 2; und (b) Gewinnen der mutierten Nukleinsäuresequenz.
  8. Verfahren zum Herstellen des Polypeptids gemäß einem beliebigen der Ansprüche 1-2, umfassend (a) Kultivieren einer Wirtszelle gemäß Anspruch 6 unter Bedingungen, die für die Herstellung des Polypeptids förderlich sind; und (b) Gewinnen des Polypeptids.
  9. Verfahren nach Anspruch 8 zum Herstellen eines Polypeptids gemäß einem beliebigen der Ansprüche 1-2, umfassend (a) Kultivieren einer Wirtszelle gemäß Anspruch 6 unter Bedingungen, die für die Herstellung des Polypeptids förderlich sind, wobei die Wirtszelle eine mutierte Nukleinsäuresequenz mit mindestens einer Mutation in der das maturierte Polypeptid kodierenden Sequenz von SEQ ID NO: 1 umfasst, wobei die mutierte Nukleinsäuresequenz ein Polypeptid kodiert, bestehend aus Aminosäuren 1 bis 485 von SEQ ID NO: 2, und (b) Gewinnen des Polypeptids.
  10. Ein Polypeptid gemäß Anspruch 1, wobei das Polypeptid eine oder mehrere Mutationen aufweist, insbesondere Substitutionen oder Deletionen in den folgenden Positionen (relativ zu SEQ ID NO: 2):
    1: R181*, G182*, D183*, G184*;
    2: N195A,R,D,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    3: I206A,R,D,N,C,E,Q,G,H,L,K,M,F,P,S,T,W,Y,V;
    4: E212A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    5: E216A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    6: K269A,R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
    7: R181A,N,D,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V,
    wobei das Polypeptid vorzugsweise ausgewählt ist aus der Gruppe von Mutanten mit den folgenden Mutationen:
    - R181*/G182*/N195A,R,D,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - G182*/D183*/N195A,R,D,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - D183*/G184*/R181A,N,D,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - D183*/G184*/N195A,R,D,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - R181*/G182*/I206A,R,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y;
    - G182*/D183*/1206A,R,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y;
    - D183*/G184*/I206A,R,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y;
    - R181*/G182*/E212A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - G182*/D183*/E212A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - D183*/G184*/E212A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V:
    - R181*/G182*/E216A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - G182*/D183*/E216A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - D183*/G184*/E216A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - R181*/G182*/K269A,R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
    - G182*/D183*/K269A,R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
    - D183*/G184*/K269A,R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
    - N195A,R,D,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V; /1206A,R,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y;
    - N195A,R,D,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V/E212A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - N195A,R,D,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V /E216A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - N195A,R,D,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V/K269A,R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
    - I206A,R,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y/E212A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - I206A,R,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y/E216A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - I206A,R,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y/K269A,R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
    - E212A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V/E216A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V;
    - E212A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V/K269A,R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V;
    - E216A,R,D,N,C,Q,G,H,I,L,K,M,F,P,S,T,W,Y,V/K269A,R,D,N,C,E,Q,G,H,I,L,M,F,P,S,T,W,Y,V,
    und wobei das Polypeptid vorzugsweise des Weiteren eine Substitution in Position E216Q umfasst, und wobei * eine Deletion bezeichnet.
  11. Verwendung des Polypeptids gemäß einem beliebigen der Ansprüche 1-2 oder einer Variante gemäß Anspruch 10 in:
    (a) einer Detergenszusammensetzung, insbesondere einer Wäsche-Detergenszusammensetzung und einer Geschirrspül-Detergenszusammensetzung; oder
    (b) einer Zusammensetzung zum Entschlichten; oder
    (c) zur Verflüssigung von Stärke; oder
    (d) zur Ethanolherstellung.
EP08075617.4A 1999-03-31 2000-03-28 Polypeptide mit Alkalin-Alpha-Amylase-Aktivität und Nukleinsäuren, die diese codieren Expired - Lifetime EP2011864B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP14199566.2A EP2889375B1 (de) 1999-03-31 2000-03-28 Polypeptide mit alkalischer Alpha-Amylase-Aktivität und Nukleinsäuren zur Codierung davon

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA199900439 1999-03-31
DKPA199900490 1999-04-13
US09/290,734 US6361989B1 (en) 1997-10-13 1999-04-13 α-amylase and α-amylase variants
EP00912416A EP1173554A2 (de) 1999-03-31 2000-03-28 POLYPEPTIDE MIT ALKALISCHER ALPHA-AMYLASE AKTIVITäT UND DAFüR KODIERENDE NUKLEINSÄUREN

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP00912416A Division EP1173554A2 (de) 1999-03-31 2000-03-28 POLYPEPTIDE MIT ALKALISCHER ALPHA-AMYLASE AKTIVITäT UND DAFüR KODIERENDE NUKLEINSÄUREN

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP14199566.2A Division EP2889375B1 (de) 1999-03-31 2000-03-28 Polypeptide mit alkalischer Alpha-Amylase-Aktivität und Nukleinsäuren zur Codierung davon

Publications (2)

Publication Number Publication Date
EP2011864A1 EP2011864A1 (de) 2009-01-07
EP2011864B1 true EP2011864B1 (de) 2014-12-31

Family

ID=27220685

Family Applications (3)

Application Number Title Priority Date Filing Date
EP08075617.4A Expired - Lifetime EP2011864B1 (de) 1999-03-31 2000-03-28 Polypeptide mit Alkalin-Alpha-Amylase-Aktivität und Nukleinsäuren, die diese codieren
EP00912416A Ceased EP1173554A2 (de) 1999-03-31 2000-03-28 POLYPEPTIDE MIT ALKALISCHER ALPHA-AMYLASE AKTIVITäT UND DAFüR KODIERENDE NUKLEINSÄUREN
EP14199566.2A Expired - Lifetime EP2889375B1 (de) 1999-03-31 2000-03-28 Polypeptide mit alkalischer Alpha-Amylase-Aktivität und Nukleinsäuren zur Codierung davon

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP00912416A Ceased EP1173554A2 (de) 1999-03-31 2000-03-28 POLYPEPTIDE MIT ALKALISCHER ALPHA-AMYLASE AKTIVITäT UND DAFüR KODIERENDE NUKLEINSÄUREN
EP14199566.2A Expired - Lifetime EP2889375B1 (de) 1999-03-31 2000-03-28 Polypeptide mit alkalischer Alpha-Amylase-Aktivität und Nukleinsäuren zur Codierung davon

Country Status (12)

Country Link
EP (3) EP2011864B1 (de)
JP (1) JP4745503B2 (de)
KR (1) KR100787392B1 (de)
CN (1) CN1234854C (de)
AR (1) AR023229A1 (de)
AU (1) AU781258B2 (de)
BR (1) BR0009392B1 (de)
CA (1) CA2365446C (de)
DK (1) DK2011864T3 (de)
ES (1) ES2532606T3 (de)
MX (1) MXPA01009706A (de)
WO (1) WO2000060060A2 (de)

Families Citing this family (607)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066712A2 (en) 2000-03-08 2001-09-13 Novozymes A/S Variants with altered properties
HUP0300840A2 (hu) * 2000-07-28 2003-07-28 Henkel Kommanditgesellschaft Auf Aktien Új, Bacillus sp. A 7-7 (DSM 12368)-ból extrahált amilolitikus enzim, valamint használata mosó- és tisztítószerekben
EP1370648A2 (de) 2000-08-01 2003-12-17 Novozymes A/S Alpha-amylase-mutanten mit veränderten eigenschaften
EP1423513B1 (de) 2001-05-15 2009-11-25 Novozymes A/S Alpha-amylasevariante mit veränderten eigenschaften
WO2004053039A2 (en) 2002-12-11 2004-06-24 Novozymes A/S Detergent composition comprising endo-glucanase
US7892808B2 (en) 2003-10-10 2011-02-22 Norozymes A/S Protease variants
CN1313608C (zh) * 2004-01-18 2007-05-02 中国科学院微生物研究所 一种碱性α－淀粉酶及其编码基因与生产方法
ATE541034T1 (de) 2004-06-21 2012-01-15 Novozymes As Nocardiopsis-proteasen
DK1781790T3 (en) * 2004-07-05 2016-01-18 Novozymes As ALFA-amylase variants WITH CHANGED PROPERTIES
EP2295557B1 (de) 2004-07-07 2017-09-06 DuPont Nutrition Biosciences ApS Exoamylasevarianten
WO2006031554A2 (en) 2004-09-10 2006-03-23 Novozymes North America, Inc. Methods for preventing, removing, reducing, or disrupting biofilm
DE102004047777B4 (de) 2004-10-01 2018-05-09 Basf Se Alpha-Amylase-Varianten mit erhöhter Lösungsmittelstabilität, Verfahren zu deren Herstellung sowie deren Verwendung
DE102004047776B4 (de) 2004-10-01 2018-05-09 Basf Se Gegen Di- und/oder Multimerisierung stabilisierte Alpha-Amylase-Varianten, Verfahren zu deren Herstellung sowie deren Verwendung
ATE489404T1 (de) 2004-12-22 2010-12-15 Novozymes As Hybridenzyme, bestehend aus einer ersten endoamylaseaminosäuresequenz und einem kohlenhydratbindenden modul als zweiter aminosäuresequenz
CN101128579B (zh) * 2004-12-23 2013-10-02 诺维信公司 α-淀粉酶变体
DE102005062984A1 (de) * 2005-12-28 2007-07-05 Henkel Kgaa Wasch- oder Reinigungsmittel mit spezieller Amylase
DE102006038448A1 (de) 2005-12-28 2008-02-21 Henkel Kgaa Enzym-haltiges Reinigungsmittel
AU2007222359B2 (en) * 2006-03-07 2012-05-10 Novozymes A/S Beer-brewing method
WO2007149699A2 (en) 2006-06-21 2007-12-27 Novozymes North America, Inc. Desizing and scouring process
JP5394922B2 (ja) 2006-08-11 2014-01-22 ノボザイムス バイオロジカルズ，インコーポレイティド 菌培養液及び菌培養液含有組成物
JP5497440B2 (ja) 2006-10-06 2014-05-21 ノボザイムス アクティーゼルスカブ 洗剤組成物及び当該組成物における酵素の組み合わせ使用
RU2009137386A (ru) * 2007-03-09 2011-04-20 ДАНИСКО ЮЭс ИНК., ДЖЕНЕНКОР ДИВИЖН (US) Варианты амилазы алкалифильных видов bacillus, композиции, содержащие варианты амилазы, и способы применения
CA2680370C (en) 2007-03-23 2017-03-14 Sarah Mchatton Preventing and reducing biofilm formation and planktonic proliferation
JP2011505121A (ja) 2007-11-05 2011-02-24 ダニスコ・ユーエス・インク 改変された性質を有するアルファ−アミラーゼ
NZ584434A (en) 2007-11-05 2011-12-22 Danisco Us Inc VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES
MX2010008359A (es) 2008-02-04 2010-08-30 Danisco Us Inc Variantes de alfa-amilasa ts23 con propiedades alteradas.
US8066818B2 (en) 2008-02-08 2011-11-29 The Procter & Gamble Company Water-soluble pouch
US20090209447A1 (en) 2008-02-15 2009-08-20 Michelle Meek Cleaning compositions
EP2100947A1 (de) 2008-03-14 2009-09-16 The Procter and Gamble Company Waschmittelzusammensetzung für Spülmaschinen
GB0810881D0 (en) 2008-06-16 2008-07-23 Unilever Plc Improvements relating to fabric cleaning
EP2149786A1 (de) 2008-08-01 2010-02-03 Unilever PLC Verbesserungen bei der Analyse von Reinigungsmitteln
BRMU8903145Y1 (pt) 2008-09-12 2017-05-09 Unilever Nv produto de lavagem embalado
EP2166092A1 (de) 2008-09-18 2010-03-24 The Procter and Gamble Company Reinigungsmittelzusammensetzung
EP2166076A1 (de) 2008-09-23 2010-03-24 The Procter & Gamble Company Reinigungszusammensetzung
EP2166075A1 (de) 2008-09-23 2010-03-24 The Procter and Gamble Company Reinigungszusammensetzung
EP2166073A1 (de) 2008-09-23 2010-03-24 The Procter & Gamble Company Reinigungszusammensetzung
DK2337837T4 (en) 2008-09-25 2017-02-06 Danisco Us Inc ALPHA-AMYLASE MIXTURES AND PROCEDURES FOR USING IT
US20100125046A1 (en) 2008-11-20 2010-05-20 Denome Frank William Cleaning products
EP2202290A1 (de) 2008-12-23 2010-06-30 Unilever PLC Fließfähige Waschmittelzusammensetzung und Verpackung dafür
EP3998328A1 (de) 2009-02-09 2022-05-18 The Procter & Gamble Company Reinigungsmittelzusammensetzung
MX2011010040A (es) 2009-04-01 2011-11-18 Danisco Us Inc Sistema de limpieza que comprende una alfa-amilasa y una proteasa.
US8439980B2 (en) 2009-05-05 2013-05-14 Conopco, Inc. Shading composition
WO2011005913A1 (en) 2009-07-09 2011-01-13 The Procter & Gamble Company A catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte
EP2451915A1 (de) 2009-07-09 2012-05-16 The Procter & Gamble Company Katalytische waschmittelzusammensetzung mit relativ geringem gehalt an wasserlöslichem elektrolyt
HUE029942T2 (en) 2009-08-13 2017-04-28 Procter & Gamble Method for washing low temperature fabrics
MX2012004091A (es) 2009-10-08 2012-04-20 Unilever Nv Composicion matizante.
BR112012007757B1 (pt) 2009-10-13 2019-08-27 Unilever Nv composição de tratamento de lavagem de tecidos e método doméstico de tratamento de tecido
MX311859B (es) 2009-10-23 2013-07-31 Unilever Nv Polimeros de tinte.
EP4159833A3 (de) 2009-12-09 2023-07-26 The Procter & Gamble Company Stoff- und heimpflegeprodukte
EP2333041B1 (de) 2009-12-10 2013-05-15 The Procter & Gamble Company Verfahren und Verwendung einer Geschirrspülmittelzusammensetzung
EP2333040B2 (de) 2009-12-10 2019-11-13 The Procter & Gamble Company Reinigungsmittelzusammensetzung
EP2333039B2 (de) 2009-12-10 2020-11-11 The Procter & Gamble Company Verfahren und Verwendung einer Geschirrspülmittelzusammensetzung
EP2333042B1 (de) 2009-12-10 2015-07-01 The Procter and Gamble Company Reinigungsmittelverwendung
WO2011080267A2 (en) 2009-12-29 2011-07-07 Novozymes A/S Polypetides having detergency enhancing effect
EP2521773A1 (de) 2010-01-04 2012-11-14 Novozymes A/S Alpha-amylasen
WO2011082889A1 (en) 2010-01-07 2011-07-14 Unilever Plc Natural shading agents
ES2477518T3 (es) 2010-02-09 2014-07-17 Unilever Nv Polímeros colorantes
CN113186178A (zh) 2010-02-10 2021-07-30 诺维信公司 在螯合剂存在下具有高稳定性的变体和包含变体的组合物
EP2357220A1 (de) * 2010-02-10 2011-08-17 The Procter & Gamble Company Reinigungszusammensetzungen mit Amylasevarianten mit hoher Stabilität in Gegenwart eines Chelatwirkstoffs
WO2011098356A1 (en) 2010-02-12 2011-08-18 Unilever Plc Laundry treatment composition comprising bis-azo shading dyes
EP2539447B1 (de) 2010-02-25 2017-07-26 Novozymes A/S Lysozym-varianten und dafür kodierende polynukleotide
EP2361964B1 (de) 2010-02-25 2012-12-12 The Procter & Gamble Company Waschmittelzusammensetzungen
ES2533368T3 (es) 2010-04-23 2015-04-09 The Procter & Gamble Company Producto para lavavajillas
EP2380962B1 (de) 2010-04-23 2016-03-30 The Procter and Gamble Company Partikel
ES2565192T3 (es) 2010-04-23 2016-04-01 The Procter & Gamble Company Método para perfumar
EP2380478A1 (de) 2010-04-23 2011-10-26 The Procter & Gamble Company Automatisches Geschirrspülprodukt
EP2380961B1 (de) 2010-04-23 2018-05-23 The Procter and Gamble Company Reinigungsmittelzusammensetzung
EP2383329A1 (de) 2010-04-23 2011-11-02 The Procter & Gamble Company Partikel
MX2012012096A (es) 2010-04-26 2012-12-17 Novozymes As Granulos de enzima.
CN102892875A (zh) 2010-04-29 2013-01-23 荷兰联合利华有限公司 双杂环偶氮染料
EP2395070A1 (de) * 2010-06-10 2011-12-14 The Procter & Gamble Company Flüssiges Waschmittelzusammensetzung mit Lipase bakterieller Herkunft
CN103069014B (zh) 2010-06-22 2016-06-08 诺维信公司 皮和兽皮的酶法脱毛
PL2420558T3 (pl) 2010-08-17 2017-12-29 The Procter And Gamble Company Stabilne, trwałe detergenty do ręcznego zmywania naczyń
PL2606111T3 (pl) 2010-08-17 2018-05-30 The Procter And Gamble Company Sposób ręcznego zmywania naczyń zapewniający długotrwałą pianę
CN103492545A (zh) 2010-08-30 2014-01-01 诺维信公司 两次浸泡洗涤
CN103189493A (zh) 2010-08-30 2013-07-03 诺维信公司 浓缩的浸泡洗涤
US20130266554A1 (en) 2010-09-16 2013-10-10 Novozymes A/S Lysozymes
GB201015672D0 (en) 2010-09-20 2010-10-27 Unilever Plc Improvements relating to fabric treatment compositions comprising targeted benefit agents
EP2441820A1 (de) 2010-10-14 2012-04-18 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Waschmittelpartikel
CN103282477B (zh) 2010-10-14 2015-04-01 荷兰联合利华有限公司 顶部装载洗衣容器的方法
CN103154228B (zh) 2010-10-14 2015-04-08 荷兰联合利华有限公司 洗衣洗涤剂颗粒
EP2627760B1 (de) 2010-10-14 2016-08-10 Unilever PLC Waschmittelteilchen
ES2529715T3 (es) 2010-10-14 2015-02-25 Unilever N.V. Composiciones de detergente particulado que comprenden agente fluorescente
MX340443B (es) 2010-10-14 2016-07-08 Unilever N V * Composicion empacada de detergente particulado.
IN2013MN00626A (de) 2010-10-14 2015-06-12 Unilever Plc
MY164216A (en) 2010-10-14 2017-11-30 Unilever Nv Laundry detergent particles
AU2011315793B2 (en) 2010-10-14 2014-03-06 Unilever Plc Laundry detergent particles
WO2012049032A1 (en) 2010-10-14 2012-04-19 Unilever Plc Refill and refillable packages of concentrated particulate detergent compositions
EP2441825A1 (de) 2010-10-14 2012-04-18 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Herstellungsverfahren für Waschmittelpartikel
WO2012049034A1 (en) 2010-10-14 2012-04-19 Unilever Plc Packaging and dispensing of detergent compositions
EP2441822A1 (de) 2010-10-14 2012-04-18 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Waschmittelpartikel
MX342221B (es) 2010-10-14 2016-09-21 Unilever N V * Composicion empacada de detergente particulado.
BR112013008954A2 (pt) 2010-10-14 2016-06-28 Unilever Nv composição detergente particulada embalada acondicionada em uma embalagem
BR112013009135B1 (pt) 2010-10-14 2021-01-05 Unilever N.V. produto embalado
CN103153813B (zh) 2010-10-14 2015-08-19 荷兰联合利华有限公司 包含洗衣组合物的包装、所述包装的分配器和利用所述分配器和所述包装进行洗涤的方法
US9284517B2 (en) 2010-10-14 2016-03-15 Conopco Inc. Laundry detergent particle
ES2537714T3 (es) 2010-10-14 2015-06-11 Unilever N.V. Partículas detergentes para colada
BR112013009456B1 (pt) 2010-10-22 2021-11-30 Unilever Ip Holdings B.V. Composição líquida detergente aquosa estruturada e processo para fabricar um líquido detergente aquoso estruturado
DE102010063458A1 (de) 2010-12-17 2012-06-21 Henkel Ag & Co. Kgaa Lagerstabiles flüssiges Wasch- oder Reinigungsmittel enthaltend Protease und Amylase
DE102010063743A1 (de) 2010-12-21 2012-06-21 Henkel Ag & Co. Kgaa Flüssige Tensidzubereitung enthaltend Lipase und Phosphonat
WO2012098046A1 (en) 2011-01-17 2012-07-26 Unilever Plc Dye polymer for laundry treatment
ES2538997T3 (es) 2011-01-31 2015-06-25 Unilever N.V. Composiciones detergentes líquidas alcalinas
WO2012112718A1 (en) 2011-02-15 2012-08-23 Novozymes Biologicals, Inc. Mitigation of odor in cleaning machines and cleaning processes
MX2013010375A (es) 2011-03-10 2013-10-30 Unilever Nv Polimero colorante.
WO2012130492A1 (en) 2011-03-25 2012-10-04 Unilever Plc Dye polymer
ES2421162T3 (es) 2011-04-04 2013-08-29 Unilever Nv Procedimiento de lavado de telas
DE102011007313A1 (de) 2011-04-13 2012-10-18 Henkel Ag & Co. Kgaa Expressionsverfahren
DE102011007627A1 (de) 2011-04-18 2012-10-18 Henkel Ag & Co. Kgaa Wasch- oder Reinigungsmittel mit fester Enzymkonfektionierung
DE102011007695A1 (de) 2011-04-19 2012-10-25 Henkel Ag & Co. Kgaa Phosphatfreies Geschirrspülmittel
MX357386B (es) 2011-05-05 2018-07-06 Procter & Gamble Composiciones y metodos que comprenden variantes de proteasa serina.
BR112013027963A2 (pt) 2011-05-05 2016-11-29 Danisco Us Inc "variante de subtilisina com atividade proteolítica, ácido nucleico, vetor de expressão, célula hospedeira, composição e método de limpeza".
EP2522715A1 (de) 2011-05-13 2012-11-14 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Konzentrierte wässrige Waschmittelzusammensetzungen
BR112013028716A2 (pt) 2011-05-13 2017-01-24 Unilever Nv detergente de lavanderia líquido concentrado aquoso, composição, método de lavagem de tecidos de poliéster e seu uso
EP2522714A1 (de) 2011-05-13 2012-11-14 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Konzentrierte wässrige Waschmittelzusammensetzungen
ES2544539T3 (es) 2011-05-26 2015-09-01 Unilever N.V. Composición líquida para lavandería
DE102011118032A1 (de) 2011-05-31 2012-12-06 Henkel Ag & Co. Kgaa Expressionsvektoren zur verbesserten Proteinsekretion
ES2671329T3 (es) 2011-06-01 2018-06-06 Unilever N.V. Composición detergente líquida que contiene polímero colorante
US20140371435A9 (en) 2011-06-03 2014-12-18 Eduardo Torres Laundry Care Compositions Containing Thiophene Azo Dyes
DE102011118037A1 (de) 2011-06-16 2012-12-20 Henkel Ag & Co. Kgaa Geschirrspülmittel mit Bleichkatalysator und Protease
CN107475235B (zh) 2011-06-20 2022-09-13 诺维信公司 颗粒组合物
EP2537918A1 (de) 2011-06-20 2012-12-26 The Procter & Gamble Company Verbraucherprodukte mit lipasenhaltigen beschichteten Partikeln
CN103649307B (zh) 2011-06-30 2020-03-27 诺维信公司 α-淀粉酶变体
CN103857781A (zh) 2011-07-21 2014-06-11 荷兰联合利华有限公司 液体洗衣组合物
EP2551335A1 (de) 2011-07-25 2013-01-30 The Procter & Gamble Company Flüssige Waschmittelzusammensetzung mit stabilisiertem Enzym
BR112014003560A2 (pt) 2011-08-19 2017-03-01 Novozymes A / S polipeptídeo, composição, polinucleotídeo, construto de ácido nucleico ou vetor de expressão, célula hospedeira, métodos de produção de polipeptídeo, para melhoria do valor nutricional de uma alimentação animal, e para o tratamento de proteínas, planta, parte de planta ou célula de planta transgênica, uso de pelo menos um polipeptídeo, aditivo de alimentação animal, e, alimentação animal
DE102011118027A1 (de) 2011-09-12 2013-03-14 Henkel Ag & Co. Kgaa Verfahren zur Anpassung eines Hydrolytischen Enzyms an eine das hydrolytische Enzym stabilisierende Komponente
HUE039835T2 (hu) 2011-10-17 2019-02-28 Novozymes As Alfa-amiláz variánsok és az azokat kódoló polinukleotidok
EP3495479A1 (de) 2011-10-17 2019-06-12 Novozymes A/S Alpha-amylase-varianten und polynukleotide zur codierung davon
EP2584028B1 (de) 2011-10-19 2017-05-10 The Procter & Gamble Company Partikel
BR112014010045B1 (pt) 2011-10-28 2021-12-21 Danisco Us Inc Polipeptídeo de alfa-amilase variante formadoras de malto-hexaose, composição compreendendo o mesmo, célula hospedeira, e métodos para remover uma mancha ou sujeira amilácea, para sacarificar uma composição que compreende amido, produção de uma composição alimentícia de desengomagem de um têxtil
DE102011088751A1 (de) 2011-12-15 2013-06-20 Henkel Ag & Co. Kgaa Lagerstabiles flüssiges Wasch- oder Reinigungsmittel enthaltend Protease und Amylase
WO2013092052A1 (en) 2011-12-20 2013-06-27 Unilever Plc Isotropic liquid detergents comprising soil release polymer
MX358963B (es) 2011-12-28 2018-09-11 Novozymes As Polipeptidos con actividad proteasa.
DE102012200959A1 (de) 2012-01-24 2013-07-25 Henkel Ag & Co. Kgaa Enzymhaltiges Wasch- oder Reinigungsmittel
DE102012201297A1 (de) 2012-01-31 2013-08-01 Basf Se Expressionsverfahren
DE102012201522A1 (de) * 2012-02-02 2013-08-08 Basf Se Lagerstabiles flüssiges Geschirrspülmittel enthaltend Protease und Amylase
CN104080902B (zh) 2012-02-03 2018-08-03 宝洁公司 具有脂肪酶的用于表面处理的组合物和方法
DE102012203475A1 (de) 2012-03-06 2013-09-12 Henkel Ag & Co. Kgaa Enzymhaltiges Handgeschirrspülmittel
EP2639291A1 (de) 2012-03-13 2013-09-18 Unilever PLC Verpackte partikelförmige Reinigungsmittelzusammensetzung
WO2013142486A1 (en) 2012-03-19 2013-09-26 The Procter & Gamble Company Laundry care compositions containing dyes
WO2013139702A1 (en) 2012-03-21 2013-09-26 Unilever Plc Laundry detergent particles
CN104204198B (zh) 2012-04-02 2018-09-25 诺维信公司 脂肪酶变体以及编码其的多核苷酸
PL2834335T3 (pl) 2012-04-03 2017-04-28 Unilever N.V. Detergentowe cząstki do prania
WO2013149752A1 (en) 2012-04-03 2013-10-10 Unilever Plc Laundry detergent particles
WO2013149753A1 (en) 2012-04-03 2013-10-10 Unilever Plc Laundry detergent particles
EP2834338B1 (de) 2012-04-03 2017-04-19 Unilever PLC, a company registered in England and Wales under company no. 41424 Waschmittelpartikel
DE102012206571A1 (de) 2012-04-20 2013-10-24 Henkel Ag & Co. Kgaa Lagerstabiles Wasch- oder Reinigungsmittel mit gesteigerter Reinigungsleistung
WO2013160025A1 (en) 2012-04-23 2013-10-31 Unilever Plc Structured aqueous liquid detergent
PL2662436T3 (pl) 2012-05-11 2018-02-28 The Procter And Gamble Company Kompozycja detergentu
DE102012209289A1 (de) 2012-06-01 2013-12-05 Henkel Ag & Co. Kgaa Lagerstabiles flüssiges Wasch- oder Reinigungsmittel enthaltend Protease
EP2674475A1 (de) 2012-06-11 2013-12-18 The Procter & Gamble Company Wasch- und Reinigungsmittel
DE102012210992A1 (de) 2012-06-27 2014-01-02 Henkel Ag & Co. Kgaa Verwendung von Sulfopolymer als Enzymstabilisator
US10246692B2 (en) 2012-07-12 2019-04-02 Novozymes A/S Polypeptides having lipase activity and polynucleotides encoding same
DE102012215107A1 (de) 2012-08-24 2014-02-27 Basf Se Festes Geschirrspülmittel mit verbesserter Proteaseleistung
EP2700703B1 (de) 2012-08-24 2018-05-02 The Procter and Gamble Company Geschirrspülverfahren
EP2700704B1 (de) 2012-08-24 2018-05-09 The Procter and Gamble Company Geschirrspülverfahren
DE102012215642A1 (de) 2012-09-04 2014-03-06 Henkel Ag & Co. Kgaa Wasch- oder Reinigungsmittel mit verbesserter Enzymleistung
IN2015MN00417A (de) 2012-09-25 2015-09-04 Unilever Plc
WO2014086659A2 (en) 2012-12-06 2014-06-12 Ahmedabad Textile Industry's Research Association Method for enzymatical preparation of textiles
DE102012224038A1 (de) 2012-12-20 2014-06-26 Henkel Ag & Co. Kgaa Enzymhaltige Granulatzusammensetzung
MX2015007802A (es) 2012-12-20 2015-09-04 Procter & Gamble Composiciones de detergente con blanqueador recubierto con silicato.
EP2746381A1 (de) 2012-12-21 2014-06-25 The Procter & Gamble Company Reinigungspack
DE102013202450A1 (de) 2013-02-14 2014-08-14 Henkel Ag & Co. Kgaa Flüssiges Wasch- oder Reinigungsmittel mit verbesserter Enzymstabilität
MX2015011690A (es) 2013-03-05 2015-12-07 Procter & Gamble Composiciones de azucares mezclados.
US9631164B2 (en) 2013-03-21 2017-04-25 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
CN105073966B (zh) 2013-03-28 2018-03-23 宝洁公司 包含聚醚胺的清洁组合物
WO2014183921A1 (en) 2013-05-17 2014-11-20 Novozymes A/S Polypeptides having alpha amylase activity
EP3699256A1 (de) 2013-05-28 2020-08-26 The Procter & Gamble Company Oberflächenbehandlungszusammensetzungen mit fotochromen farbstoffen
WO2014194034A2 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
EP3882346A1 (de) 2013-05-29 2021-09-22 Danisco US Inc. Neuartige metalloproteasen
EP3004314B1 (de) 2013-05-29 2018-06-20 Danisco US Inc. Neuartige metalloproteasen
EP3004342B1 (de) 2013-05-29 2023-01-11 Danisco US Inc. Neuartige metalloproteasen
US20160122690A1 (en) 2013-05-30 2016-05-05 Novozymes A/S Particulate Enzyme Composition
CN114634921B (zh) * 2013-06-06 2024-09-10 诺维信公司 α-淀粉酶变体以及对其进行编码的多核苷酸
US20160130489A1 (en) 2013-06-12 2016-05-12 Novozymes A/S Dust suppressant
US9834682B2 (en) 2013-09-18 2017-12-05 Milliken & Company Laundry care composition comprising carboxylate dye
WO2015042086A1 (en) 2013-09-18 2015-03-26 The Procter & Gamble Company Laundry care composition comprising carboxylate dye
MX2016003538A (es) 2013-09-18 2016-06-28 Procter & Gamble Composiciones para el cuidado de la ropa que contienen colorantes azoicos de tiofeno y carboxilato.
CA2921433A1 (en) 2013-09-18 2015-03-26 The Procter & Gamble Company Laundry care composition comprising carboxylate dye
EP2857485A1 (de) 2013-10-07 2015-04-08 WeylChem Switzerland AG Beutel mit mehreren Fächern mit alkanolaminfreien Reinigungszusammensetzungen, Waschverfahren und Verwendung zum Waschen und Reinigen von Textilien und Geschirr
EP2857487A1 (de) 2013-10-07 2015-04-08 WeylChem Switzerland AG Beutel mit mehreren Fächern mit Reinigungszusammensetzungen, Waschverfahren und Verwendung zum Waschen und Reinigen von Textilien und Geschirr
EP2857486A1 (de) 2013-10-07 2015-04-08 WeylChem Switzerland AG Beutel mit mehreren Fächern mit Reinigungszusammensetzungen, Waschverfahren und Verwendung zum Waschen und Reinigen von Textilien und Geschirr
DK3080263T3 (da) 2013-12-13 2019-10-07 Danisco Us Inc Serinproteaser af bacillus gibsonii-clade
EP3514230B1 (de) 2013-12-13 2021-09-22 Danisco US Inc. Serinproteasen aus einer bacillus-spezies
EP3083704B1 (de) 2013-12-16 2022-08-17 Nutrition & Biosciences USA 4, Inc. Verwendung von poly-alpha-1,3-glucan-ethern als viskositätsmodifikatoren
EP3789407B1 (de) 2013-12-18 2024-07-24 Nutrition & Biosciences USA 4, Inc. Kationische polyalpha-1,3-glucanether
DE102013226835A1 (de) 2013-12-20 2015-06-25 Henkel Ag & Co. Kgaa Wasch- oder Reinigungsmittel mit reduziertem Tensidgehalt
WO2015112341A1 (en) 2014-01-22 2015-07-30 The Procter & Gamble Company Fabric treatment composition
WO2015112338A1 (en) 2014-01-22 2015-07-30 The Procter & Gamble Company Method of treating textile fabrics
WO2015112340A1 (en) 2014-01-22 2015-07-30 The Procter & Gamble Company Method of treating textile fabrics
EP3097173B1 (de) 2014-01-22 2020-12-23 The Procter and Gamble Company Gewebebehandlungszusammensetzung
CA2841024C (en) 2014-01-30 2017-03-07 The Procter & Gamble Company Unit dose article
US20150232785A1 (en) 2014-02-14 2015-08-20 E I Du Pont De Nemours And Company Polysaccharides for viscosity modification
WO2015130653A1 (en) 2014-02-25 2015-09-03 The Procter & Gamble Company A process for making renewable surfactant intermediates and surfactants from fats and oils and products thereof
US9994497B2 (en) 2014-02-25 2018-06-12 The Procter & Gamble Company Process for making renewable surfactant intermediates and surfactants from fats and oils and products thereof
WO2015127891A1 (en) 2014-02-26 2015-09-03 The Procter & Gamble Company Cleaning compositions comprising alkoxylated polyalkyleneimine, organomodified silicone and silixane-based diluent
EP2915872A1 (de) 2014-03-06 2015-09-09 The Procter and Gamble Company Geschirrspülzusammensetzung
EP2915873A1 (de) 2014-03-06 2015-09-09 The Procter and Gamble Company Geschirrspülzusammensetzung
US9695253B2 (en) 2014-03-11 2017-07-04 E I Du Pont De Nemours And Company Oxidized poly alpha-1,3-glucan
EP3587569B1 (de) 2014-03-21 2022-08-03 Danisco US Inc. Serinproteasen aus einer bacillus-spezies
JP6262365B2 (ja) 2014-03-27 2018-01-17 ザ プロクター アンド ギャンブル カンパニー ポリエーテルアミンを含有する洗浄組成物
US20150275143A1 (en) 2014-03-27 2015-10-01 The Procter & Gamble Company Cleaning compositions containing a polyetheramine
US9719052B2 (en) 2014-03-27 2017-08-01 The Procter & Gamble Company Cleaning compositions containing a polyetheramine
EP2924106A1 (de) 2014-03-28 2015-09-30 The Procter and Gamble Company Dosierungsartikel für wasserlösliche Einheit
EP2924105A1 (de) 2014-03-28 2015-09-30 The Procter and Gamble Company Dosierungsartikel für wasserlösliche Einheit
DE102014206051A1 (de) 2014-03-31 2015-10-01 Henkel Ag & Co. Kgaa Proteasen mit verbesserter Wasserhärtetoleranz
EP3126479A1 (de) 2014-04-01 2017-02-08 Novozymes A/S Polypeptide mit alpha-amylase-aktivität
EP3129478B1 (de) 2014-04-10 2019-03-27 Novozymes A/S Alpha-amylase-varianten und sie kodierende polynukleotide
EP2940116B1 (de) 2014-04-30 2018-10-17 The Procter and Gamble Company Reinigungsmittel
WO2015171592A1 (en) 2014-05-06 2015-11-12 Milliken & Company Laundry care compositions
DE102014208509A1 (de) 2014-05-07 2015-11-12 Henkel Ag & Co. Kgaa Reinigungsmittel
DE102014208507A1 (de) 2014-05-07 2015-11-12 Henkel Ag & Co. Kgaa Waschmittel
DE102014209241A1 (de) 2014-05-15 2015-11-19 Henkel Ag & Co. Kgaa Wasch- und Reinigungsmittel mit erhöhter Bleichleistung
WO2015187757A1 (en) 2014-06-06 2015-12-10 The Procter & Gamble Company Detergent composition comprising polyalkyleneimine polymers
US20170121695A1 (en) 2014-06-12 2017-05-04 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
WO2015189372A1 (en) 2014-06-12 2015-12-17 Novozymes A/S Alpha-amylase variants
US9714403B2 (en) 2014-06-19 2017-07-25 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
EP3158043B1 (de) 2014-06-19 2021-03-10 Nutrition & Biosciences USA 4, Inc. Zusammensetzungen mit einer oder mehreren poly-alpha-1,3-glucan-ether-verbindungen
US9617502B2 (en) 2014-09-15 2017-04-11 The Procter & Gamble Company Detergent compositions containing salts of polyetheramines and polymeric acid
EP3194543B1 (de) 2014-09-18 2018-04-04 Unilever Plc. Bleichungszusammensetzung
US20160090552A1 (en) 2014-09-25 2016-03-31 The Procter & Gamble Company Detergent compositions containing a polyetheramine and an anionic soil release polymer
EP3197988B1 (de) 2014-09-25 2018-08-01 The Procter & Gamble Company Reinigungszusammensetzungen mit einem polyetheramin
US9388368B2 (en) 2014-09-26 2016-07-12 The Procter & Gamble Company Cleaning compositions containing a polyetheramine
EP3207129B1 (de) 2014-10-17 2019-11-20 Danisco US Inc. Serinproteasen aus einer bacillus-spezies
EP3212781B1 (de) 2014-10-27 2019-09-18 Danisco US Inc. Serinproteasen
US20180010074A1 (en) 2014-10-27 2018-01-11 Danisco Us Inc. Serine proteases of bacillus species
DK3212662T3 (da) 2014-10-27 2020-07-20 Danisco Us Inc Serinproteaser
EP3212782B1 (de) 2014-10-27 2019-04-17 Danisco US Inc. Serinproteasen
EP3212783B1 (de) 2014-10-27 2024-06-26 Danisco US Inc. Serinproteasen
CA3096486C (en) 2014-11-14 2023-02-07 The Procter & Gamble Company Silicone compounds
EP3256563A1 (de) 2014-11-17 2017-12-20 The Procter and Gamble Company Pflegemittelverabreichungszusammensetzungen
CN107075489A (zh) 2014-11-20 2017-08-18 诺维信公司 脂环酸芽孢杆菌变体以及编码它们的多核苷酸
DE102014223969A1 (de) 2014-11-25 2016-05-25 Henkel Ag & Co. Kgaa Verwendung von Molkenproteinisolat in enzymhaltigen Wasch- oder Reinigungsmitteln zur Erhöhung der Stabilität von Enzymen
PL3026099T3 (pl) 2014-11-26 2021-06-14 The Procter & Gamble Company Saszetka czyszcząca
ES2690336T3 (es) 2014-11-26 2018-11-20 The Procter & Gamble Company Bolsa limpiadora
ES2690335T3 (es) 2014-11-26 2018-11-20 The Procter & Gamble Company Bolsa limpiadora
EP3026102B1 (de) 2014-11-26 2018-12-26 The Procter and Gamble Company Reinigungsbeutel
DE102014224825A1 (de) 2014-12-04 2016-06-09 Henkel Ag & Co. Kgaa Proteasevarianten mit verbesserter Waschleistung
DE102014018149A1 (de) 2014-12-10 2016-06-16 Henkel Ag & Co. Kgaa Festes Wasch- und Reinigungsmittel mit Amylase
DE102014225478A1 (de) * 2014-12-10 2016-06-16 Henkel Ag & Co. Kgaa Wasch- oder Reinigungsmittel mit spezieller a-Amylase und definierter Wasseraktivität aw
DE102014225473A1 (de) 2014-12-10 2016-06-16 Henkel Ag & Co. Kgaa Wasch- und Reinigungsmittel mit einer Kombination aus Amylase und Protease
EP3034597A1 (de) 2014-12-17 2016-06-22 The Procter and Gamble Company Reinigungsmittelzusammensetzung
EP3034592A1 (de) 2014-12-17 2016-06-22 The Procter and Gamble Company Verfahren zum maschinellen Geschirrspülen
EP3034590A1 (de) 2014-12-17 2016-06-22 The Procter and Gamble Company Verfahren zum maschinellen Geschirrspülen
DE102014226251A1 (de) 2014-12-17 2016-06-23 Henkel Ag & Co. Kgaa Verwendung anorganischer Oxide, Hydroxide oder Oxidhydroxide in enzymhaltigen Wasch- oder Reinigungsmitteln zur Erhöhung der Stabilität von Enzymen
EP3034589A1 (de) 2014-12-17 2016-06-22 The Procter and Gamble Company Reinigungsmittelzusammensetzung
EP3034591A1 (de) 2014-12-17 2016-06-22 The Procter and Gamble Company Verfahren zum maschinellen Geschirrspülen
EP3034588B1 (de) * 2014-12-17 2019-04-24 The Procter and Gamble Company Reinigungsmittelzusammensetzung
EP3034596B2 (de) 2014-12-17 2021-11-10 The Procter & Gamble Company Reinigungsmittelzusammensetzung
DE102014226681A1 (de) 2014-12-19 2016-06-23 Henkel Ag & Co. Kgaa Flüssige Tensidzusammensetzung mit spezieller Tensidkombination und Enzym
PL3037512T3 (pl) 2014-12-22 2018-08-31 The Procter And Gamble Company Proces recyklingu saszetek z detergentem
AU2015369965B2 (en) 2014-12-23 2020-01-30 Nutrition & Biosciences USA 4, Inc. Enzymatically produced cellulose
BR112017014673B1 (pt) 2015-01-09 2022-11-01 Unilever Ip Holdings B.V Composição de tratamento para lavagem de roupas
EP3050954A1 (de) 2015-02-02 2016-08-03 The Procter and Gamble Company Neue Verwendung von sulfonierten Polymeren
ES2714130T3 (es) 2015-02-02 2019-05-27 Procter & Gamble Composición detergente
EP3050948B1 (de) 2015-02-02 2018-09-19 The Procter and Gamble Company Neue Verwendung eines Komplexbildners
EP3050947A1 (de) 2015-02-02 2016-08-03 The Procter and Gamble Company Waschmittelpackung
EP3050950B1 (de) 2015-02-02 2018-09-19 The Procter and Gamble Company Neue Verwendung von sulfonierten Polymeren
EP3050951A1 (de) 2015-02-02 2016-08-03 The Procter and Gamble Company Verfahren zum Geschirrspülen
EP3050952A1 (de) 2015-02-02 2016-08-03 The Procter and Gamble Company Verfahren zum Geschirrspülen
EP3050955B2 (de) 2015-02-02 2023-11-08 The Procter & Gamble Company Waschmittelpackung
ES2702768T3 (es) 2015-02-13 2019-03-05 Unilever Nv Composición líquida de lavado de ropa
BR112017019942A2 (pt) 2015-04-02 2018-06-12 Unilever Nv composição líquida para lavagem de roupas e uso de polímero para a liberação de sujeira
WO2016176280A1 (en) 2015-04-29 2016-11-03 The Procter & Gamble Company Method of treating a fabric
DK3088503T3 (en) 2015-04-29 2018-08-20 Procter & Gamble PROCEDURE FOR TREATING A TEXTILE SUBSTANCE
EP3088506B1 (de) 2015-04-29 2018-05-23 The Procter and Gamble Company Reinigungsmittelzusammensetzung
WO2016176296A1 (en) 2015-04-29 2016-11-03 The Procter & Gamble Company Method of laundering a fabric
CN112143591A (zh) 2015-04-29 2020-12-29 宝洁公司 处理织物的方法
CN111718806B (zh) 2015-05-04 2022-01-04 美利肯公司 在洗衣护理组合物中作为上蓝剂的隐色三苯甲烷着色剂
EP3294882B1 (de) 2015-05-08 2021-07-07 Novozymes A/S Alpha-amylase-varianten und polynukleotide zur codierung davon
AU2016259703B2 (en) 2015-05-08 2021-12-23 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
WO2016183509A1 (en) 2015-05-13 2016-11-17 Danisco Us Inc. AprL-CLADE PROTEASE VARIANTS AND USES THEREOF
EP3101102B2 (de) 2015-06-05 2023-12-13 The Procter & Gamble Company Kompaktierte flüssigwaschmittelzusammensetzung
EP3101103B1 (de) 2015-06-05 2019-04-24 The Procter and Gamble Company Kompaktierte flüssigwaschmittelzusammensetzung
EP3101107B1 (de) 2015-06-05 2019-04-24 The Procter and Gamble Company Kompaktierte flüssigwaschmittelzusammensetzung
ES2666186T3 (es) 2015-06-05 2018-05-03 The Procter & Gamble Company Composición detergente líquida compactada para lavado de ropa
WO2016201040A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc. Water-triggered enzyme suspension
EP3307427B1 (de) 2015-06-09 2023-08-16 Danisco US Inc. Osmotische burst-kapseln
WO2016201069A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Low-density enzyme-containing particles
EP3310911B1 (de) 2015-06-17 2023-03-15 Danisco US Inc. Bacillus-gibboni-clade-serin-proteasen
EP3124586A1 (de) 2015-07-29 2017-02-01 The Procter and Gamble Company Verfahren zur geruchsverringerung in einer verpackung
EP3124587B1 (de) 2015-07-29 2019-03-20 The Procter and Gamble Company Portioniertes mehrphasiges reinigungsmittel
DE102015215591A1 (de) 2015-08-14 2017-02-16 Henkel Ag & Co. Kgaa Wasserarme, zweiphasige Flüssigwaschmittel mit saurem pH-Wert
CN107922897A (zh) 2015-08-28 2018-04-17 荷兰联合利华有限公司 包含蛋白酶和非蛋白酶的酶的液体洗涤组合物
DE102015217594A1 (de) 2015-09-15 2017-03-16 Henkel Ag & Co. Kgaa Stabilisierung von Enzymen in Wasch- oder Reinigungsmitteln
DE102015217816A1 (de) 2015-09-17 2017-03-23 Henkel Ag & Co. Kgaa Verwendung hochkonzentrierter Enzymgranulate zur Erhöhung der Lagerstabilität von Enzymen
CN108603183B (zh) 2015-11-05 2023-11-03 丹尼斯科美国公司 类芽孢杆菌属物种和芽孢杆菌属物种甘露聚糖酶
CN109072208A (zh) 2015-11-05 2018-12-21 丹尼斯科美国公司 类芽孢杆菌属物种甘露聚糖酶
US10844324B2 (en) 2015-11-13 2020-11-24 Dupont Industrial Biosciences Usa, Llc Glucan fiber compositions for use in laundry care and fabric care
JP2019504932A (ja) 2015-11-13 2019-02-21 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ 洗濯ケアおよび織物ケアにおいて使用するためのグルカン繊維組成物
EP3374488B1 (de) 2015-11-13 2020-10-14 DuPont Industrial Biosciences USA, LLC Glucanfaserzusammensetzungen zur verwendung in der wäsche- und textilpflege
DE102015223269A1 (de) 2015-11-25 2017-06-01 Henkel Ag & Co. Kgaa Verwendung von Polyoxyalkylenaminen in enzymhaltigen Wasch- oder Reinigungsmitteln zur Erhöhung der Stabilität von Enzymen
DE102015223270A1 (de) 2015-11-25 2017-06-01 Henkel Ag & Co. Kgaa Proteasevarianten mit verbesserter Enzymstabilität in Wasch- und Reinigungsmitteln
CN108291180A (zh) 2015-11-26 2018-07-17 宝洁公司 包含蛋白酶和经包封的脂肪酶的液体洗涤剂组合物
EP3178917A1 (de) 2015-12-08 2017-06-14 The Procter and Gamble Company Reinigungsbeutel
CN108779448B (zh) 2015-12-09 2023-08-18 丹尼斯科美国公司 α-淀粉酶组合变体
DE102015225465A1 (de) 2015-12-16 2017-06-22 Henkel Ag & Co. Kgaa Flüssige Tensidzusammensetzung mit spezieller Kombination aus Enzym und Stabilisator
US20180362946A1 (en) 2015-12-18 2018-12-20 Danisco Us Inc. Polypeptides with endoglucanase activity and uses thereof
EP3397761B1 (de) 2015-12-30 2022-11-09 Novozymes A/S Enzymvarianten und diese kodierende nukleinsäuren
TR201808208T4 (tr) 2016-01-07 2018-07-23 Unilever Nv Acı parçacık.
WO2017121714A1 (en) 2016-01-15 2017-07-20 Unilever Plc Dye
JP6665307B2 (ja) 2016-02-02 2020-03-13 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 組成物
WO2017136370A1 (en) 2016-02-02 2017-08-10 The Procter & Gamble Company Compositions containing antifoams
WO2017133879A1 (en) 2016-02-04 2017-08-10 Unilever Plc Detergent liquid
CN108603140B (zh) 2016-02-17 2020-09-08 荷兰联合利华有限公司 增白组合物
EP3417039B1 (de) 2016-02-17 2019-07-10 Unilever PLC Bleichungszusammensetzung
WO2017162378A1 (en) 2016-03-21 2017-09-28 Unilever Plc Laundry detergent composition
EP3228687B1 (de) 2016-04-08 2019-05-22 The Procter and Gamble Company Reinigungsmittel für geschirrspülmaschinen
ES2802454T3 (es) 2016-04-08 2021-01-19 Procter & Gamble Composición de limpieza para lavavajillas
EP3228686B1 (de) 2016-04-08 2021-10-27 The Procter & Gamble Company Automatisches geschirrspülen
WO2017176501A1 (en) 2016-04-08 2017-10-12 The Procter & Gamble Company Automatic dishwashing cleaning composition
WO2017174769A2 (en) 2016-04-08 2017-10-12 Novozymes A/S Detergent compositions and uses of the same
BR112018070468B1 (pt) 2016-04-08 2022-07-12 Unilever Ip Holdings B.V Composição de detergente líquida aquosa para lavagem de roupas e método doméstico de tratamento de um tecido
EP3241889B1 (de) 2016-05-03 2019-03-20 The Procter and Gamble Company Reinigungszusammensetzung
EP3241890B1 (de) 2016-05-03 2019-06-26 The Procter and Gamble Company Spülmittelzusammensetzung für automatisches geschirrspülen
EP3241891B1 (de) 2016-05-03 2019-04-03 The Procter and Gamble Company Spülmittelzusammensetzung für automatisches geschirrspülen
EP3452569A1 (de) 2016-05-03 2019-03-13 The Procter and Gamble Company Spülmittelzusammensetzung für geschirrspülautomat
WO2017192692A1 (en) 2016-05-03 2017-11-09 Danisco Us Inc Protease variants and uses thereof
EP3452497B1 (de) 2016-05-03 2021-02-17 Novozymes A/S Alpha-amylase enzymvarianten und polynukleotide zur codierung davon
WO2017192300A1 (en) 2016-05-05 2017-11-09 Danisco Us Inc Protease variants and uses thereof
US20170327647A1 (en) 2016-05-13 2017-11-16 The Procter & Gamble Company Silicone compounds
US10717823B2 (en) 2016-05-13 2020-07-21 The Procter & Gamble Company Silicone compounds
US20190185791A1 (en) * 2016-05-26 2019-06-20 Novozymes A/S Use of enzymes, cleaning composition and method for washing
US11661567B2 (en) 2016-05-31 2023-05-30 Danisco Us Inc. Protease variants and uses thereof
WO2017211697A1 (en) 2016-06-09 2017-12-14 Unilever Plc Laundry products
EP3472313B1 (de) 2016-06-17 2022-08-31 Danisco US Inc. Proteasevarianten und verwendungen davon
EP3257931A1 (de) 2016-06-17 2017-12-20 The Procter and Gamble Company Reinigungsmittelzusammensetzung
EP3266860B1 (de) 2016-07-08 2020-04-08 The Procter and Gamble Company Verfahren zur herstellung eines partikels
EP3275988B1 (de) 2016-07-26 2020-07-08 The Procter and Gamble Company Spülmittelzusammensetzung für automatisches geschirrspülen
EP3275986B1 (de) 2016-07-26 2020-07-08 The Procter and Gamble Company Spülmittelzusammensetzung für automatisches geschirrspülen
EP3275985A1 (de) 2016-07-26 2018-01-31 The Procter and Gamble Company Spülmittelzusammensetzung für automatisches geschirrspülen
EP3275987A1 (de) 2016-07-26 2018-01-31 The Procter and Gamble Company Spülmittelzusammensetzung für automatisches geschirrspülen
EP3290503A3 (de) 2016-09-01 2018-05-30 The Procter & Gamble Company Reinigungszusammensetzung zum automatischen geschirrspülen
WO2018072979A1 (en) 2016-10-18 2018-04-26 Unilever Plc Whitening composition
EP3312265A1 (de) 2016-10-18 2018-04-25 The Procter and Gamble Company Reinigungsmittelzusammensetzung
JP6790257B2 (ja) 2016-11-01 2020-11-25 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 洗濯ケア組成物における青味剤としてのロイコ着色剤、その包装、キット及び方法
US10851329B2 (en) 2016-11-01 2020-12-01 Milliken & Company Leuco colorants as bluing agents in laundry care compositions
CN109890950A (zh) 2016-11-01 2019-06-14 宝洁公司 衣物洗涤护理组合物中作为上蓝剂的隐色着色剂
US20180119056A1 (en) 2016-11-03 2018-05-03 Milliken & Company Leuco Triphenylmethane Colorants As Bluing Agents in Laundry Care Compositions
EP3535365A2 (de) 2016-11-07 2019-09-11 Danisco US Inc. Wäschewaschmittelzusammensetzung
KR20190086540A (ko) 2016-12-01 2019-07-22 바스프 에스이 조성물 중 효소의 안정화
CN110088261B (zh) 2016-12-02 2022-05-06 宝洁公司 包含酶的清洁组合物
CN110023476B (zh) 2016-12-02 2021-07-06 宝洁公司 包含酶的清洁组合物
US10550443B2 (en) 2016-12-02 2020-02-04 The Procter & Gamble Company Cleaning compositions including enzymes
BR112019011999B1 (pt) 2016-12-15 2022-11-08 Unilever Ip Holdings B.V Composição de detergente líquida aquosa para lavagem de roupas e método doméstico de tratamento de um tecido
US11946081B2 (en) 2016-12-21 2024-04-02 Danisco Us Inc. Bacillus gibsonii-clade serine proteases
CN110312795B (zh) 2016-12-21 2024-07-23 丹尼斯科美国公司 蛋白酶变体及其用途
US10047321B2 (en) 2016-12-22 2018-08-14 Henkel Ag & Co. Kgaa Liquid surfactant compositions having a modified oxo-alcohol derivative
EP3339410A1 (de) 2016-12-22 2018-06-27 The Procter & Gamble Company Automatische geschirrspülzusammensetzung
US10385291B2 (en) 2016-12-22 2019-08-20 Henkel Ag & Co. Kgaa Liquid surfactant compositions and associated methods
EP3577219B1 (de) 2017-02-01 2023-08-23 Novozymes A/S Alpha-amylase varianten
EP3357994B1 (de) 2017-02-01 2023-11-01 The Procter & Gamble Company Reinigungszusammensetzungen mit amylasevarianten
WO2018169750A1 (en) 2017-03-15 2018-09-20 Danisco Us Inc Trypsin-like serine proteases and uses thereof
EP3601515A1 (de) 2017-03-31 2020-02-05 Danisco US Inc. Enzymformulierungen mit verzögerter freisetzung für bleichmittelhaltige waschmittel
CN110662836B (zh) 2017-03-31 2024-04-12 丹尼斯科美国公司 α-淀粉酶组合变体
EP3606936B1 (de) 2017-04-03 2021-10-20 Novozymes A/S Verfahren zur rückgewinnung
EP3622045B1 (de) 2017-05-10 2021-03-10 Unilever PLC, a company registered in England and Wales under company no. 41424 of Waschmittelzusammensetzung
WO2018206202A1 (en) 2017-05-10 2018-11-15 Unilever Plc Laundry detergent composition
EP3415592A1 (de) 2017-06-15 2018-12-19 The Procter & Gamble Company Wasserlöslicher einmaldosierartikel mit einem festen waschmittel
EP3418365A1 (de) 2017-06-19 2018-12-26 The Procter & Gamble Company Reinigungszusammensetzung zum automatischen geschirrspülen
EP3418364A1 (de) 2017-06-19 2018-12-26 The Procter & Gamble Company Reinigungszusammensetzung zum automatischen geschirrspülen
EP3418366A1 (de) 2017-06-19 2018-12-26 The Procter & Gamble Company Reinigungszusammensetzung zum automatischen geschirrspülen
WO2018234056A1 (en) 2017-06-20 2018-12-27 Unilever N.V. PARTICULATE DETERGENT COMPOSITION COMPRISING A FRAGRANCE
WO2018234003A1 (en) 2017-06-21 2018-12-27 Unilever Plc PACKAGING AND DISTRIBUTION OF DETERGENT COMPOSITIONS
EP3645696A1 (de) 2017-06-30 2020-05-06 Danisco US Inc. Niedrigagglomerierte enzymhaltige partikel
EP3649221B8 (de) 2017-07-07 2024-05-29 Unilever IP Holdings B.V. Wäschereinigungszusammensetzung
WO2019008036A1 (en) 2017-07-07 2019-01-10 Unilever Plc WHITENING COMPOSITION
EP3441450A1 (de) 2017-08-11 2019-02-13 The Procter & Gamble Company Zusammensetzung zum automatischen geschirrspülen
CN111212906B (zh) 2017-08-18 2024-02-02 丹尼斯科美国公司 α-淀粉酶变体
WO2019038187A1 (en) 2017-08-24 2019-02-28 Unilever Plc IMPROVEMENTS RELATING TO THE CLEANING OF FABRICS
WO2019038186A1 (en) 2017-08-24 2019-02-28 Unilever Plc IMPROVEMENTS RELATING TO THE CLEANING OF FABRICS
DE102017215015A1 (de) 2017-08-28 2019-02-28 Henkel Ag & Co. Kgaa Verfahren zur verbesserten Expression von Enzymen
EP3456808A1 (de) 2017-09-13 2019-03-20 The Procter & Gamble Company Reinigungszusammensetzung zum automatischen geschirrspülen
EP3467086B1 (de) 2017-10-05 2021-03-24 The Procter & Gamble Company Reinigungsmittel für geschirrspülmaschinen
EP3467085A1 (de) 2017-10-05 2019-04-10 The Procter & Gamble Company Geschirrspülmittelreinigungszusammensetzung
US10731112B2 (en) 2017-10-12 2020-08-04 The Procter & Gamble Company Leuco colorants in combination with a second whitening agent as bluing agents in laundry care compositions
CA3075090A1 (en) 2017-10-12 2019-04-18 The Procter & Gamble Company Leuco colorants as bluing agents in laundry care compositions
TWI715878B (zh) 2017-10-12 2021-01-11 美商美力肯及公司 隱色著色劑及組成物
US10717950B2 (en) 2017-10-12 2020-07-21 The Procter & Gamble Company Leuco colorants as bluing agents in laundry care composition
US11053392B2 (en) 2017-11-01 2021-07-06 Milliken & Company Leuco compounds, colorant compounds, and compositions containing the same
CN111373039A (zh) 2017-11-29 2020-07-03 丹尼斯科美国公司 具有改善的稳定性的枯草杆菌蛋白酶变体
JP2021504546A (ja) 2017-11-29 2021-02-15 ビーエイエスエフ・ソシエタス・エウロパエアＢａｓｆ Ｓｅ 組成物、その製造方法および使用方法
BR112020010648A2 (pt) 2017-11-30 2021-02-02 Unilever N.V. composição detergente, composição detergente de lavanderia, método para aprimorar limpeza enzimática em água e uso de uma enzima protease
EP3502244A1 (de) 2017-12-19 2019-06-26 The Procter & Gamble Company Spülmittelzusammensetzung für geschirrspülautomat
EP3502245A1 (de) 2017-12-19 2019-06-26 The Procter & Gamble Company Spülmittelzusammensetzung für geschirrspülautomat
EP3502227B1 (de) 2017-12-19 2024-09-04 The Procter & Gamble Company Spülmittelzusammensetzung für geschirrspülautomat
EP3502246A1 (de) 2017-12-19 2019-06-26 The Procter & Gamble Company Spülmittelzusammensetzung für geschirrspülautomat
CN111742041B (zh) 2017-12-21 2023-06-06 丹尼斯科美国公司 包含耐热干燥剂的含酶的热熔细粒
EP3737737A4 (de) * 2018-01-09 2021-10-06 Novozymes A/S Verwendung eines enzyms zur entfernung von luftpartikeln aus textilien
WO2019156670A1 (en) 2018-02-08 2019-08-15 Danisco Us Inc. Thermally-resistant wax matrix particles for enzyme encapsulation
EP3530723B1 (de) 2018-02-21 2023-03-29 The Procter & Gamble Company Maschinelles geschirrspülmittel
CA3089284A1 (en) 2018-02-28 2019-09-06 The Procter & Gamble Company Methods of cleaning using a glycogen debranching enzyme
EP3533859A1 (de) 2018-02-28 2019-09-04 The Procter & Gamble Company Reinigungszusammensetzungen
EP3784779A1 (de) 2018-04-26 2021-03-03 Basf Se Lipaseenzyme
EP3788145A1 (de) 2018-05-03 2021-03-10 Basf Se Amylaseenzyme
WO2019219531A1 (en) 2018-05-17 2019-11-21 Unilever Plc Cleaning composition
EP3775122A1 (de) 2018-05-17 2021-02-17 Unilever PLC Reinigungszusammensetzung mit rhamnolipid und alkylethercarboxylattensiden
WO2019238761A1 (en) 2018-06-15 2019-12-19 Basf Se Water soluble multilayer films containing wash active chemicals and enzymes
WO2019245705A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
EP3810767A1 (de) 2018-06-19 2021-04-28 Danisco US Inc. Subtilisin-varianten
EP3810769A1 (de) 2018-06-19 2021-04-28 The Procter & Gamble Company Spülmittelzusammensetzung für geschirrspülautomat
WO2019245838A1 (en) 2018-06-19 2019-12-26 The Procter & Gamble Company Automatic dishwashing detergent composition
BR112021000774A2 (pt) 2018-07-17 2021-04-13 Unilever Ip Holdings B.V. Uso de ramnolipídio em um sistema de tensoativo para detergentes para lavagem manual
CN112543801A (zh) 2018-07-27 2021-03-23 荷兰联合利华有限公司 洗衣洗涤剂
WO2020028443A1 (en) 2018-07-31 2020-02-06 Danisco Us Inc Variant alpha-amylases having amino acid substitutions that lower the pka of the general acid
US20210189295A1 (en) 2018-08-30 2021-06-24 Danisco Us Inc Enzyme-containing granules
BR112021004507A2 (pt) 2018-09-17 2021-06-08 Unilever Ip Holdings B.V. composição detergente, método de tratamento de um substrato com uma composição detergente e uso de uma enzima lipase bacteriana
EP3856882A1 (de) 2018-09-27 2021-08-04 Danisco US Inc. Zusammensetzungen für die reinigung von medizinischen instrumenten
JP7531965B2 (ja) 2018-10-05 2024-08-13 ベーアーエスエフ・エスエー 液体中のヒドロラーゼを安定化する化合物
BR112021006317A2 (pt) 2018-10-05 2021-07-06 Basf Se preparação de enzima, processo para preparar uma preparação de enzima estável, métodos para reduzir perda da atividade amiolítica, de preparação de uma formulação detergente, para remover manchas sensíveis à amilase e para aumentar a estabilidade no armazenamento de uma formulação detergente líquida, usos de um composto e da preparação de enzima, e, formulação detergente
EP3861116A1 (de) 2018-10-05 2021-08-11 Basf Se Verbindungen zur stabilisierung von hydrolasen in flüssigkeiten
EP3677676A1 (de) 2019-01-03 2020-07-08 Basf Se Verbindungen zur stabilisierung von amylasen in flüssigkeiten
DE102018217392A1 (de) 2018-10-11 2020-04-16 Henkel Ag & Co. Kgaa Mehrkomponenten-Waschmittel mit Catechol-Metallkomplex
DE102018217399A1 (de) 2018-10-11 2020-04-16 Henkel Ag & Co. Kgaa Flüssige Zusammensetzung mit Dihydroxyterephthalsäurediamid-Verbindung und hoher Tensidmenge
DE102018217398A1 (de) 2018-10-11 2020-04-16 Henkel Ag & Co. Kgaa Flüssigwaschmittel mit Dihydroxyterephthalsäurediamid-Verbindung
DE102018217393A1 (de) 2018-10-11 2020-04-16 Henkel Ag & Co. Kgaa Waschmittelzusammensetzung mit Catechol-Metallkomplexverbindung
DE102018217397A1 (de) 2018-10-11 2020-04-16 Henkel Ag & Co. Kgaa Verwendung von übergangsmetallfreien Abtönungsfarbstoffen in Kombination mit Catecholderivaten
WO2020077331A2 (en) 2018-10-12 2020-04-16 Danisco Us Inc Alpha-amylases with mutations that improve stability in the presence of chelants
BR112021009789A2 (pt) 2018-11-20 2021-08-17 Unilever Ip Holdings B.V. composição detergente, método de tratamento de um substrato de tecido e uso de uma enzima esterase
CN113015781B (zh) 2018-11-20 2022-09-13 联合利华知识产权控股有限公司 洗涤剂组合物
BR112021009828A2 (pt) 2018-11-20 2021-08-17 Unilever Ip Holdings B.V. composição detergente líquida, método de tratamento de um substrato de tecido e uso de uma enzima esterol esterase
CN113166689A (zh) 2018-11-20 2021-07-23 联合利华知识产权控股有限公司 洗涤剂组合物
CN113056549B (zh) 2018-11-20 2023-03-10 联合利华知识产权控股有限公司 洗涤剂组合物
US20230028935A1 (en) 2018-11-28 2023-01-26 Danisco Us Inc Subtilisin variants having improved stability
EP3666872B1 (de) 2018-12-12 2021-08-11 Henkel AG & Co. KGaA Phosphonierte acrylcopolymere zur oberflächenhydrophilierung
US20220098520A1 (en) 2019-01-22 2022-03-31 Conopco, Inc., D/B/A Unilever Laundry detergent
BR112021014332A2 (pt) 2019-01-22 2021-09-28 Unilever Ip Holdings B.V. Composição detergente de lavanderia, método doméstico para tratar um tecido e corante tonalizante não leuco azul ou violeta
CN114127256A (zh) 2019-02-20 2022-03-01 巴斯夫欧洲公司 用确定成分培养基和微量元素补料的芽孢杆菌工业发酵工艺
US20220186177A1 (en) 2019-02-20 2022-06-16 Basf Se Industrial fermentation process for bacillus using defined medium and magnesium feed
CA3127167A1 (en) 2019-03-14 2020-09-17 The Procter & Gamble Company Cleaning compositions comprising enzymes
EP3938503A1 (de) 2019-03-14 2022-01-19 The Procter & Gamble Company Verfahren zur behandlung von baumwolle
JP7275298B2 (ja) 2019-03-14 2023-05-17 ザ プロクター アンド ギャンブル カンパニー 酵素を含むクリーニング組成物
US20220170001A1 (en) 2019-03-25 2022-06-02 Basf Se Amylase Enzymes
WO2020193535A2 (en) 2019-03-25 2020-10-01 Basf Se Amylase enzymes
WO2020193532A1 (en) 2019-03-25 2020-10-01 Basf Se Cleaning composition having amylase enzymes
DE102019204792A1 (de) 2019-04-04 2020-10-08 Henkel Ag & Co. Kgaa Verwendung von Mannanase-Enzym in Kombination mit Catecholderivaten
WO2020229480A1 (en) 2019-05-14 2020-11-19 Basf Se Compounds stabilizing hydrolases in liquids
WO2020229535A1 (en) 2019-05-16 2020-11-19 Unilever Plc Laundry composition
EP3741283A1 (de) 2019-05-22 2020-11-25 The Procter & Gamble Company Automatisches geschirrspülverfahren
EP3976775A1 (de) 2019-05-24 2022-04-06 The Procter & Gamble Company Spülmittelzusammensetzung für geschirrspülautomat
WO2020242858A1 (en) 2019-05-24 2020-12-03 Danisco Us Inc Subtilisin variants and methods of use
WO2020247582A1 (en) 2019-06-06 2020-12-10 Danisco Us Inc Methods and compositions for cleaning
EP3983425A1 (de) 2019-06-13 2022-04-20 Basf Se Verfahren zur rückgewinnung eines proteins aus fermentationsbrühe mithilfe eines divalenten kations
WO2020264552A1 (en) 2019-06-24 2020-12-30 The Procter & Gamble Company Cleaning compositions comprising amylase variants
US20220372397A1 (en) 2019-06-28 2022-11-24 Conopco, Inc., D/B/A Unilever Detergent composition
CN113891930A (zh) 2019-06-28 2022-01-04 联合利华知识产权控股有限公司 洗涤剂组合物
WO2020260006A1 (en) 2019-06-28 2020-12-30 Unilever Plc Detergent compositions
CN113906124B (zh) 2019-06-28 2024-08-02 联合利华知识产权控股有限公司 洗涤剂组合物
EP3990603B1 (de) 2019-06-28 2022-12-07 Unilever Global Ip Limited Reinigungsmittelzusammensetzung
EP3990604B1 (de) 2019-06-28 2022-12-14 Unilever Global IP Limited Reinigungsmittelzusammensetzung
EP3760699A1 (de) 2019-07-02 2021-01-06 The Procter & Gamble Company Spülmittelzusammensetzung für geschirrspülautomat
WO2021004830A1 (en) 2019-07-05 2021-01-14 Basf Se Industrial fermentation process for microbial cells using a fed-batch pre-culture
CN114364795A (zh) 2019-08-22 2022-04-15 巴斯夫欧洲公司 淀粉酶变体
BR112022003050A2 (pt) 2019-09-02 2022-05-17 Unilever Ip Holdings B V Composição detergente de lavagem de roupas aquosa e método doméstico para tratar um tecido
CN114423851A (zh) 2019-09-19 2022-04-29 联合利华知识产权控股有限公司 洗涤剂组合物
AR120142A1 (es) 2019-10-07 2022-02-02 Unilever Nv Composición detergente
EP4045625A1 (de) 2019-10-18 2022-08-24 Basf Se Lagerstabile hydrolase-haltige flüssigkeiten
US20210122998A1 (en) 2019-10-24 2021-04-29 The Procter & Gamble Company Automatic dishwashing detergent composition comprising an amylase
US20220403359A1 (en) 2019-10-24 2022-12-22 Danisco Us Inc Variant maltopentaose/maltohexaose-forming alpha-amylases
US11492571B2 (en) 2019-10-24 2022-11-08 The Procter & Gamble Company Automatic dishwashing detergent composition comprising a protease
BR112021021050A2 (pt) 2019-11-29 2022-09-13 Basf Se Composição, uso de uma composição, polímero, processo para preparar polímeros, e, método para melhorar o desempenho de limpeza de uma composição líquida de detergente
EP3835396A1 (de) 2019-12-09 2021-06-16 The Procter & Gamble Company Waschmittelzusammensetzung mit einem polymer
WO2021115912A1 (en) 2019-12-09 2021-06-17 Basf Se Formulations comprising a hydrophobically modified polyethyleneimine and one or more enzymes
CA3160401A1 (en) 2019-12-19 2021-06-24 Neil Joseph Lant Cleaning compositions comprising polypeptides having alpha amylase activity
CA3159083A1 (en) 2019-12-19 2021-06-24 Novozymes A/S Alpha-amylase variants
WO2021151536A1 (en) 2020-01-29 2021-08-05 Unilever Ip Holdings B.V. Laundry detergent product
EP3862412A1 (de) 2020-02-04 2021-08-11 The Procter & Gamble Company Reinigungsmittelzusammensetzung
CN115279877A (zh) 2020-03-11 2022-11-01 联合利华知识产权控股有限公司 低泡固体清洁组合物
EP4121502A1 (de) 2020-03-19 2023-01-25 Unilever IP Holdings B.V. Reinigungsmittelzusammensetzung
WO2021185956A1 (en) 2020-03-19 2021-09-23 Unilever Ip Holdings B.V. Detergent composition
DE102020205400A1 (de) 2020-04-29 2021-11-04 Henkel Ag & Co. Kgaa Hochalkalisches Textilwaschmittel mit Protease
DE102020205381A1 (de) 2020-04-29 2021-11-04 Henkel Ag & Co. Kgaa Hochalkalisches Textilwaschmittel mit Protease
EP4162016A1 (de) 2020-06-05 2023-04-12 The Procter & Gamble Company Waschmittelzusammensetzungen mit einem verzweigten tensid
BR112022024537A2 (pt) 2020-06-08 2022-12-27 Unilever Ip Holdings B V Método de aprimoramento da atividade de protease em uma composição detergente e uso de saponina
WO2022008732A1 (en) 2020-07-10 2022-01-13 Basf Se Enhancing the activity of antimicrobial preservatives
EP4183859A4 (de) 2020-07-15 2024-07-31 Kao Corp Amylase enthaltende reinigungsmittelzusammensetzung
CN116096846A (zh) 2020-08-04 2023-05-09 宝洁公司 自动盘碟洗涤方法
JP2023536081A (ja) 2020-08-04 2023-08-23 ザ プロクター アンド ギャンブル カンパニー 自動食器洗浄方法
WO2022031309A1 (en) 2020-08-04 2022-02-10 The Procter & Gamble Company Automatic dishwashing method
CA3187735A1 (en) 2020-08-04 2022-02-10 Nina Elizabeth GRAY Automatic dishwashing method and pack
CN116018394A (zh) 2020-08-26 2023-04-25 联合利华知识产权控股有限公司 包含羟乙基磺酸盐表面活性剂的洗涤剂组合物
US20240034960A1 (en) 2020-08-27 2024-02-01 Danisco Us Inc Enzymes and enzyme compositions for cleaning
EP4204526B1 (de) 2020-08-28 2024-04-24 Unilever IP Holdings B.V. Tensid und waschmittelzusammensetzung
WO2022042977A1 (en) 2020-08-28 2022-03-03 Unilever Ip Holdings B.V. Detergent composition
CN116018396A (zh) 2020-08-28 2023-04-25 联合利华知识产权控股有限公司 洗涤剂组合物
US20230287300A1 (en) 2020-08-28 2023-09-14 Conopco, Inc., D/B/A Unilever Surfactant and detergent composition
WO2022043042A1 (en) 2020-08-28 2022-03-03 Unilever Ip Holdings B.V. Detergent composition
CN116057066A (zh) 2020-09-22 2023-05-02 巴斯夫欧洲公司 包含肽醛的液体组合物
US20240240114A1 (en) 2020-09-22 2024-07-18 Basf Se Improved Combination of Protease and Protease Inhibitor with Secondary Enzyme
ES2956240T3 (es) 2020-09-29 2023-12-15 Procter & Gamble Composición limpiadora para lavavajillas
CN116323910A (zh) 2020-10-02 2023-06-23 花王株式会社 α－淀粉酶突变体
US20230392018A1 (en) 2020-10-27 2023-12-07 Milliken & Company Compositions comprising leuco compounds and colorants
JP7568839B2 (ja) 2020-10-29 2024-10-16 ザ プロクター アンド ギャンブル カンパニー アルギナーゼ酵素を含有する洗浄組成物
JP2023547853A (ja) 2020-11-17 2023-11-14 ザ プロクター アンド ギャンブル カンパニー アルカリ性すすぎによる自動食器洗浄方法
WO2022108766A1 (en) 2020-11-17 2022-05-27 The Procter & Gamble Company Automatic dishwashing composition comprising amphiphilic graft polymer
EP4001388A1 (de) 2020-11-17 2022-05-25 The Procter & Gamble Company Verfahren zum automatischen geschirrspülen mit amphiphilem pfropfpolymer in der spülung
EP4006131A1 (de) 2020-11-30 2022-06-01 The Procter & Gamble Company Verfahren zum waschen von textilien
EP4256020A1 (de) 2020-12-07 2023-10-11 Unilever IP Holdings B.V. Waschmittelzusammensetzungen
US20240010951A1 (en) 2020-12-07 2024-01-11 Conopco Inc., D/B/A Unilever Detergent compositions
WO2022128620A1 (de) 2020-12-14 2022-06-23 Henkel Ag & Co. Kgaa Verfahren zur reinigung einer elektromotorisch betriebenen küchenmaschine
EP4012011A1 (de) 2020-12-14 2022-06-15 Henkel AG & Co. KGaA Reinigungsmittel insbesondere für eine küchenmaschine
DE102021213462A1 (de) 2021-11-30 2023-06-01 Henkel Ag & Co. Kgaa Verfahren zur Reinigung einer elektromotorisch betriebenen Küchenmaschine
EP4011256A1 (de) 2020-12-14 2022-06-15 Henkel AG & Co. KGaA Verfahren zur reinigung einer elektromotorisch betriebenen küchenmaschine
CN116583583A (zh) 2020-12-17 2023-08-11 联合利华知识产权控股有限公司 用途和清洁组合物
US20240002751A1 (en) 2020-12-17 2024-01-04 Conopco, Inc., D/B/A Unilever Cleaning composition
EP4015629A1 (de) 2020-12-18 2022-06-22 Basf Se Polymermischungen zur erhöhung der stabilität und leistung von hydrolasehaltigen waschmitteln
JP2023551014A (ja) 2020-12-23 2023-12-06 ビーエーエスエフ ソシエタス・ヨーロピア 両親媒性アルコキシル化ポリアミン及びそれらの使用
CN116997642A (zh) 2021-01-29 2023-11-03 丹尼斯科美国公司 清洁组合物及其相关的方法
EP4047088A1 (de) 2021-02-22 2022-08-24 Basf Se Amylasevarianten
MX2023009756A (es) 2021-02-22 2023-09-04 Basf Se Variantes de amilasa.
JP2023548846A (ja) 2021-03-15 2023-11-21 ザ プロクター アンド ギャンブル カンパニー ポリペプチドバリアントを含有する洗浄組成物
WO2022199418A1 (en) 2021-03-26 2022-09-29 Novozymes A/S Detergent composition with reduced polymer content
MX2023012548A (es) 2021-05-05 2023-11-03 Procter & Gamble Metodos para elaborar composiciones de limpieza y detectar suciedades.
EP4086330A1 (de) 2021-05-06 2022-11-09 The Procter & Gamble Company Oberflächenbehandlung
EP4108767A1 (de) 2021-06-22 2022-12-28 The Procter & Gamble Company Reinigungs- oder behandlungszusammensetzungen mit nuklease-enzymen
EP4108150B1 (de) 2021-06-22 2024-10-16 The Procter & Gamble Company Verfahren zur behandlung von geschirr in einer haushaltsgeschirrspülmaschine
WO2023278297A1 (en) 2021-06-30 2023-01-05 Danisco Us Inc Variant lipases and uses thereof
EP4123007A1 (de) 2021-07-19 2023-01-25 The Procter & Gamble Company Behandlung von gewebe mit bakteriellen sporen
EP4123006A1 (de) 2021-07-19 2023-01-25 The Procter & Gamble Company Zusammensetzung mit sporen und pro-duftstoffen
CA3228918A1 (en) 2021-08-10 2023-02-16 Nippon Shokubai Co., Ltd. Polyalkylene-oxide-containing compound
CN117916354A (zh) 2021-09-03 2024-04-19 丹尼斯科美国公司 用于清洁的衣物洗涤组合物
WO2023039270A2 (en) 2021-09-13 2023-03-16 Danisco Us Inc. Bioactive-containing granules
WO2023041694A1 (en) 2021-09-20 2023-03-23 Unilever Ip Holdings B.V. Detergent composition
EP4416255A1 (de) 2021-10-14 2024-08-21 The Procter & Gamble Company Gewebe und haushaltspflegeprodukt mit kationischem schmutzabweisendem polymer und lipaseenzym
EP4194536A1 (de) 2021-12-08 2023-06-14 The Procter & Gamble Company Wäschebehandlungskartusche
EP4194537A1 (de) 2021-12-08 2023-06-14 The Procter & Gamble Company Wäschebehandlungskartusche
CN118369413A (zh) 2021-12-16 2024-07-19 宝洁公司 包含淀粉酶的家庭护理组合物
EP4448751A2 (de) 2021-12-16 2024-10-23 Danisco US Inc. Subtilisinvarianten und verfahren zur verwendung
WO2023114794A1 (en) 2021-12-16 2023-06-22 The Procter & Gamble Company Fabric and home care composition comprising a protease
EP4448707A1 (de) 2021-12-16 2024-10-23 The Procter & Gamble Company Heimpflegezusammensetzung
CN118715318A (zh) 2021-12-16 2024-09-27 丹尼斯科美国公司 枯草杆菌蛋白酶变体及其用途
US20240166973A1 (en) 2021-12-16 2024-05-23 The Procter & Gamble Company Automatic dishwashing composition comprising a protease
CN118679252A (zh) 2021-12-16 2024-09-20 丹尼斯科美国公司 枯草杆菌蛋白酶变体和使用方法
CA3241094A1 (en) 2021-12-16 2023-06-22 Jonathan LASSILA Variant maltopentaose/maltohexaose-forming alpha-amylases
WO2023117895A1 (en) 2021-12-21 2023-06-29 Basf Se Chemical product passport for production data
JP2023095355A (ja) 2021-12-24 2023-07-06 花王株式会社 アミラーゼ配合洗浄剤組成物
WO2023168234A1 (en) 2022-03-01 2023-09-07 Danisco Us Inc. Enzymes and enzyme compositions for cleaning
WO2023176970A1 (ja) 2022-03-18 2023-09-21 花王株式会社 α－アミラーゼ変異体
WO2023190938A1 (ja) 2022-03-31 2023-10-05 花王株式会社 α－アミラーゼ変異体
EP4273210A1 (de) 2022-05-04 2023-11-08 The Procter & Gamble Company Enzymhaltige waschmittelzusammensetzungen
EP4273209A1 (de) 2022-05-04 2023-11-08 The Procter & Gamble Company Enzymhaltige maschinenreinigungszusammensetzungen
EP4279571A1 (de) 2022-05-19 2023-11-22 The Procter & Gamble Company Sporenhaltige wäschezusammensetzung
WO2023227375A1 (en) 2022-05-27 2023-11-30 Unilever Ip Holdings B.V. Laundry liquid composition comprising a surfactant, an aminocarboxylate, an organic acid and a fragrance
WO2023227331A1 (en) 2022-05-27 2023-11-30 Unilever Ip Holdings B.V. Composition comprising a specific methyl ester ethoxylate surfactant and a lipase
WO2023227332A1 (en) 2022-05-27 2023-11-30 Unilever Ip Holdings B.V. Laundry liquid composition comprising a surfactant, an alkoxylated zwitterionic polyamine polymer and a protease
WO2023227335A1 (en) 2022-05-27 2023-11-30 Unilever Ip Holdings B.V. Liquid composition comprising linear alkyl benzene sulphonate, methyl ester ethoxylate and alkoxylated zwitterionic polyamine polymer
WO2023227356A1 (en) 2022-05-27 2023-11-30 Unilever Ip Holdings B.V. Composition containing enzyme
WO2023227421A1 (en) 2022-05-27 2023-11-30 Unilever Ip Holdings B.V. Laundry liquid composition comprising a surfactant, an alkoxylated zwitterionic polyamine polymer, and a fragrance
DE102022205591A1 (de) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Wasch- und reinigungsmittel mit verbesserter enzymstabilität
DE102022205588A1 (de) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Wasch- und reinigungsmittel mit verbesserter enzymstabilität
DE102022205593A1 (de) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Wasch- und reinigungsmittel mit verbesserter enzymstabilität
EP4286501A1 (de) 2022-06-01 2023-12-06 The Procter & Gamble Company Geschirrspülmittelzusammensetzung mit xylanase und blockcopolymer
DE102022205594A1 (de) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Leistungsverbesserte und lagerstabile protease-varianten
EP4286499A1 (de) 2022-06-01 2023-12-06 The Procter & Gamble Company Geschirrspülmittelzusammensetzung mit xylanase und sulfoniertem carboxylatpolymer
EP4286500A1 (de) 2022-06-01 2023-12-06 The Procter & Gamble Company Verwendung von xylanase in einem geschirrspülverfahren
WO2023233025A1 (en) 2022-06-03 2023-12-07 Unilever Ip Holdings B.V. Liquid detergent product
WO2023250301A1 (en) 2022-06-21 2023-12-28 Danisco Us Inc. Methods and compositions for cleaning comprising a polypeptide having thermolysin activity
WO2024012894A1 (en) 2022-07-15 2024-01-18 Basf Se Alkanolamine formates for enzyme stabilization in liquid formulations
WO2024028160A1 (en) 2022-08-04 2024-02-08 Unilever Ip Holdings B.V. Packaged homecare product
WO2024028161A1 (en) 2022-08-04 2024-02-08 Unilever Ip Holdings B.V. Packaged homecare product
WO2024028159A1 (en) 2022-08-04 2024-02-08 Unilever Ip Holdings B.V. Packaged homecare product
EP4321604A1 (de) 2022-08-08 2024-02-14 The Procter & Gamble Company Textil- und heimpflegezusammensetzung, die ein tensid und ein polyester umfasst
WO2024033136A1 (en) 2022-08-11 2024-02-15 Basf Se Amylase variants
WO2024033135A2 (en) 2022-08-11 2024-02-15 Basf Se Amylase variants
EP4324900A1 (de) 2022-08-17 2024-02-21 Henkel AG & Co. KGaA Waschmittelzusammensetzung mit enzymen
WO2024050346A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Detergent compositions and methods related thereto
WO2024050339A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Mannanase variants and methods of use
WO2024050343A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Subtilisin variants and methods related thereto
WO2024056333A1 (en) 2022-09-13 2024-03-21 Unilever Ip Holdings B.V. Washing machine and washing method
WO2024056334A1 (en) 2022-09-13 2024-03-21 Unilever Ip Holdings B.V. Washing machine and washing method
WO2024056332A1 (en) 2022-09-13 2024-03-21 Unilever Ip Holdings B.V. Washing machine and washing method
WO2024056278A1 (en) 2022-09-13 2024-03-21 Unilever Ip Holdings B.V. Washing machine and washing method
US20240093130A1 (en) 2022-09-16 2024-03-21 The Procter & Gamble Company Methods and apparatuses for automatic dishwashing chemical distribution
EP4349947A1 (de) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Flüssigwaschmittelzusammensetzung
EP4349948A1 (de) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Flüssigwaschmittelzusammensetzung
EP4349945A1 (de) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Flüssigwaschmittelzusammensetzung
EP4349944A1 (de) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Flüssigwaschmittelzusammensetzung
EP4349946A1 (de) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Einheitsdosisprodukt zur behandlung von textilien
EP4349942A1 (de) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Flüssigwaschmittelzusammensetzung
EP4349943A1 (de) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Flüssigwaschmittelzusammensetzung
WO2024088716A1 (en) 2022-10-25 2024-05-02 Unilever Ip Holdings B.V. Composition
EP4361239A1 (de) 2022-10-25 2024-05-01 Unilever IP Holdings B.V. Flüssigwaschmittelzusammensetzung
WO2024088706A1 (en) 2022-10-25 2024-05-02 Unilever Ip Holdings B.V. Composition
EP4361061A1 (de) 2022-10-26 2024-05-01 The Procter & Gamble Company Waschmittelprodukt
WO2024094803A1 (en) 2022-11-04 2024-05-10 The Procter & Gamble Company Fabric and home care composition
WO2024094790A1 (en) 2022-11-04 2024-05-10 Clariant International Ltd Polyesters
WO2024094735A1 (en) 2022-11-04 2024-05-10 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2024094802A1 (en) 2022-11-04 2024-05-10 The Procter & Gamble Company Fabric and home care composition
WO2024094732A1 (en) 2022-11-04 2024-05-10 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2024094733A1 (en) 2022-11-04 2024-05-10 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2024102698A1 (en) 2022-11-09 2024-05-16 Danisco Us Inc. Subtilisin variants and methods of use
WO2024115106A1 (en) 2022-11-29 2024-06-06 Unilever Ip Holdings B.V. Composition
DE102022131732A1 (de) 2022-11-30 2024-06-06 Henkel Ag & Co. Kgaa Verbesserte Waschleistung durch den Einsatz einer Protease fusioniert mit speziellem Adhäsionsvermittlerpeptid
WO2024119298A1 (en) 2022-12-05 2024-06-13 The Procter & Gamble Company Fabric and home care composition comprising a polyalkylenecarbonate compound
WO2024129520A1 (en) 2022-12-12 2024-06-20 The Procter & Gamble Company Fabric and home care composition
EP4386074A1 (de) 2022-12-16 2024-06-19 The Procter & Gamble Company Stoff- und heimpflegezusammensetzung
EP4388967A1 (de) 2022-12-19 2024-06-26 The Procter & Gamble Company Geschirrspülverfahren
EP4389864A1 (de) 2022-12-20 2024-06-26 Basf Se Cutinasen
WO2024146919A1 (en) 2023-01-05 2024-07-11 Basf Se Use of foldases to improve heterologous expression of secreted molecules
WO2024151573A1 (en) 2023-01-09 2024-07-18 The Procter & Gamble Company Superposed multi-sectioned water-soluble unit dose automatic dishwashing detergent pouch
US20240263162A1 (en) 2023-02-01 2024-08-08 The Procter & Gamble Company Detergent compositions containing enzymes
WO2024163584A1 (en) 2023-02-01 2024-08-08 Danisco Us Inc. Subtilisin variants and methods of use
WO2024186819A1 (en) 2023-03-06 2024-09-12 Danisco Us Inc. Subtilisin variants and methods of use
WO2024191711A1 (en) 2023-03-16 2024-09-19 Nutrition & Biosciences USA 4, Inc. Brevibacillus fermentate extracts for cleaning and malodor control and use thereof
WO2024194190A1 (en) 2023-03-17 2024-09-26 Unilever Ip Holdings B.V. Composition
WO2024193937A1 (en) 2023-03-17 2024-09-26 Unilever Ip Holdings B.V. Machine dishwash filter cleaner
WO2024194098A1 (en) 2023-03-21 2024-09-26 Unilever Ip Holdings B.V. Detergent unit dose

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1296839A (de) 1969-05-29 1972-11-22
GB1372034A (en) 1970-12-31 1974-10-30 Unilever Ltd Detergent compositions
US3912590A (en) 1973-01-03 1975-10-14 Novo Industri As Procedure for liquefying starch
GB1483591A (en) 1973-07-23 1977-08-24 Novo Industri As Process for coating water soluble or water dispersible particles by means of the fluid bed technique
GB1590432A (en) 1976-07-07 1981-06-03 Novo Industri As Process for the production of an enzyme granulate and the enzyme granuate thus produced
DK187280A (da) 1980-04-30 1981-10-31 Novo Industri As Ruhedsreducerende middel til et fuldvaskemiddel fuldvaskemiddel og fuldvaskemetode
FR2498783B1 (fr) 1981-01-23 1988-03-04 Decis Mario Dispositif de controle automatique de presence
JPS57174089A (en) 1981-04-20 1982-10-26 Novo Industri As Chain dividing enzyme product
FR2543181B1 (fr) 1983-03-22 1985-07-26 Ugine Kuhlmann Procede ameliore de desencollage-blanchiment simultane des tissus
US4760025A (en) 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
DK263584D0 (da) 1984-05-29 1984-05-29 Novo Industri As Enzymholdige granulater anvendt som detergentadditiver
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
JPH0697997B2 (ja) 1985-08-09 1994-12-07 ギスト ブロカデス ナ−ムロ−ゼ フエンノ−トチヤツプ 新規の酵素的洗浄剤添加物
EG18543A (en) 1986-02-20 1993-07-30 Albright & Wilson Protected enzyme systems
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
DK166460B1 (da) 1986-07-09 1993-05-24 Novo Nordisk As Blandinger af alfa-amylaser og deres anvendelse til stivelsesforflydning
ES2058119T3 (es) 1986-08-29 1994-11-01 Novo Nordisk As Aditivo detergente enzimatico.
NZ221627A (en) 1986-09-09 1993-04-28 Genencor Inc Preparation of enzymes, modifications, catalytic triads to alter ratios or transesterification/hydrolysis ratios
ATE125865T1 (de) 1987-08-28 1995-08-15 Novo Nordisk As Rekombinante humicola-lipase und verfahren zur herstellung von rekombinanten humicola-lipasen.
JPS6474992A (en) 1987-09-16 1989-03-20 Fuji Oil Co Ltd Dna sequence, plasmid and production of lipase
DK6488D0 (da) 1988-01-07 1988-01-07 Novo Industri As Enzymer
DE68924654T2 (de) 1988-01-07 1996-04-04 Novonordisk As Spezifische Protease.
JP3079276B2 (ja) 1988-02-28 2000-08-21 天野製薬株式会社 組換え体ｄｎａ、それを含むシュードモナス属菌及びそれを用いたリパーゼの製造法
WO1989009259A1 (en) 1988-03-24 1989-10-05 Novo-Nordisk A/S A cellulase preparation
US5776757A (en) 1988-03-24 1998-07-07 Novo Nordisk A/S Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase and method of making thereof
GB8915658D0 (en) 1989-07-07 1989-08-23 Unilever Plc Enzymes,their production and use
US5147796A (en) 1989-09-19 1992-09-15 Kao Corporation Alkaline pullulanase Y having α-amylase activity
DE59101948D1 (de) 1990-04-14 1994-07-21 Kali Chemie Ag Alkalische bacillus-lipasen, hierfür codierende dna-sequenzen sowie bacilli, die diese lipasen produzieren.
EP0531372B2 (de) 1990-05-09 2004-04-14 Novozymes A/S Eine ein endoglucanase enzym enthaltende zellulasezubereitung
DK115890D0 (da) 1990-05-09 1990-05-09 Novo Nordisk As Enzym
WO1992005249A1 (en) 1990-09-13 1992-04-02 Novo Nordisk A/S Lipase variants
EP0495257B1 (de) 1991-01-16 2002-06-12 The Procter & Gamble Company Kompakte Waschmittelzusammensetzungen mit hochaktiven Cellulasen
ES2085024T3 (es) 1991-04-30 1996-05-16 Procter & Gamble Detergentes liquidos reforzados con complejo de acido borico-poliol para inhibir la enzima proteolitica.
EP0511456A1 (de) 1991-04-30 1992-11-04 The Procter & Gamble Company Flüssiges Reinigungsmittel mit einem aromatischen Boratester zur Inhibierung des proteolytischen Enzyms
DE69226182T2 (de) 1991-05-01 1999-01-21 Novo Nordisk A/S, Bagsvaerd Stabilisierte enzyme und waschmittelzusammensetzungen
DK72992D0 (da) 1992-06-01 1992-06-01 Novo Nordisk As Enzym
DK88892D0 (da) 1992-07-06 1992-07-06 Novo Nordisk As Forbindelse
JP3678309B2 (ja) 1992-07-23 2005-08-03 ノボザイムス アクティーゼルスカブ 突然変異α−アミラーゼ、洗剤、皿洗い剤及び液化剤
ATE262035T1 (de) 1992-10-06 2004-04-15 Novozymes As Zellulosevarianten
DK0867504T4 (da) 1993-02-11 2011-08-29 Genencor Int Oxidativ stabil alfa-amylase
AU6107094A (en) 1993-02-19 1994-09-14 Novo Nordisk A/S An amylolytic enzyme
KR950702240A (ko) 1993-04-27 1995-06-19 한스 발터 라벤 세제로의 이용을 위한 새로운 리파제 변형체
DK52393D0 (de) 1993-05-05 1993-05-05 Novo Nordisk As
JP2859520B2 (ja) 1993-08-30 1999-02-17 ノボ ノルディスク アクティーゼルスカブ リパーゼ及びそれを生産する微生物及びリパーゼ製造方法及びリパーゼ含有洗剤組成物
US5830837A (en) 1994-11-22 1998-11-03 Novo Nordisk A/S Amylase variants
WO1995010603A1 (en) 1993-10-08 1995-04-20 Novo Nordisk A/S Amylase variants
CA2173946A1 (en) 1993-10-13 1995-04-20 Anders Hjelholt Pedersen H2o2-stable peroxidase variants
DK131193D0 (de) 1993-11-23 1993-11-23 Novo Nordisk As
JPH07143883A (ja) 1993-11-24 1995-06-06 Showa Denko Kk リパーゼ遺伝子及び変異体リパーゼ
MY111537A (en) 1994-02-02 2000-07-31 Novo Nordisk As A combined desizing and bleaching process.
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
ATE222604T1 (de) 1994-02-22 2002-09-15 Novozymes As Methode zur herstellung einer variante eines lipolytischen enzymes
DE69534513T2 (de) 1994-03-08 2006-07-27 Novozymes A/S Neuartige alkalische zellulasen
US5824531A (en) 1994-03-29 1998-10-20 Novid Nordisk Alkaline bacilus amylase
AU2524695A (en) 1994-05-04 1995-11-29 Genencor International, Inc. Lipases with improved surfactant resistance
AU2884595A (en) 1994-06-20 1996-01-15 Unilever Plc Modified pseudomonas lipases and their use
WO1996000292A1 (en) 1994-06-23 1996-01-04 Unilever N.V. Modified pseudomonas lipases and their use
DE4422198C2 (de) 1994-06-24 1997-08-28 Audi Ag Verfahren zum Steuern der elektrischen Beheizung eines Katalysators
EP1995303A3 (de) 1994-10-06 2008-12-31 Novozymes A/S Ein Enzympräparat mit Enduglucanase-Aktivität
BE1008998A3 (fr) 1994-10-14 1996-10-01 Solvay Lipase, microorganisme la produisant, procede de preparation de cette lipase et utilisations de celle-ci.
KR970707275A (ko) 1994-10-26 1997-12-01 안네 제케르 지질분해 활성을 갖는 효소(an enzyme with lipolytic activity)
AR000862A1 (es) * 1995-02-03 1997-08-06 Novozymes As Variantes de una ó-amilasa madre, un metodo para producir la misma, una estructura de adn y un vector de expresion, una celula transformada por dichaestructura de adn y vector, un aditivo para detergente, composicion detergente, una composicion para lavado de ropa y una composicion para la eliminacion del
JPH08228778A (ja) 1995-02-27 1996-09-10 Showa Denko Kk 新規なリパーゼ遺伝子及びそれを用いたリパーゼの製造方法
CN102080070B (zh) 1995-03-17 2016-01-20 诺沃奇梅兹有限公司 新的内切葡聚糖酶
JP3025627B2 (ja) 1995-06-14 2000-03-27 花王株式会社 液化型アルカリα−アミラーゼ遺伝子
DE69633825T2 (de) 1995-07-14 2005-11-10 Novozymes A/S Modifiziertes enzym mit lipolytischer aktivität
JP4068142B2 (ja) 1995-08-11 2008-03-26 ノボザイムス アクティーゼルスカブ 新規の脂肪分解酵素
JP2000505502A (ja) * 1996-03-07 2000-05-09 ザ、プロクター、エンド、ギャンブル、カンパニー 改良アミラーゼを含んでなる洗剤組成物
US5763385A (en) 1996-05-14 1998-06-09 Genencor International, Inc. Modified α-amylases having altered calcium binding properties
CN1229428A (zh) * 1996-08-01 1999-09-22 普罗格特-甘布尔公司 用于清洗污秽织物的包含改进的淀粉酶的洗涤剂组合物
AU3938997A (en) 1996-08-26 1998-03-19 Novo Nordisk A/S A novel endoglucanase
EP1726644A1 (de) 1996-09-17 2006-11-29 Novozymes A/S Zellulase Varianten
CA2265734A1 (en) 1996-10-08 1998-04-16 Novo Nordisk A/S Diaminobenzoic acid derivatives as dye precursors
DE69739020D1 (de) 1996-11-04 2008-11-13 Novozymes As Subtilase varianten und verbindungen
KR100561826B1 (ko) 1996-11-04 2006-03-16 노보자임스 에이/에스 섭틸라제 변종과 조성물
WO1998034946A1 (en) 1997-02-12 1998-08-13 Massachusetts Institute Of Technology Daxx, a novel fas-binding protein that activates jnk and apoptosis
KR20010015754A (ko) * 1997-10-13 2001-02-26 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 α-아밀라제 변이체
CA2308119C (en) * 1997-10-30 2014-06-03 Novo Nordisk A/S .alpha.-amylase mutants

Also Published As

Publication number Publication date
AU781258B2 (en) 2005-05-12
EP2011864A1 (de) 2009-01-07
EP2889375A1 (de) 2015-07-01
JP2002540786A (ja) 2002-12-03
MXPA01009706A (es) 2002-05-14
EP1173554A2 (de) 2002-01-23
EP2889375B1 (de) 2019-03-20
CA2365446C (en) 2012-07-10
AU3419400A (en) 2000-10-23
KR100787392B1 (ko) 2007-12-21
CN1234854C (zh) 2006-01-04
DK2011864T3 (en) 2015-04-07
JP4745503B2 (ja) 2011-08-10
BR0009392A (pt) 2002-01-08
AR023229A1 (es) 2002-09-04
CN1367824A (zh) 2002-09-04
WO2000060060A2 (en) 2000-10-12
KR20020002415A (ko) 2002-01-09
BR0009392B1 (pt) 2012-06-12
ES2532606T3 (es) 2015-03-30
WO2000060060A3 (en) 2001-04-19
CA2365446A1 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
EP2011864B1 (de) Polypeptide mit Alkalin-Alpha-Amylase-Aktivität und Nukleinsäuren, die diese codieren
EP1169434B1 (de) Polypeptide mit alkaliner alpha-amylase-aktivität und für diese kodierende nukleinsäuren
US8263368B2 (en) Alpha-amylase mutants
US6309871B1 (en) Polypeptides having alkaline α-amylase activity
US10563186B2 (en) Alpha-amylase variants with altered properties
AU2004252572B2 (en) Polypeptides having alpha-amylase activity and polypeptides encoding same
US7833771B2 (en) Polypeptides having alpha-amylase activity and polynucleotides encoding same
US20080153733A1 (en) Alpha-Amylase Variant With Altered Properties
US20090275078A1 (en) Alpha-Amylase Variants
WO2001064852A1 (en) Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same
EP2414515A2 (de) Reinigungssystem mit einer alpha-amylase und einer protease
US6623948B1 (en) Nucleic acid sequences encoding alkaline alpha-amylases
EP1975229A2 (de) Alpha-Amylase-Variante mit veränderten Eigenschaften

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080725

AC Divisional application: reference to earlier application

Ref document number: 1173554

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17Q First examination report despatched

Effective date: 20090706

AKX Designation fees paid

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20140722

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AC Divisional application: reference to earlier application

Ref document number: 1173554

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: GB

Ref legal event code: FG4D

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HOECK, LISBETH HEDEGAARD

Inventor name: SVENDSEN, ALLAN

Inventor name: NIELSEN, BJARNE RONFELDT

Inventor name: OUTTRUP, HELLE

Inventor name: ANDERSEN, CARSTEN

Inventor name: BISGARD-FRANTZEN, HENRIK

Inventor name: NIELSEN, VIBEKE SKOVGAARD

Inventor name: BORCHERT, TORBEN VEDEL

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 704430

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 60048826

Country of ref document: DE

Effective date: 20150219

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2532606

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20150330

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20150401

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20150219

Year of fee payment: 16

Ref country code: ES

Payment date: 20150227

Year of fee payment: 16

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141231

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150401

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 704430

Country of ref document: AT

Kind code of ref document: T

Effective date: 20141231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141231

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 60048826

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141231

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150328

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20151001

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150331

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150331

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150328

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160328

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FI

Payment date: 20170309

Year of fee payment: 18

Ref country code: FR

Payment date: 20170213

Year of fee payment: 18

Ref country code: NL

Payment date: 20170320

Year of fee payment: 18

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20170428

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20170328

Year of fee payment: 18

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20141231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150501

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160329

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

Effective date: 20180331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180328

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20180401

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180401

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180331

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20190327

Year of fee payment: 20

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180331

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20190327

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20190404

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 60048826

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20200327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20200327

REG Reference to a national code

Ref country code: BE

Ref legal event code: MK

Effective date: 20200328